Gene |
Phenotype |
Probability |
Known |
Training |
FDR |
BLK
|
abnormal igm level
|
0.89 |
false |
true |
1.0 |
BLK
|
abnormal mature b cell morphology
|
0.88 |
false |
true |
1.0 |
LCK
|
decreased t cell number
|
0.88 |
true |
true |
0.67 |
MS4A1
|
abnormal mature b cell morphology
|
0.87 |
true |
true |
0.5 |
BLK
|
abnormal b cell differentiation
|
0.87 |
false |
true |
0.6 |
CD3D
|
abnormal effector t cell morphology
|
0.86 |
true |
true |
0.5 |
CD3D
|
abnormal alpha-beta t cell number
|
0.86 |
true |
true |
0.43 |
HOXB6
|
abnormal presacral vertebrae morphology
|
0.86 |
true |
true |
0.38 |
CD3D
|
decreased alpha-beta t cell number
|
0.86 |
true |
true |
0.33 |
CD3D
|
abnormal alpha-beta t cell morphology
|
0.86 |
true |
true |
0.3 |
LCK
|
abnormal effector t cell morphology
|
0.86 |
true |
true |
0.27 |
LCK
|
abnormal alpha-beta t cell number
|
0.86 |
true |
true |
0.25 |
LCK
|
abnormal alpha-beta t cell morphology
|
0.86 |
true |
true |
0.23 |
LCK
|
abnormal cd8-positive, alpha beta t cell morphology
|
0.85 |
true |
true |
0.21 |
MS4A1
|
abnormal igm level
|
0.85 |
false |
true |
0.27 |
CD19
|
abnormal mature b cell morphology
|
0.85 |
true |
true |
0.25 |
LCK
|
abnormal cd8-positive, alpha-beta t cell number
|
0.84 |
true |
true |
0.24 |
CD2
|
abnormal alpha-beta t cell morphology
|
0.84 |
false |
true |
0.28 |
LCK
|
decreased alpha-beta t cell number
|
0.84 |
true |
true |
0.26 |
CD79A
|
abnormal immunoglobulin level
|
0.84 |
true |
true |
0.25 |
CD2
|
abnormal alpha-beta t cell number
|
0.84 |
false |
true |
0.29 |
MS4A1
|
abnormal b cell differentiation
|
0.84 |
true |
true |
0.27 |
CD79A
|
abnormal mature b cell morphology
|
0.84 |
true |
true |
0.26 |
CD3D
|
abnormal cd8-positive, alpha beta t cell morphology
|
0.83 |
true |
true |
0.25 |
CD79A
|
abnormal igm level
|
0.83 |
true |
true |
0.24 |
CD2
|
abnormal effector t cell morphology
|
0.83 |
false |
true |
0.27 |
LCK
|
abnormal t cell differentiation
|
0.83 |
true |
true |
0.26 |
CD79A
|
abnormal b cell differentiation
|
0.83 |
true |
true |
0.25 |
CD79A
|
abnormal igg level
|
0.83 |
true |
true |
0.24 |
LCK
|
abnormal cd4-positive, alpha beta t cell morphology
|
0.83 |
true |
true |
0.23 |
LCK
|
abnormal t cell number
|
0.83 |
true |
true |
0.23 |
CD3D
|
abnormal cd4-positive, alpha beta t cell morphology
|
0.82 |
true |
true |
0.22 |
BLK
|
decreased mature b cell number
|
0.82 |
false |
true |
0.24 |
MS4A1
|
abnormal immunoglobulin level
|
0.82 |
false |
true |
0.26 |
NR1H4
|
abnormal thyroid hormone level
|
0.82 |
false |
true |
0.29 |
CD79A
|
abnormal b cell physiology
|
0.82 |
true |
true |
0.28 |
CD3D
|
abnormal cd8-positive, alpha-beta t cell number
|
0.82 |
true |
true |
0.27 |
CD79A
|
abnormal humoral immune response
|
0.82 |
true |
true |
0.26 |
CD19
|
abnormal b cell differentiation
|
0.82 |
true |
true |
0.26 |
BLK
|
abnormal igg level
|
0.81 |
false |
true |
0.28 |
CD2
|
abnormal cd8-positive, alpha beta t cell morphology
|
0.81 |
false |
true |
0.29 |
BLK
|
abnormal immunoglobulin level
|
0.81 |
false |
true |
0.31 |
LCK
|
abnormal cd4-positive, alpha beta t cell number
|
0.81 |
true |
true |
0.3 |
CD2
|
decreased alpha-beta t cell number
|
0.81 |
false |
true |
0.32 |
MS4A1
|
abnormal igg level
|
0.81 |
false |
true |
0.33 |
NR1H4
|
abnormal thyroxine level
|
0.81 |
false |
true |
0.35 |
LCK
|
abnormal t cell morphology
|
0.8 |
true |
true |
0.34 |
CD3D
|
abnormal cd4-positive, alpha beta t cell number
|
0.8 |
true |
true |
0.33 |
HOXB6
|
abnormal thoracic cage morphology
|
0.8 |
true |
true |
0.33 |
CCR7
|
abnormal immunoglobulin level
|
0.8 |
true |
true |
0.32 |
BLK
|
abnormal b cell physiology
|
0.8 |
false |
true |
0.33 |
CD3G
|
abnormal effector t cell morphology
|
0.8 |
true |
true |
0.33 |
MS4A1
|
abnormal b cell physiology
|
0.8 |
true |
true |
0.32 |
NFKB1
|
abnormal b cell activation
|
0.8 |
true |
true |
0.31 |
CD2
|
abnormal cd8-positive, alpha-beta t cell number
|
0.8 |
false |
true |
0.33 |
CD3G
|
decreased alpha-beta t cell number
|
0.8 |
true |
true |
0.32 |
MS4A1
|
abnormal humoral immune response
|
0.8 |
false |
true |
0.33 |
CD3G
|
abnormal alpha-beta t cell morphology
|
0.79 |
true |
true |
0.33 |
CD3G
|
abnormal alpha-beta t cell number
|
0.79 |
true |
true |
0.32 |
CD79A
|
decreased igg level
|
0.79 |
true |
true |
0.32 |
CD19
|
abnormal igm level
|
0.79 |
true |
true |
0.31 |
CCR7
|
abnormal b cell physiology
|
0.79 |
true |
true |
0.31 |
NFKB1
|
abnormal b cell proliferation
|
0.79 |
true |
true |
0.3 |
CD2
|
abnormal cd4-positive, alpha beta t cell number
|
0.79 |
false |
true |
0.31 |
CD2
|
abnormal cd4-positive, alpha beta t cell morphology
|
0.79 |
false |
true |
0.32 |
CD3G
|
abnormal cd8-positive, alpha beta t cell morphology
|
0.79 |
true |
true |
0.32 |
CD3D
|
decreased cd4-positive, alpha beta t cell number
|
0.79 |
true |
true |
0.31 |
NR1H4
|
abnormal circulating thyroxine level
|
0.79 |
false |
true |
0.32 |
CD79A
|
decreased immunoglobulin level
|
0.78 |
true |
true |
0.32 |
CD3D
|
abnormal t cell differentiation
|
0.78 |
true |
true |
0.31 |
IFNG
|
altered susceptibility to parasitic infection
|
0.78 |
true |
true |
0.31 |
CCL5
|
altered susceptibility to autoimmune disorder
|
0.78 |
false |
true |
0.32 |
CD2
|
abnormal t cell number
|
0.78 |
false |
true |
0.33 |
BLK
|
abnormal b cell activation
|
0.78 |
false |
true |
0.34 |
CCR7
|
abnormal humoral immune response
|
0.78 |
true |
true |
0.33 |
CD3D
|
decreased t cell number
|
0.78 |
true |
true |
0.33 |
BLK
|
abnormal humoral immune response
|
0.78 |
false |
true |
0.34 |
ZAP70
|
abnormal effector t cell morphology
|
0.78 |
true |
true |
0.33 |
MS4A1
|
decreased mature b cell number
|
0.78 |
true |
true |
0.33 |
CD2
|
decreased t cell number
|
0.78 |
false |
true |
0.34 |
BLK
|
decreased igg level
|
0.78 |
false |
true |
0.35 |
HOXB6
|
abnormal vertebrae morphology
|
0.77 |
true |
true |
0.34 |
ITK
|
abnormal effector t cell morphology
|
0.77 |
true |
true |
0.34 |
MS4A1
|
abnormal b cell activation
|
0.77 |
false |
true |
0.35 |
CD3D
|
decreased cd8-positive, alpha-beta t cell number
|
0.77 |
true |
true |
0.34 |
CD19
|
decreased mature b cell number
|
0.77 |
true |
true |
0.34 |
ITK
|
abnormal cd8-positive, alpha beta t cell morphology
|
0.77 |
true |
true |
0.33 |
ZAP70
|
abnormal alpha-beta t cell number
|
0.77 |
true |
true |
0.33 |
CD79A
|
decreased mature b cell number
|
0.77 |
true |
true |
0.33 |
HOXB6
|
vertebral transformation
|
0.77 |
true |
true |
0.32 |
CD79B
|
abnormal mature b cell morphology
|
0.77 |
true |
true |
0.32 |
CD3G
|
abnormal cd4-positive, alpha beta t cell morphology
|
0.77 |
false |
true |
0.33 |
CCR1
|
abnormal innate immunity
|
0.77 |
true |
true |
0.32 |
BLK
|
decreased immunoglobulin level
|
0.77 |
false |
true |
0.33 |
ZAP70
|
abnormal alpha-beta t cell morphology
|
0.76 |
true |
true |
0.33 |
CCR7
|
abnormal igg level
|
0.76 |
true |
true |
0.32 |
CD3G
|
abnormal cd8-positive, alpha-beta t cell number
|
0.76 |
true |
true |
0.32 |
CD19
|
abnormal b cell number
|
0.76 |
true |
true |
0.32 |
IL10
|
abnormal interferon-gamma secretion
|
0.76 |
true |
true |
0.31 |
CCL5
|
abnormal t cell physiology
|
0.76 |
true |
true |
0.31 |
IFNG
|
increased susceptibility to infection
|
0.76 |
true |
true |
0.31 |
BLK
|
abnormal spleen white pulp morphology
|
0.76 |
false |
true |
0.31 |
ZAP70
|
abnormal cd4-positive, alpha beta t cell morphology
|
0.76 |
true |
true |
0.31 |
NR1H4
|
decreased circulating levels of thyroid hormone
|
0.76 |
false |
true |
0.32 |
ITK
|
abnormal cd8-positive, alpha-beta t cell number
|
0.76 |
true |
true |
0.31 |
CD79A
|
abnormal b cell activation
|
0.76 |
true |
true |
0.31 |
NR1H4
|
decreased thyroxine level
|
0.76 |
false |
true |
0.32 |
HOXB6
|
abnormal cervical vertebrae morphology
|
0.76 |
true |
true |
0.31 |
CCL5
|
abnormal interferon-gamma secretion
|
0.75 |
true |
true |
0.31 |
CD79B
|
abnormal immunoglobulin level
|
0.75 |
true |
true |
0.31 |
CD79B
|
abnormal b cell differentiation
|
0.75 |
true |
true |
0.31 |
LCK
|
abnormal lymphopoiesis
|
0.75 |
true |
true |
0.3 |
CCL5
|
abnormal self tolerance
|
0.75 |
false |
true |
0.31 |
BLK
|
abnormal b cell morphology
|
0.75 |
false |
true |
0.32 |
CCL5
|
autoimmune response
|
0.75 |
false |
true |
0.32 |
ZAP70
|
abnormal cd8-positive, alpha beta t cell morphology
|
0.75 |
true |
true |
0.32 |
CD79B
|
abnormal igm level
|
0.75 |
true |
true |
0.32 |
MS4A1
|
decreased igg level
|
0.75 |
false |
true |
0.32 |
CD19
|
abnormal igg level
|
0.75 |
true |
true |
0.32 |
BLK
|
abnormal b cell proliferation
|
0.75 |
false |
true |
0.33 |
CCL5
|
abnormal immune tolerance
|
0.75 |
false |
true |
0.33 |
ITK
|
abnormal alpha-beta t cell number
|
0.75 |
true |
true |
0.33 |
CD19
|
abnormal immunoglobulin level
|
0.75 |
true |
true |
0.33 |
ITK
|
abnormal alpha-beta t cell morphology
|
0.75 |
true |
true |
0.32 |
LCK
|
decreased cd4-positive, alpha beta t cell number
|
0.75 |
true |
true |
0.32 |
MS4A1
|
decreased immunoglobulin level
|
0.75 |
false |
true |
0.33 |
IL10
|
abnormal interferon secretion
|
0.75 |
true |
true |
0.32 |
ITK
|
abnormal t cell differentiation
|
0.75 |
true |
true |
0.32 |
HOXB5
|
abnormal presacral vertebrae morphology
|
0.75 |
true |
true |
0.32 |
CD3E
|
abnormal cd8-positive, alpha beta t cell morphology
|
0.75 |
true |
true |
0.32 |
CD3E
|
decreased alpha-beta t cell number
|
0.74 |
true |
true |
0.31 |
ZAP70
|
abnormal cd4-positive, alpha beta t cell number
|
0.74 |
true |
true |
0.31 |
NR1I3
|
abnormal thyroid hormone level
|
0.74 |
true |
true |
0.31 |
LCK
|
abnormal t cell physiology
|
0.74 |
true |
true |
0.31 |
MS4A1
|
abnormal spleen white pulp morphology
|
0.74 |
false |
true |
0.31 |
CD19
|
abnormal b cell morphology
|
0.74 |
true |
true |
0.31 |
NR1H4
|
decreased circulating thyroxine level
|
0.74 |
false |
true |
0.31 |
BLK
|
abnormal b cell number
|
0.74 |
false |
true |
0.32 |
PTPRC
|
abnormal cd4-positive, alpha beta t cell morphology
|
0.74 |
true |
true |
0.32 |
ITK
|
abnormal cd4-positive, alpha beta t cell morphology
|
0.74 |
true |
true |
0.31 |
LCK
|
decreased cd8-positive, alpha-beta t cell number
|
0.74 |
true |
true |
0.31 |
CD3G
|
abnormal cd4-positive, alpha beta t cell number
|
0.74 |
false |
true |
0.32 |
CCR1
|
abnormal cytokine secretion
|
0.74 |
true |
true |
0.31 |
CD3E
|
abnormal effector t cell morphology
|
0.74 |
true |
true |
0.31 |
ZAP70
|
abnormal cd8-positive, alpha-beta t cell number
|
0.74 |
true |
true |
0.31 |
HOXB6
|
abnormal rib morphology
|
0.74 |
true |
true |
0.31 |
CD19
|
abnormal b cell physiology
|
0.74 |
true |
true |
0.31 |
CD79A
|
abnormal b cell proliferation
|
0.73 |
true |
true |
0.3 |
CD79B
|
abnormal igg level
|
0.73 |
true |
true |
0.3 |
ZAP70
|
abnormal t cell differentiation
|
0.73 |
true |
true |
0.3 |
NFKB1
|
abnormal spleen white pulp morphology
|
0.73 |
true |
true |
0.3 |
CD79B
|
abnormal humoral immune response
|
0.73 |
true |
true |
0.3 |
CXCR4
|
abnormal lymphopoiesis
|
0.73 |
true |
true |
0.29 |
IRF1
|
abnormal t cell physiology
|
0.73 |
true |
true |
0.29 |
NFKB1
|
abnormal b cell differentiation
|
0.73 |
true |
true |
0.29 |
IL15
|
altered susceptibility to infection induced morbidity/mortality
|
0.73 |
true |
true |
0.29 |
IFNG
|
abnormal t cell physiology
|
0.73 |
true |
true |
0.29 |
ITK
|
decreased alpha-beta t cell number
|
0.73 |
true |
true |
0.28 |
CD79B
|
abnormal b cell physiology
|
0.73 |
true |
true |
0.28 |
HOXB5
|
abnormal cervical vertebrae morphology
|
0.73 |
true |
true |
0.28 |
CD3D
|
abnormal t cell physiology
|
0.73 |
false |
true |
0.29 |
PTPRC
|
abnormal effector t cell morphology
|
0.73 |
true |
true |
0.28 |
IL15
|
abnormal immunoglobulin level
|
0.73 |
true |
true |
0.28 |
HOXB6
|
abnormal sternum morphology
|
0.73 |
false |
true |
0.29 |
MS4A1
|
abnormal b cell proliferation
|
0.73 |
false |
true |
0.29 |
CD3D
|
abnormal t cell number
|
0.73 |
true |
true |
0.29 |
CD19
|
abnormal humoral immune response
|
0.73 |
true |
true |
0.29 |
CD79A
|
abnormal b cell morphology
|
0.73 |
true |
true |
0.29 |
CD2
|
abnormal t cell morphology
|
0.73 |
false |
true |
0.29 |
LCK
|
abnormal t cell activation
|
0.72 |
true |
true |
0.29 |
CD3E
|
abnormal alpha-beta t cell morphology
|
0.72 |
true |
true |
0.29 |
CD3E
|
abnormal cd8-positive, alpha-beta t cell number
|
0.72 |
true |
true |
0.28 |
CD3E
|
abnormal alpha-beta t cell number
|
0.72 |
true |
true |
0.28 |
NR1H4
|
abnormal triiodothyronine level
|
0.72 |
false |
true |
0.29 |
MS4A1
|
abnormal igg1 level
|
0.72 |
false |
true |
0.29 |
CCL5
|
abnormal interferon secretion
|
0.72 |
true |
true |
0.29 |
CD19
|
abnormal immature b cell morphology
|
0.72 |
false |
true |
0.29 |
CD19
|
abnormal b cell activation
|
0.72 |
true |
true |
0.29 |
HOXB5
|
abnormal thoracic cage morphology
|
0.72 |
true |
true |
0.29 |
HOXB6
|
abnormal pectoral girdle bone morphology
|
0.72 |
false |
true |
0.29 |
CD37
|
abnormal igg level
|
0.72 |
true |
true |
0.29 |
BLK
|
decreased b cell number
|
0.72 |
false |
true |
0.3 |
PTPRC
|
abnormal t cell physiology
|
0.72 |
true |
true |
0.3 |
MS4A1
|
abnormal b cell morphology
|
0.72 |
true |
true |
0.29 |
IL15
|
abnormal b cell physiology
|
0.72 |
true |
true |
0.29 |
CD79A
|
abnormal igg1 level
|
0.72 |
true |
true |
0.29 |
CD79B
|
abnormal b cell activation
|
0.72 |
true |
true |
0.29 |
CD2
|
increased t cell number
|
0.72 |
false |
true |
0.29 |
CD3G
|
abnormal t cell differentiation
|
0.72 |
true |
true |
0.29 |
NR1I3
|
abnormal thyroxine level
|
0.72 |
true |
true |
0.29 |
CCR1
|
abnormal macrophage physiology
|
0.72 |
true |
true |
0.29 |
ITK
|
abnormal cd4-positive, alpha beta t cell number
|
0.72 |
true |
true |
0.29 |
PTPRC
|
abnormal alpha-beta t cell morphology
|
0.72 |
true |
true |
0.28 |
LCK
|
abnormal t cell proliferation
|
0.72 |
true |
true |
0.28 |
CCR1
|
decreased inflammatory response
|
0.72 |
true |
true |
0.28 |
CCR1
|
altered susceptibility to infection
|
0.72 |
true |
true |
0.28 |
PTPN7
|
abnormal t cell differentiation
|
0.72 |
false |
true |
0.28 |
CD37
|
abnormal immunoglobulin level
|
0.72 |
true |
true |
0.28 |
CD2
|
decreased cd4-positive, alpha beta t cell number
|
0.72 |
false |
true |
0.29 |
CCL5
|
abnormal acute inflammation
|
0.72 |
true |
true |
0.29 |
BLK
|
abnormal igg1 level
|
0.72 |
false |
true |
0.29 |
LCK
|
increased t cell number
|
0.72 |
false |
true |
0.29 |
PTPRC
|
abnormal response to infection
|
0.72 |
true |
true |
0.29 |
CCR7
|
increased immunoglobulin level
|
0.72 |
true |
true |
0.29 |
ZAP70
|
increased t cell number
|
0.72 |
true |
true |
0.29 |
CD3G
|
decreased t cell number
|
0.72 |
true |
true |
0.29 |
CD79B
|
decreased mature b cell number
|
0.71 |
true |
true |
0.29 |
CD79B
|
decreased immunoglobulin level
|
0.71 |
true |
true |
0.28 |
IL2RG
|
abnormal t cell activation
|
0.71 |
true |
true |
0.28 |
PTPRC
|
abnormal alpha-beta t cell number
|
0.71 |
true |
true |
0.28 |
LCK
|
decreased lymphocyte cell number
|
0.71 |
true |
true |
0.28 |
PTPRC
|
abnormal cd4-positive, alpha beta t cell number
|
0.71 |
true |
true |
0.28 |
MS4A1
|
abnormal b cell number
|
0.71 |
true |
true |
0.28 |
IFNG
|
altered susceptibility to infection
|
0.71 |
true |
true |
0.28 |
CCR1
|
abnormal hypersensitivity reaction
|
0.71 |
true |
true |
0.27 |
CD3D
|
abnormal t cell morphology
|
0.71 |
true |
true |
0.27 |
ZAP70
|
abnormal t cell number
|
0.71 |
true |
true |
0.27 |
CXCR4
|
abnormal immunoglobulin level
|
0.71 |
true |
true |
0.27 |
CD19
|
decreased b cell number
|
0.71 |
true |
true |
0.27 |
CD19
|
increased b cell number
|
0.71 |
false |
true |
0.27 |
CD79A
|
abnormal b cell number
|
0.71 |
true |
true |
0.27 |
IL6
|
increased susceptibility to infection
|
0.71 |
true |
true |
0.27 |
IFNG
|
abnormal response to infection
|
0.71 |
true |
true |
0.27 |
CD19
|
abnormal b cell proliferation
|
0.71 |
true |
true |
0.27 |
CCR1
|
abnormal response to infection
|
0.71 |
true |
true |
0.27 |
CXCR4
|
abnormal leukopoiesis
|
0.71 |
true |
true |
0.27 |
SH2D1A
|
abnormal alpha-beta t cell morphology
|
0.71 |
true |
true |
0.26 |
SH2D1A
|
abnormal alpha-beta t cell number
|
0.71 |
true |
true |
0.26 |
LCK
|
abnormal leukopoiesis
|
0.71 |
true |
true |
0.26 |
SH2D1A
|
decreased alpha-beta t cell number
|
0.71 |
true |
true |
0.26 |
CD37
|
abnormal mature b cell morphology
|
0.71 |
false |
true |
0.26 |
CCR7
|
abnormal professional antigen presenting cell physiology
|
0.71 |
true |
true |
0.26 |
CD3E
|
decreased t cell number
|
0.71 |
true |
true |
0.26 |
IFNG
|
increased susceptibility to parasitic infection
|
0.71 |
true |
true |
0.26 |
PTPRC
|
abnormal immunoglobulin level
|
0.71 |
true |
true |
0.26 |
PTPRC
|
abnormal professional antigen presenting cell physiology
|
0.71 |
true |
true |
0.26 |
CD3G
|
decreased cd8-positive, alpha-beta t cell number
|
0.71 |
true |
true |
0.26 |
PTPRC
|
decreased alpha-beta t cell number
|
0.71 |
true |
true |
0.26 |
CD37
|
abnormal b cell physiology
|
0.71 |
true |
true |
0.26 |
CXCR4
|
abnormal b cell physiology
|
0.71 |
true |
true |
0.25 |
BLK
|
abnormal marginal zone b cell morphology
|
0.71 |
false |
true |
0.26 |
CXCR4
|
abnormal b cell morphology
|
0.71 |
true |
true |
0.26 |
PTPN7
|
abnormal t cell number
|
0.71 |
false |
true |
0.26 |
CCR1
|
abnormal interleukin secretion
|
0.7 |
true |
true |
0.26 |
HOXA5
|
abnormal presacral vertebrae morphology
|
0.7 |
true |
true |
0.26 |
IL15
|
abnormal cytokine secretion
|
0.7 |
true |
true |
0.26 |
PTPRC
|
abnormal b cell physiology
|
0.7 |
true |
true |
0.26 |
IL6
|
increased susceptibility to infection induced morbidity/mortality
|
0.7 |
true |
true |
0.25 |
CD3G
|
decreased cd4-positive, alpha beta t cell number
|
0.7 |
false |
true |
0.26 |
PTPN7
|
decreased t cell number
|
0.7 |
false |
true |
0.26 |
CD2
|
decreased cd8-positive, alpha-beta t cell number
|
0.7 |
false |
true |
0.26 |
NR1I3
|
abnormal circulating thyroxine level
|
0.7 |
false |
true |
0.27 |
NFKB1
|
abnormal mature b cell morphology
|
0.7 |
true |
true |
0.26 |
IL15
|
increased susceptibility to infection
|
0.7 |
true |
true |
0.26 |
CXCR4
|
abnormal cd4-positive, alpha beta t cell morphology
|
0.7 |
true |
true |
0.26 |
CXCR5
|
abnormal immunoglobulin level
|
0.7 |
false |
true |
0.27 |
SH2D1A
|
abnormal effector t cell morphology
|
0.7 |
true |
true |
0.26 |
IL2RG
|
abnormal t cell proliferation
|
0.7 |
true |
true |
0.26 |
IL15
|
abnormal igg level
|
0.7 |
true |
true |
0.26 |
CD6
|
abnormal effector t cell morphology
|
0.7 |
false |
false |
0.26 |
NFKB1
|
abnormal lymphopoiesis
|
0.7 |
true |
true |
0.26 |
CCR1
|
abnormal acute inflammation
|
0.7 |
true |
true |
0.26 |
TNFSF10
|
abnormal cytokine secretion
|
0.7 |
true |
true |
0.26 |
CXCR5
|
abnormal b cell physiology
|
0.7 |
false |
true |
0.26 |
CCR7
|
abnormal b cell differentiation
|
0.7 |
true |
true |
0.26 |
ITK
|
decreased t cell number
|
0.7 |
true |
true |
0.26 |
IL10RA
|
abnormal t cell physiology
|
0.7 |
false |
true |
0.26 |
IL15
|
abnormal humoral immune response
|
0.7 |
true |
true |
0.26 |
BLK
|
abnormal spleen marginal zone morphology
|
0.7 |
false |
true |
0.26 |
PTPRC
|
abnormal lymphocyte physiology
|
0.7 |
true |
true |
0.26 |
IL15
|
abnormal professional antigen presenting cell physiology
|
0.7 |
true |
true |
0.26 |
CCL5
|
decreased inflammatory response
|
0.7 |
true |
true |
0.26 |
CD79B
|
decreased igg level
|
0.7 |
true |
true |
0.26 |
IL15
|
abnormal response to infection
|
0.7 |
true |
true |
0.26 |
HOXB5
|
vertebral transformation
|
0.7 |
true |
true |
0.26 |
CXCR4
|
abnormal b cell number
|
0.7 |
true |
true |
0.26 |
CD37
|
abnormal b cell differentiation
|
0.7 |
true |
true |
0.26 |
ITK
|
abnormal t cell activation
|
0.7 |
true |
true |
0.26 |
IL10
|
increased susceptibility to infection
|
0.7 |
true |
true |
0.26 |
ZAP70
|
abnormal t cell morphology
|
0.7 |
true |
true |
0.25 |
PTPN7
|
abnormal effector t cell morphology
|
0.7 |
false |
true |
0.26 |
HOXA3
|
abnormal presacral vertebrae morphology
|
0.7 |
true |
true |
0.26 |
PTPN7
|
abnormal t cell morphology
|
0.69 |
false |
true |
0.26 |
IL2RB
|
abnormal effector t cell morphology
|
0.69 |
true |
true |
0.26 |
SH2D1A
|
abnormal cd8-positive, alpha beta t cell morphology
|
0.69 |
true |
true |
0.26 |
IFNG
|
altered susceptibility to autoimmune disorder
|
0.69 |
true |
true |
0.26 |
CCL5
|
decreased acute inflammation
|
0.69 |
true |
true |
0.26 |
CD79B
|
abnormal b cell proliferation
|
0.69 |
true |
true |
0.25 |
IL15
|
abnormal lymphocyte physiology
|
0.69 |
true |
true |
0.25 |
PTPN7
|
abnormal lymphopoiesis
|
0.69 |
false |
true |
0.26 |
CCL5
|
abnormal t cell differentiation
|
0.69 |
true |
true |
0.26 |
IRF1
|
abnormal response to infection
|
0.69 |
true |
true |
0.25 |
CXCR4
|
abnormal humoral immune response
|
0.69 |
true |
true |
0.25 |
CD3E
|
abnormal t cell differentiation
|
0.69 |
true |
true |
0.25 |
CD37
|
abnormal humoral immune response
|
0.69 |
true |
true |
0.25 |
ZAP70
|
decreased t cell number
|
0.69 |
true |
true |
0.25 |
CCL5
|
abnormal lymphocyte physiology
|
0.69 |
true |
true |
0.25 |
CD6
|
abnormal t cell differentiation
|
0.69 |
false |
false |
0.25 |
NFKB1
|
abnormal spleen marginal zone morphology
|
0.69 |
true |
true |
0.25 |
ZAP70
|
decreased alpha-beta t cell number
|
0.69 |
true |
true |
0.25 |
CD19
|
abnormal b-1 b cell number
|
0.69 |
true |
true |
0.25 |
CD19
|
abnormal b-1 b cell morphology
|
0.69 |
true |
true |
0.25 |
HOXA5
|
abnormal thoracic cage morphology
|
0.69 |
true |
true |
0.25 |
CD6
|
abnormal alpha-beta t cell number
|
0.69 |
false |
false |
0.25 |
PTPN7
|
abnormal alpha-beta t cell number
|
0.69 |
false |
true |
0.25 |
PTPN7
|
abnormal alpha-beta t cell morphology
|
0.69 |
false |
true |
0.25 |
CXCR5
|
abnormal humoral immune response
|
0.69 |
false |
true |
0.25 |
PTPRC
|
decreased t cell number
|
0.69 |
true |
true |
0.25 |
IL15
|
altered susceptibility to infection
|
0.69 |
true |
true |
0.25 |
NFKB1
|
abnormal b cell physiology
|
0.69 |
true |
true |
0.25 |
CXCR4
|
abnormal b cell differentiation
|
0.69 |
true |
true |
0.25 |
CCR7
|
autoimmune response
|
0.69 |
true |
true |
0.25 |
POU2AF1
|
abnormal b cell differentiation
|
0.69 |
true |
true |
0.25 |
CCR7
|
abnormal self tolerance
|
0.69 |
true |
true |
0.25 |
CD3E
|
decreased cd8-positive, alpha-beta t cell number
|
0.69 |
true |
true |
0.25 |
IL2RG
|
abnormal t cell physiology
|
0.69 |
true |
true |
0.25 |
CD37
|
abnormal igm level
|
0.69 |
false |
true |
0.25 |
CCR7
|
abnormal lymphopoiesis
|
0.69 |
true |
true |
0.25 |
CCR7
|
abnormal b cell morphology
|
0.69 |
true |
true |
0.25 |
CCR7
|
abnormal immune tolerance
|
0.69 |
true |
true |
0.25 |
CD3D
|
abnormal double-positive t cell morphology
|
0.69 |
false |
true |
0.25 |
CXCR4
|
abnormal effector t cell morphology
|
0.69 |
true |
true |
0.25 |
CD6
|
abnormal alpha-beta t cell morphology
|
0.69 |
false |
false |
0.25 |
IL10
|
abnormal response to infection
|
0.69 |
true |
true |
0.25 |
CCR1
|
abnormal interferon secretion
|
0.69 |
true |
true |
0.25 |
CXCR4
|
abnormal t cell differentiation
|
0.69 |
true |
true |
0.25 |
IRF1
|
increased susceptibility to infection
|
0.69 |
true |
true |
0.24 |
PTPRC
|
abnormal humoral immune response
|
0.69 |
true |
true |
0.24 |
PTPN7
|
abnormal leukopoiesis
|
0.68 |
false |
true |
0.25 |
CD6
|
abnormal cd4-positive, alpha beta t cell morphology
|
0.68 |
false |
false |
0.25 |
NFKB1
|
decreased b cell proliferation
|
0.68 |
true |
true |
0.25 |
PTPN7
|
abnormal cd4-positive, alpha beta t cell morphology
|
0.68 |
false |
true |
0.25 |
ITK
|
abnormal t cell morphology
|
0.68 |
true |
true |
0.25 |
ITK
|
abnormal t cell proliferation
|
0.68 |
true |
true |
0.25 |
CD3D
|
abnormal t cell activation
|
0.68 |
false |
true |
0.25 |
CD79A
|
abnormal igg3 level
|
0.68 |
true |
true |
0.25 |
CD79A
|
abnormal spleen white pulp morphology
|
0.68 |
true |
true |
0.25 |
IRF1
|
altered susceptibility to infection
|
0.68 |
true |
true |
0.25 |
NFKB1
|
abnormal b cell morphology
|
0.68 |
true |
true |
0.25 |
CCL5
|
abnormal t cell activation
|
0.68 |
true |
true |
0.24 |
HOXB6
|
abnormal vertebral column morphology
|
0.68 |
true |
true |
0.24 |
CD3G
|
abnormal t cell number
|
0.68 |
true |
true |
0.24 |
CCR1
|
abnormal professional antigen presenting cell physiology
|
0.68 |
true |
true |
0.24 |
SH2D1A
|
abnormal cd8-positive, alpha-beta t cell number
|
0.68 |
true |
true |
0.24 |
CCL5
|
abnormal hypersensitivity reaction
|
0.68 |
true |
true |
0.24 |
BLK
|
abnormal b-1 b cell number
|
0.68 |
false |
true |
0.24 |
BLK
|
abnormal b-1 b cell morphology
|
0.68 |
false |
true |
0.25 |
IL10
|
altered susceptibility to infection
|
0.68 |
true |
true |
0.24 |
IL10RA
|
abnormal t cell differentiation
|
0.68 |
false |
true |
0.25 |
NFKB1
|
decreased mature b cell number
|
0.68 |
true |
true |
0.25 |
CD3D
|
abnormal t cell proliferation
|
0.68 |
false |
true |
0.25 |
IL10
|
abnormal cytokine secretion
|
0.68 |
true |
true |
0.25 |
NR1H4
|
abnormal circulating triiodothyronine level
|
0.68 |
false |
true |
0.25 |
PTPN7
|
abnormal t cell activation
|
0.68 |
false |
true |
0.25 |
CXCR4
|
altered susceptibility to autoimmune disorder
|
0.68 |
false |
true |
0.25 |
CCR1
|
altered susceptibility to autoimmune disorder
|
0.68 |
true |
true |
0.25 |
CXCR5
|
abnormal mature b cell morphology
|
0.68 |
false |
true |
0.26 |
PTPRC
|
abnormal t cell differentiation
|
0.68 |
true |
true |
0.25 |
CD3G
|
abnormal t cell morphology
|
0.68 |
true |
true |
0.25 |
TNFSF10
|
abnormal interleukin secretion
|
0.68 |
true |
true |
0.25 |
CD3E
|
abnormal cd4-positive, alpha beta t cell morphology
|
0.68 |
true |
true |
0.25 |
IL15
|
increased susceptibility to infection induced morbidity/mortality
|
0.68 |
true |
true |
0.25 |
MS4A1
|
abnormal b-1 b cell number
|
0.68 |
true |
true |
0.25 |
MS4A1
|
abnormal b-1 b cell morphology
|
0.68 |
true |
true |
0.25 |
MS4A1
|
abnormal spleen marginal zone morphology
|
0.68 |
false |
true |
0.25 |
CCR7
|
abnormal lymphocyte physiology
|
0.68 |
true |
true |
0.25 |
PTPN7
|
abnormal t cell proliferation
|
0.68 |
false |
true |
0.25 |
IL2RB
|
abnormal t cell physiology
|
0.68 |
true |
true |
0.25 |
ITK
|
abnormal t cell number
|
0.68 |
true |
true |
0.25 |
CXCR5
|
abnormal igg level
|
0.68 |
false |
true |
0.25 |
IL2RG
|
abnormal t cell differentiation
|
0.68 |
true |
true |
0.25 |
HOXA5
|
abnormal cervical vertebrae morphology
|
0.68 |
true |
true |
0.25 |
CCR7
|
abnormal mature b cell morphology
|
0.67 |
false |
true |
0.26 |
PTPRC
|
altered susceptibility to infection
|
0.67 |
false |
true |
0.26 |
ITK
|
abnormal lymphopoiesis
|
0.67 |
true |
true |
0.26 |
IL4
|
altered susceptibility to parasitic infection
|
0.67 |
true |
true |
0.26 |
CXCR4
|
autoimmune response
|
0.67 |
false |
true |
0.26 |
CD79A
|
decreased b cell number
|
0.67 |
true |
true |
0.26 |
IRF1
|
abnormal lymphocyte physiology
|
0.67 |
true |
true |
0.26 |
CXCR4
|
abnormal self tolerance
|
0.67 |
false |
true |
0.26 |
CD19
|
decreased immunoglobulin level
|
0.67 |
true |
true |
0.26 |
CCL5
|
abnormal cytokine secretion
|
0.67 |
true |
true |
0.26 |
IL15
|
abnormal interferon-gamma secretion
|
0.67 |
true |
true |
0.26 |
IL10
|
decreased susceptibility to autoimmune disorder
|
0.67 |
false |
true |
0.26 |
NR1I3
|
decreased circulating levels of thyroid hormone
|
0.67 |
false |
true |
0.26 |
CD2
|
decreased lymphocyte cell number
|
0.67 |
false |
true |
0.26 |
CXCR4
|
abnormal immune tolerance
|
0.67 |
false |
true |
0.26 |
CXCR4
|
increased immunoglobulin level
|
0.67 |
true |
true |
0.26 |
CD3E
|
abnormal t cell number
|
0.67 |
true |
true |
0.26 |
CD3G
|
abnormal t cell physiology
|
0.67 |
true |
true |
0.26 |
CD37
|
abnormal b cell morphology
|
0.67 |
true |
true |
0.26 |
IL10RA
|
abnormal alpha-beta t cell morphology
|
0.67 |
false |
true |
0.26 |
HOXB6
|
abnormal rib attachment
|
0.67 |
false |
true |
0.27 |
IL2
|
increased susceptibility to infection
|
0.67 |
true |
true |
0.26 |
TRAT1
|
abnormal alpha-beta t cell number
|
0.67 |
false |
true |
0.27 |
TRAT1
|
abnormal alpha-beta t cell morphology
|
0.67 |
false |
true |
0.27 |
POU2AF1
|
abnormal mature b cell morphology
|
0.67 |
true |
true |
0.27 |
CD79A
|
abnormal b-1 b cell number
|
0.67 |
true |
true |
0.27 |
CD79A
|
abnormal b-1 b cell morphology
|
0.67 |
true |
true |
0.27 |
IFNG
|
abnormal self tolerance
|
0.67 |
true |
true |
0.27 |
CCL5
|
abnormal t cell proliferation
|
0.67 |
true |
true |
0.27 |
PTPN7
|
abnormal cd4-positive, alpha beta t cell number
|
0.67 |
false |
true |
0.27 |
IL15
|
abnormal immune serum protein physiology
|
0.67 |
true |
true |
0.27 |
BLK
|
decreased igm level
|
0.67 |
false |
true |
0.27 |
MS4A1
|
increased b cell number
|
0.67 |
true |
true |
0.27 |
CD19
|
decreased igg level
|
0.67 |
true |
true |
0.27 |
PTPRC
|
abnormal cd8-positive, alpha beta t cell morphology
|
0.67 |
true |
true |
0.27 |
IFNG
|
autoimmune response
|
0.67 |
true |
true |
0.27 |
IL4
|
abnormal response to infection
|
0.67 |
true |
true |
0.26 |
NFKB1
|
abnormal igg level
|
0.67 |
true |
true |
0.26 |
CCR7
|
decreased immunoglobulin level
|
0.67 |
true |
true |
0.26 |
IFNG
|
abnormal lymphocyte physiology
|
0.67 |
true |
true |
0.26 |
PTPRC
|
abnormal igg level
|
0.67 |
true |
true |
0.26 |
LCK
|
abnormal lymphocyte cell number
|
0.67 |
true |
true |
0.26 |
IL2RB
|
abnormal alpha-beta t cell number
|
0.67 |
true |
true |
0.26 |
CD2
|
abnormal t cell physiology
|
0.67 |
false |
true |
0.26 |
ZAP70
|
abnormal t cell activation
|
0.67 |
true |
true |
0.26 |
IFNG
|
abnormal immune tolerance
|
0.67 |
true |
true |
0.26 |
IL13
|
abnormal response to infection
|
0.67 |
true |
true |
0.26 |
PTPRC
|
abnormal lymphopoiesis
|
0.67 |
true |
true |
0.26 |
CD6
|
decreased alpha-beta t cell number
|
0.67 |
false |
false |
0.26 |
CCR1
|
increased susceptibility to infection
|
0.67 |
true |
true |
0.26 |
ZAP70
|
abnormal lymphopoiesis
|
0.67 |
true |
true |
0.26 |
NFKB1
|
abnormal leukopoiesis
|
0.67 |
true |
true |
0.26 |
CD19
|
abnormal spleen white pulp morphology
|
0.67 |
true |
true |
0.26 |
IL2RB
|
abnormal alpha-beta t cell morphology
|
0.67 |
true |
true |
0.26 |
SH2D1A
|
abnormal cd4-positive, alpha beta t cell morphology
|
0.67 |
true |
true |
0.26 |
CXCR4
|
abnormal cd4-positive, alpha beta t cell number
|
0.67 |
true |
true |
0.26 |
IL13
|
altered susceptibility to parasitic infection
|
0.67 |
true |
true |
0.26 |
CXCL10
|
abnormal interferon secretion
|
0.67 |
true |
true |
0.25 |
IFNG
|
abnormal nk cell physiology
|
0.67 |
true |
true |
0.25 |
GADD45A
|
tumorigenesis
|
0.67 |
true |
true |
0.25 |
HOXA5
|
abnormal sternum morphology
|
0.67 |
true |
true |
0.25 |
IL13
|
altered susceptibility to infection
|
0.66 |
true |
true |
0.25 |
TRAT1
|
abnormal effector t cell morphology
|
0.66 |
false |
true |
0.25 |
NR1I3
|
decreased thyroxine level
|
0.66 |
false |
true |
0.26 |
CD2
|
abnormal t cell differentiation
|
0.66 |
false |
true |
0.26 |
NFKB1
|
abnormal immunoglobulin level
|
0.66 |
true |
true |
0.26 |
IL10
|
abnormal interleukin level
|
0.66 |
true |
true |
0.26 |
PTPRC
|
abnormal innate immunity
|
0.66 |
true |
true |
0.26 |
CD3E
|
abnormal cd4-positive, alpha beta t cell number
|
0.66 |
true |
true |
0.26 |
IL10RA
|
abnormal alpha-beta t cell number
|
0.66 |
false |
true |
0.26 |
CCR1
|
abnormal immune serum protein physiology
|
0.66 |
true |
true |
0.26 |
IRF1
|
abnormal cytokine secretion
|
0.66 |
true |
true |
0.26 |
CD6
|
abnormal cd4-positive, alpha beta t cell number
|
0.66 |
false |
false |
0.26 |
CD6
|
decreased t cell number
|
0.66 |
false |
false |
0.26 |
IL13
|
increased susceptibility to infection
|
0.66 |
true |
true |
0.26 |
CXCR4
|
abnormal igg level
|
0.66 |
true |
true |
0.25 |
IRF1
|
altered susceptibility to viral infection
|
0.66 |
true |
true |
0.25 |
NR1I3
|
abnormal triiodothyronine level
|
0.66 |
true |
true |
0.25 |
PTPN7
|
decreased lymphocyte cell number
|
0.66 |
false |
true |
0.26 |
CD79B
|
abnormal igg1 level
|
0.66 |
true |
true |
0.25 |
ITK
|
abnormal t cell physiology
|
0.66 |
true |
true |
0.25 |
STAT1
|
abnormal t cell physiology
|
0.66 |
true |
true |
0.25 |
CD3D
|
increased t cell number
|
0.66 |
false |
true |
0.26 |
PTPRC
|
decreased cd4-positive, alpha beta t cell number
|
0.66 |
true |
true |
0.25 |
MS4A1
|
decreased b cell number
|
0.66 |
true |
true |
0.25 |
CXCR4
|
decreased b cell number
|
0.66 |
true |
true |
0.25 |
HOXB5
|
abnormal pectoral girdle bone morphology
|
0.66 |
true |
true |
0.25 |
CCR7
|
abnormal leukopoiesis
|
0.66 |
true |
true |
0.25 |
NFKB2
|
abnormal b cell activation
|
0.66 |
true |
true |
0.25 |
ZAP70
|
abnormal t cell proliferation
|
0.66 |
true |
true |
0.25 |
NFKB2
|
abnormal b cell proliferation
|
0.66 |
true |
true |
0.25 |
CCR5
|
abnormal leukocyte migration
|
0.66 |
true |
true |
0.25 |
CXCR4
|
decreased lymphocyte cell number
|
0.66 |
true |
true |
0.25 |
CCR1
|
abnormal phagocyte morphology
|
0.66 |
true |
true |
0.25 |
PTPRC
|
abnormal cd8-positive, alpha-beta t cell number
|
0.66 |
true |
true |
0.25 |
ITK
|
decreased cd8-positive, alpha-beta t cell number
|
0.66 |
true |
true |
0.25 |
HOXA5
|
abnormal pectoral girdle bone morphology
|
0.66 |
true |
true |
0.25 |
NR1I3
|
decreased circulating thyroxine level
|
0.66 |
false |
true |
0.25 |
IL2RB
|
abnormal cd4-positive, alpha beta t cell morphology
|
0.66 |
true |
true |
0.25 |
PTPRC
|
abnormal leukopoiesis
|
0.66 |
true |
true |
0.25 |
SH2D1A
|
decreased t cell number
|
0.66 |
true |
true |
0.25 |
CCR7
|
increased lymphocyte cell number
|
0.66 |
true |
true |
0.25 |
CD79A
|
decreased igg1 level
|
0.66 |
true |
true |
0.25 |
CD2
|
abnormal lymphocyte cell number
|
0.66 |
false |
true |
0.25 |
CD79A
|
increased immunoglobulin level
|
0.66 |
true |
true |
0.25 |
CXCR4
|
abnormal t cell morphology
|
0.66 |
true |
true |
0.25 |
CCL5
|
decreased susceptibility to autoimmune disorder
|
0.66 |
false |
true |
0.25 |
ITK
|
decreased cd4-positive, alpha beta t cell number
|
0.66 |
true |
true |
0.25 |
CD37
|
abnormal b cell number
|
0.66 |
false |
true |
0.25 |
MS4A1
|
abnormal marginal zone b cell morphology
|
0.66 |
false |
true |
0.25 |
PTPRC
|
increased lymphocyte cell number
|
0.66 |
true |
true |
0.25 |
PTPN7
|
increased lymphocyte cell number
|
0.66 |
false |
true |
0.25 |
IL10
|
decreased interferon-gamma secretion
|
0.65 |
false |
true |
0.25 |
PGR
|
increased pituitary hormone level
|
0.65 |
true |
true |
0.25 |
CD3E
|
decreased cd4-positive, alpha beta t cell number
|
0.65 |
true |
true |
0.25 |
MS4A1
|
decreased igm level
|
0.65 |
false |
true |
0.25 |
IL4
|
altered susceptibility to infection
|
0.65 |
true |
true |
0.25 |
CD8A
|
abnormal t cell physiology
|
0.65 |
true |
true |
0.25 |
CXCL10
|
abnormal response to infection
|
0.65 |
true |
true |
0.25 |
CXCR4
|
decreased susceptibility to autoimmune disorder
|
0.65 |
false |
true |
0.25 |
IFNG
|
abnormal t cell morphology
|
0.65 |
true |
true |
0.25 |
MS4A1
|
abnormal immature b cell morphology
|
0.65 |
true |
true |
0.25 |
PTPN7
|
abnormal lymphocyte cell number
|
0.65 |
false |
true |
0.25 |
HOXB5
|
abnormal sternum morphology
|
0.65 |
false |
true |
0.26 |
LCK
|
abnormal double-positive t cell morphology
|
0.65 |
true |
true |
0.26 |
ZAP70
|
abnormal t cell physiology
|
0.65 |
true |
true |
0.26 |
CXCL10
|
abnormal cytokine level
|
0.65 |
true |
true |
0.25 |
CXCR4
|
increased lymphocyte cell number
|
0.65 |
true |
true |
0.25 |
IL6
|
altered susceptibility to infection induced morbidity/mortality
|
0.65 |
true |
true |
0.25 |
CCR1
|
autoimmune response
|
0.65 |
true |
true |
0.25 |
CD3E
|
abnormal t cell morphology
|
0.65 |
true |
true |
0.25 |
IL10RA
|
abnormal lymphocyte physiology
|
0.65 |
true |
true |
0.25 |
CXCL10
|
abnormal cytokine secretion
|
0.65 |
true |
true |
0.25 |
IL15
|
abnormal interferon secretion
|
0.65 |
true |
true |
0.25 |
CXCL10
|
decreased acute inflammation
|
0.65 |
true |
true |
0.25 |
SH2D1A
|
abnormal cd4-positive, alpha beta t cell number
|
0.65 |
true |
true |
0.25 |
CXCR4
|
abnormal immature b cell morphology
|
0.65 |
true |
true |
0.25 |
CCR1
|
abnormal interferon-gamma secretion
|
0.65 |
true |
true |
0.25 |
HOXB6
|
abnormal thoracic vertebrae morphology
|
0.65 |
true |
true |
0.25 |
CXCR4
|
abnormal professional antigen presenting cell morphology
|
0.65 |
true |
true |
0.25 |
CCR1
|
abnormal macrophage morphology
|
0.65 |
true |
true |
0.25 |
CD79A
|
abnormal marginal zone b cell morphology
|
0.65 |
true |
true |
0.25 |
CD79A
|
abnormal immature b cell morphology
|
0.65 |
true |
true |
0.25 |
CXCL10
|
decreased inflammatory response
|
0.65 |
true |
true |
0.25 |
IL10RA
|
abnormal effector t cell morphology
|
0.65 |
false |
true |
0.25 |
CD3D
|
abnormal lymphopoiesis
|
0.65 |
true |
true |
0.25 |
CCL5
|
abnormal t cell morphology
|
0.65 |
true |
true |
0.25 |
IL15
|
altered susceptibility to parasitic infection
|
0.65 |
true |
true |
0.25 |
PTPRC
|
abnormal t cell number
|
0.65 |
true |
true |
0.25 |
CCL5
|
abnormal lymphopoiesis
|
0.65 |
true |
true |
0.25 |
HOXA4
|
abnormal thoracic cage morphology
|
0.65 |
true |
true |
0.24 |
IFNG
|
abnormal innate immunity
|
0.65 |
true |
true |
0.24 |
CCR1
|
abnormal self tolerance
|
0.65 |
true |
true |
0.24 |
HOXB4
|
abnormal thoracic cage morphology
|
0.65 |
true |
true |
0.24 |
IL10
|
abnormal immunoglobulin level
|
0.65 |
true |
true |
0.24 |
CD79A
|
decreased igm level
|
0.65 |
true |
true |
0.24 |
IL10RA
|
abnormal lymphopoiesis
|
0.65 |
false |
true |
0.24 |
CCR1
|
abnormal immune tolerance
|
0.65 |
true |
true |
0.24 |
IL2RG
|
decreased t cell proliferation
|
0.65 |
true |
true |
0.24 |
CD37
|
abnormal lymphopoiesis
|
0.65 |
true |
true |
0.24 |
CD79B
|
abnormal b cell morphology
|
0.65 |
true |
true |
0.24 |
HOXA7
|
abnormal thoracic cage morphology
|
0.65 |
false |
true |
0.24 |
NFKB1
|
abnormal marginal zone b cell morphology
|
0.65 |
true |
true |
0.24 |
ITK
|
increased t cell number
|
0.65 |
true |
true |
0.24 |
CCL5
|
decreased interferon-gamma secretion
|
0.65 |
true |
true |
0.24 |
CD6
|
abnormal t cell morphology
|
0.65 |
false |
false |
0.24 |
CCR1
|
abnormal mononuclear phagocyte morphology
|
0.65 |
true |
true |
0.24 |
ITGB2
|
abnormal cytokine secretion
|
0.65 |
true |
true |
0.24 |
IL4
|
altered susceptibility to autoimmune disorder
|
0.65 |
true |
true |
0.24 |
IL2RB
|
abnormal t cell differentiation
|
0.65 |
true |
true |
0.24 |
PTPN7
|
increased t cell number
|
0.65 |
false |
true |
0.24 |
CXCL10
|
abnormal interferon-gamma secretion
|
0.65 |
true |
true |
0.24 |
PTPN7
|
abnormal t cell physiology
|
0.65 |
false |
true |
0.24 |
CD79A
|
abnormal lymphopoiesis
|
0.65 |
true |
true |
0.24 |
IL10
|
altered susceptibility to parasitic infection
|
0.65 |
true |
true |
0.24 |
BIRC3
|
abnormal cytokine secretion
|
0.65 |
true |
true |
0.24 |
CXCL10
|
abnormal intercellular signaling peptide or protein level
|
0.65 |
true |
true |
0.24 |
CCR1
|
abnormal myeloid leukocyte morphology
|
0.65 |
true |
true |
0.24 |
IL1B
|
decreased inflammatory response
|
0.65 |
true |
true |
0.24 |
MS4A1
|
abnormal igg3 level
|
0.64 |
false |
true |
0.24 |
BLK
|
abnormal immature b cell morphology
|
0.64 |
false |
true |
0.24 |
PTPRC
|
abnormal t cell morphology
|
0.64 |
true |
true |
0.24 |
HOXB5
|
abnormal rib morphology
|
0.64 |
false |
true |
0.24 |
IL2RB
|
abnormal t cell activation
|
0.64 |
true |
true |
0.24 |
CXCL10
|
altered susceptibility to infection
|
0.64 |
true |
true |
0.24 |
PTPRC
|
increased susceptibility to infection
|
0.64 |
false |
true |
0.24 |
CCL5
|
abnormal immune serum protein physiology
|
0.64 |
true |
true |
0.24 |
BIRC3
|
abnormal lymphopoiesis
|
0.64 |
true |
true |
0.24 |
CCR7
|
abnormal lymphocyte cell number
|
0.64 |
true |
true |
0.24 |
IL15
|
abnormal interleukin secretion
|
0.64 |
true |
true |
0.24 |
IL10
|
altered susceptibility to autoimmune disorder
|
0.64 |
false |
true |
0.24 |
IL2RB
|
abnormal t cell proliferation
|
0.64 |
true |
true |
0.24 |
CD79A
|
abnormal spleen marginal zone morphology
|
0.64 |
true |
true |
0.24 |
HOXA7
|
abnormal presacral vertebrae morphology
|
0.64 |
false |
true |
0.24 |
IL10RA
|
abnormal t cell morphology
|
0.64 |
false |
true |
0.25 |
CXCR4
|
abnormal lymphocyte physiology
|
0.64 |
true |
true |
0.25 |
IL2
|
altered susceptibility to parasitic infection
|
0.64 |
false |
true |
0.25 |
IRF1
|
abnormal t cell activation
|
0.64 |
true |
true |
0.25 |
CCR7
|
abnormal hypersensitivity reaction
|
0.64 |
true |
true |
0.25 |
IL2RB
|
abnormal t cell morphology
|
0.64 |
true |
true |
0.25 |
CCR7
|
abnormal b cell number
|
0.64 |
false |
true |
0.25 |
HOXB4
|
abnormal presacral vertebrae morphology
|
0.64 |
true |
true |
0.25 |
CD79A
|
increased b cell number
|
0.64 |
true |
true |
0.25 |
MS4A1
|
decreased igg1 level
|
0.64 |
false |
true |
0.25 |
LCK
|
abnormal double-negative t cell morphology
|
0.64 |
true |
true |
0.25 |
HOXB3
|
abnormal presacral vertebrae morphology
|
0.64 |
true |
true |
0.25 |
NFKB1
|
decreased b cell number
|
0.64 |
true |
true |
0.25 |
CCR1
|
decreased susceptibility to infection
|
0.64 |
true |
true |
0.25 |
CD6
|
abnormal t cell number
|
0.64 |
false |
false |
0.25 |
TRAT1
|
abnormal cd8-positive, alpha beta t cell morphology
|
0.64 |
false |
true |
0.25 |
ITGB2
|
abnormal immune serum protein physiology
|
0.64 |
true |
true |
0.25 |
CD6
|
abnormal t cell activation
|
0.64 |
false |
false |
0.25 |
IL10RA
|
abnormal t cell activation
|
0.64 |
false |
true |
0.25 |
IRF1
|
abnormal interferon secretion
|
0.64 |
true |
true |
0.25 |
CD6
|
abnormal cd8-positive, alpha beta t cell morphology
|
0.64 |
false |
false |
0.25 |
TRAT1
|
abnormal cd4-positive, alpha beta t cell morphology
|
0.64 |
false |
true |
0.25 |
IFNG
|
abnormal t cell number
|
0.64 |
true |
true |
0.25 |
CXCR5
|
abnormal b cell differentiation
|
0.64 |
false |
true |
0.25 |
PTPN7
|
decreased alpha-beta t cell number
|
0.64 |
false |
true |
0.25 |
NFKB1
|
abnormal humoral immune response
|
0.64 |
true |
true |
0.25 |
CXCR5
|
abnormal b cell activation
|
0.64 |
false |
true |
0.25 |
CXCR5
|
abnormal spleen white pulp morphology
|
0.64 |
true |
true |
0.25 |
IL6
|
abnormal cytokine level
|
0.64 |
true |
true |
0.25 |
NFKB1
|
abnormal b cell number
|
0.64 |
true |
true |
0.25 |
CXCR4
|
abnormal lymphocyte cell number
|
0.64 |
true |
true |
0.25 |
CD79B
|
abnormal b cell number
|
0.64 |
true |
true |
0.25 |
PTPN7
|
abnormal cd8-positive, alpha beta t cell morphology
|
0.64 |
false |
true |
0.25 |
IL2RG
|
abnormal effector t cell morphology
|
0.64 |
true |
true |
0.25 |
IL10
|
abnormal cytokine level
|
0.64 |
true |
true |
0.25 |
CXCL10
|
abnormal acute inflammation
|
0.64 |
true |
true |
0.25 |
CD8A
|
abnormal t cell differentiation
|
0.64 |
true |
true |
0.25 |
IL10RA
|
abnormal cd4-positive, alpha beta t cell number
|
0.64 |
false |
true |
0.25 |
IL15
|
abnormal t cell physiology
|
0.64 |
true |
true |
0.25 |
IL6
|
abnormal intercellular signaling peptide or protein level
|
0.64 |
true |
true |
0.25 |
IL10
|
abnormal b cell physiology
|
0.64 |
true |
true |
0.25 |
CD79B
|
abnormal spleen white pulp morphology
|
0.64 |
true |
true |
0.25 |
IRF1
|
abnormal t cell differentiation
|
0.64 |
true |
true |
0.25 |
IL6
|
abnormal response to infection
|
0.64 |
true |
true |
0.25 |
HOXB7
|
abnormal thoracic cage morphology
|
0.64 |
true |
true |
0.25 |
TRAT1
|
decreased alpha-beta t cell number
|
0.64 |
false |
true |
0.25 |
IL10RA
|
abnormal cd4-positive, alpha beta t cell morphology
|
0.64 |
false |
true |
0.25 |
CCR7
|
increased igg level
|
0.64 |
true |
true |
0.25 |
PRKDC
|
increased lymphoma incidence
|
0.64 |
true |
true |
0.25 |
CCR5
|
autoimmune response
|
0.64 |
false |
true |
0.25 |
CXCR4
|
abnormal t cell number
|
0.64 |
true |
true |
0.25 |
CXCR4
|
abnormal professional antigen presenting cell physiology
|
0.64 |
true |
true |
0.25 |
CCR5
|
abnormal immunoglobulin level
|
0.64 |
true |
true |
0.25 |
BIRC3
|
abnormal professional antigen presenting cell physiology
|
0.64 |
true |
true |
0.25 |
HOXB5
|
abnormal thoracic vertebrae morphology
|
0.64 |
true |
true |
0.25 |
CCR7
|
abnormal professional antigen presenting cell morphology
|
0.64 |
true |
true |
0.25 |
CCR5
|
abnormal self tolerance
|
0.64 |
false |
true |
0.25 |
IL10
|
abnormal professional antigen presenting cell physiology
|
0.64 |
true |
true |
0.25 |
CD79B
|
abnormal b-1 b cell number
|
0.64 |
true |
true |
0.25 |
CD79B
|
abnormal b-1 b cell morphology
|
0.64 |
true |
true |
0.25 |
IL10
|
abnormal igg level
|
0.64 |
true |
true |
0.25 |
ZAP70
|
decreased cd4-positive, alpha beta t cell number
|
0.64 |
true |
true |
0.25 |
CD6
|
abnormal t cell proliferation
|
0.64 |
false |
false |
0.25 |
BTK
|
abnormal mature b cell morphology
|
0.64 |
true |
true |
0.25 |
PTPRC
|
abnormal t cell activation
|
0.64 |
true |
true |
0.25 |
IRF1
|
abnormal immune serum protein physiology
|
0.64 |
true |
true |
0.25 |
CCR1
|
decreased acute inflammation
|
0.64 |
true |
true |
0.25 |
IL4
|
increased susceptibility to infection
|
0.64 |
true |
true |
0.24 |
LCK
|
decreased t cell proliferation
|
0.63 |
true |
true |
0.24 |
CD2
|
increased lymphocyte cell number
|
0.63 |
false |
true |
0.25 |
CD19
|
abnormal marginal zone b cell morphology
|
0.63 |
false |
true |
0.25 |
CCR1
|
abnormal professional antigen presenting cell morphology
|
0.63 |
true |
true |
0.25 |
CCR5
|
abnormal effector t cell morphology
|
0.63 |
true |
true |
0.25 |
BLK
|
increased b cell number
|
0.63 |
false |
true |
0.25 |
CXCR4
|
abnormal alpha-beta t cell number
|
0.63 |
true |
true |
0.25 |
DRD5
|
abnormal behavioral response to addictive substance
|
0.63 |
true |
true |
0.25 |
BLK
|
decreased igg1 level
|
0.63 |
false |
true |
0.25 |
IL2RG
|
abnormal cd4-positive, alpha beta t cell morphology
|
0.63 |
true |
true |
0.25 |
CXCR4
|
abnormal spleen white pulp morphology
|
0.63 |
true |
true |
0.25 |
IFNG
|
abnormal effector t cell morphology
|
0.63 |
true |
true |
0.25 |
IL10
|
abnormal interleukin secretion
|
0.63 |
false |
true |
0.25 |
CD37
|
decreased igg level
|
0.63 |
true |
true |
0.25 |
CXCR4
|
abnormal mature b cell morphology
|
0.63 |
true |
true |
0.25 |
IRF1
|
autoimmune response
|
0.63 |
true |
true |
0.25 |
CCR5
|
abnormal immune tolerance
|
0.63 |
false |
true |
0.25 |
IL2RB
|
abnormal cd8-positive, alpha beta t cell morphology
|
0.63 |
true |
true |
0.25 |
IL15
|
abnormal dendritic cell morphology
|
0.63 |
true |
true |
0.25 |
IRF1
|
abnormal self tolerance
|
0.63 |
true |
true |
0.25 |
CCR7
|
altered susceptibility to autoimmune disorder
|
0.63 |
true |
true |
0.25 |
CXCR4
|
abnormal alpha-beta t cell morphology
|
0.63 |
true |
true |
0.25 |
CD3E
|
abnormal t cell physiology
|
0.63 |
true |
true |
0.25 |
NR1I3
|
abnormal circulating triiodothyronine level
|
0.63 |
false |
true |
0.25 |
PTPN7
|
abnormal cd8-positive, alpha-beta t cell number
|
0.63 |
false |
true |
0.25 |
IL10
|
altered susceptibility to infection induced morbidity/mortality
|
0.63 |
false |
true |
0.25 |
NFKB1
|
abnormal lymphocyte physiology
|
0.63 |
true |
true |
0.25 |
BIRC3
|
abnormal immune serum protein physiology
|
0.63 |
true |
true |
0.25 |
PDGFRA
|
abnormal cardiovascular development
|
0.63 |
true |
true |
0.25 |
CD19
|
abnormal spleen marginal zone morphology
|
0.63 |
false |
true |
0.25 |
TRAT1
|
abnormal cd4-positive, alpha beta t cell number
|
0.63 |
false |
true |
0.25 |
BIRC3
|
abnormal innate immunity
|
0.63 |
true |
true |
0.25 |
CCR1
|
abnormal leukocyte migration
|
0.63 |
true |
true |
0.25 |
IL10
|
abnormal humoral immune response
|
0.63 |
true |
true |
0.25 |
CD86
|
abnormal cytokine secretion
|
0.63 |
true |
true |
0.25 |
CD19
|
abnormal igg1 level
|
0.63 |
true |
true |
0.25 |
CXCR4
|
decreased leukocyte cell number
|
0.63 |
true |
true |
0.25 |
IRF1
|
abnormal immune tolerance
|
0.63 |
true |
true |
0.25 |
BLK
|
abnormal igg3 level
|
0.63 |
false |
true |
0.25 |
CCL5
|
abnormal leukopoiesis
|
0.63 |
true |
true |
0.25 |
IL6
|
decreased tumor incidence
|
0.63 |
true |
true |
0.25 |
IL15
|
abnormal lymphopoiesis
|
0.63 |
true |
true |
0.25 |
CCL5
|
abnormal interleukin secretion
|
0.63 |
true |
true |
0.25 |
TRAT1
|
abnormal cd8-positive, alpha-beta t cell number
|
0.63 |
false |
true |
0.25 |
CD6
|
abnormal t cell physiology
|
0.63 |
false |
false |
0.25 |
CCR7
|
abnormal igg1 level
|
0.63 |
true |
true |
0.25 |
HOXB4
|
abnormal cervical vertebrae morphology
|
0.63 |
true |
true |
0.25 |
CCR5
|
abnormal innate immunity
|
0.63 |
true |
true |
0.25 |
CXCR4
|
increased b cell number
|
0.63 |
true |
true |
0.25 |
SH2D1A
|
abnormal t cell number
|
0.63 |
true |
true |
0.25 |
CCL5
|
abnormal effector t cell morphology
|
0.63 |
true |
true |
0.25 |
CCR5
|
abnormal humoral immune response
|
0.63 |
true |
true |
0.25 |
IL10
|
abnormal granulocyte number
|
0.63 |
true |
true |
0.25 |
CTGF
|
abnormal angiogenesis
|
0.63 |
true |
true |
0.24 |
TRAF1
|
abnormal igg level
|
0.63 |
false |
true |
0.25 |
IL6
|
altered susceptibility to infection
|
0.63 |
true |
true |
0.25 |
PTPRC
|
abnormal mature b cell morphology
|
0.63 |
true |
true |
0.25 |
CXCR4
|
abnormal immune serum protein physiology
|
0.63 |
true |
true |
0.24 |
SH2D1A
|
decreased cd4-positive, alpha beta t cell number
|
0.63 |
true |
true |
0.24 |
CCL5
|
abnormal cd4-positive, alpha beta t cell morphology
|
0.63 |
true |
true |
0.24 |
IL10
|
abnormal granulocyte morphology
|
0.63 |
true |
true |
0.24 |
PTPRC
|
abnormal lymphocyte cell number
|
0.63 |
true |
true |
0.24 |
IL7R
|
abnormal immunoglobulin level
|
0.63 |
false |
true |
0.24 |
IL1R2
|
abnormal cytokine secretion
|
0.63 |
false |
false |
0.24 |
NFKB2
|
abnormal t cell physiology
|
0.63 |
true |
true |
0.24 |
MS4A1
|
increased immunoglobulin level
|
0.63 |
false |
true |
0.25 |
HOXA7
|
abnormal sternum morphology
|
0.63 |
false |
true |
0.25 |
CCR1
|
decreased susceptibility to autoimmune disorder
|
0.63 |
true |
true |
0.25 |
IL13
|
altered susceptibility to infection induced morbidity/mortality
|
0.63 |
true |
true |
0.25 |
CSF2
|
altered susceptibility to parasitic infection
|
0.63 |
true |
true |
0.25 |
PRKDC
|
increased hemolymphoid system tumor incidence
|
0.63 |
true |
true |
0.24 |
ITK
|
abnormal leukopoiesis
|
0.63 |
true |
true |
0.24 |
HOXB7
|
abnormal presacral vertebrae morphology
|
0.63 |
false |
true |
0.25 |
CD3G
|
abnormal t cell activation
|
0.63 |
true |
true |
0.25 |
CD79A
|
abnormal professional antigen presenting cell physiology
|
0.62 |
true |
true |
0.24 |
IRF1
|
abnormal t cell morphology
|
0.62 |
true |
true |
0.24 |
BIRC3
|
abnormal igg level
|
0.62 |
true |
true |
0.24 |
PTPRC
|
decreased lymphocyte cell number
|
0.62 |
true |
true |
0.24 |
LCK
|
increased lymphocyte cell number
|
0.62 |
false |
true |
0.24 |
ZAP70
|
decreased lymphocyte cell number
|
0.62 |
true |
true |
0.24 |
MS4A1
|
decreased b cell proliferation
|
0.62 |
false |
true |
0.25 |
ITK
|
decreased t cell proliferation
|
0.62 |
true |
true |
0.25 |
HOXB6
|
abnormal rib-sternum attachment
|
0.62 |
false |
true |
0.25 |
PLK1
|
abnormal cell cycle
|
0.62 |
true |
true |
0.25 |
IL10
|
abnormal intercellular signaling peptide or protein level
|
0.62 |
true |
true |
0.25 |
BIRC3
|
abnormal lymphocyte physiology
|
0.62 |
true |
true |
0.25 |
HOXA5
|
abnormal vertebrae morphology
|
0.62 |
true |
true |
0.25 |
PGR
|
increased circulating pituitary hormone level
|
0.62 |
true |
true |
0.24 |
NFKB1
|
decreased igg level
|
0.62 |
true |
true |
0.24 |
ITGB2
|
abnormal immunoglobulin level
|
0.62 |
true |
true |
0.24 |
IL10
|
abnormal immune serum protein physiology
|
0.62 |
true |
true |
0.24 |
IL4
|
decreased inflammatory response
|
0.62 |
true |
true |
0.24 |
IL4
|
increased susceptibility to parasitic infection
|
0.62 |
true |
true |
0.24 |
STAT1
|
abnormal lymphocyte physiology
|
0.62 |
true |
true |
0.24 |
IL10
|
abnormal innate immunity
|
0.62 |
true |
true |
0.24 |
IL2RB
|
abnormal cd4-positive, alpha beta t cell number
|
0.62 |
true |
true |
0.24 |
IRF1
|
abnormal effector t cell morphology
|
0.62 |
true |
true |
0.24 |
IL10
|
abnormal acute inflammation
|
0.62 |
true |
true |
0.24 |
IL2
|
increased susceptibility to parasitic infection
|
0.62 |
false |
true |
0.24 |
IL15
|
abnormal acute inflammation
|
0.62 |
true |
true |
0.24 |
CXCR4
|
decreased t cell number
|
0.62 |
true |
true |
0.24 |
NFKB1
|
decreased immunoglobulin level
|
0.62 |
true |
true |
0.24 |
BIRC3
|
abnormal immunoglobulin level
|
0.62 |
true |
true |
0.24 |
IL15
|
abnormal interleukin level
|
0.62 |
false |
true |
0.24 |
IL2RG
|
abnormal lymphopoiesis
|
0.62 |
true |
true |
0.24 |
CD6
|
abnormal cd8-positive, alpha-beta t cell number
|
0.62 |
false |
false |
0.24 |
CCR5
|
abnormal b cell physiology
|
0.62 |
true |
true |
0.24 |
SH2D1A
|
abnormal t cell differentiation
|
0.62 |
true |
true |
0.24 |
IL4
|
abnormal cytokine level
|
0.62 |
false |
true |
0.24 |
CD79A
|
abnormal lymphocyte physiology
|
0.62 |
true |
true |
0.24 |
CD79B
|
abnormal marginal zone b cell morphology
|
0.62 |
true |
true |
0.24 |
TRAT1
|
abnormal t cell differentiation
|
0.62 |
false |
true |
0.24 |
CCR5
|
altered susceptibility to autoimmune disorder
|
0.62 |
false |
true |
0.24 |
CCR7
|
increased b cell number
|
0.62 |
false |
true |
0.24 |
CCL5
|
abnormal type iv hypersensitivity reaction
|
0.62 |
true |
true |
0.24 |
NFKB2
|
abnormal b cell physiology
|
0.62 |
true |
true |
0.24 |
IL10
|
abnormal phagocyte morphology
|
0.62 |
true |
true |
0.24 |
HOXB5
|
abnormal vertebrae morphology
|
0.62 |
true |
true |
0.24 |
IL6
|
abnormal interleukin level
|
0.62 |
true |
true |
0.24 |
BIRC3
|
abnormal interferon secretion
|
0.62 |
true |
true |
0.24 |
STAT1
|
abnormal interferon secretion
|
0.62 |
true |
true |
0.24 |
HOXA7
|
abnormal pectoral girdle bone morphology
|
0.62 |
false |
true |
0.24 |
IRF1
|
abnormal t cell proliferation
|
0.62 |
true |
true |
0.24 |
CXCR5
|
abnormal igm level
|
0.62 |
false |
true |
0.24 |
IL10RA
|
abnormal t cell proliferation
|
0.62 |
false |
true |
0.24 |
CD79B
|
decreased b cell number
|
0.62 |
true |
true |
0.24 |
TNFSF10
|
abnormal immune serum protein physiology
|
0.62 |
true |
true |
0.24 |
STAT1
|
abnormal t cell morphology
|
0.62 |
true |
true |
0.24 |
HOXA4
|
abnormal presacral vertebrae morphology
|
0.62 |
true |
true |
0.24 |
PTPRC
|
abnormal t cell proliferation
|
0.62 |
true |
true |
0.24 |
IFNG
|
increased immunoglobulin level
|
0.62 |
true |
true |
0.24 |
CD3G
|
abnormal t cell proliferation
|
0.62 |
true |
true |
0.24 |
IL10RA
|
abnormal t cell number
|
0.62 |
false |
true |
0.24 |
NFKB1
|
abnormal igg1 level
|
0.62 |
true |
true |
0.24 |
IL10RA
|
abnormal leukopoiesis
|
0.62 |
false |
true |
0.24 |
IL2RB
|
decreased t cell proliferation
|
0.62 |
true |
true |
0.24 |
IRF1
|
altered susceptibility to autoimmune disorder
|
0.62 |
true |
true |
0.24 |
IFNG
|
abnormal cytokine level
|
0.62 |
true |
true |
0.24 |
ITGAL
|
abnormal alpha-beta t cell morphology
|
0.62 |
true |
true |
0.24 |
ITK
|
decreased lymphocyte cell number
|
0.62 |
true |
true |
0.24 |
IRF1
|
abnormal lymphopoiesis
|
0.62 |
true |
true |
0.24 |
ITGB2
|
abnormal humoral immune response
|
0.62 |
true |
true |
0.24 |
CD79A
|
decreased b cell proliferation
|
0.62 |
true |
true |
0.24 |
HOXB4
|
abnormal sternum morphology
|
0.62 |
true |
true |
0.24 |
IL2
|
altered susceptibility to infection
|
0.62 |
true |
true |
0.24 |
BIRC3
|
abnormal b cell physiology
|
0.62 |
true |
true |
0.24 |
HOXA5
|
vertebral transformation
|
0.62 |
true |
true |
0.24 |
BIRC3
|
abnormal leukopoiesis
|
0.62 |
true |
true |
0.24 |
IL6
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
0.62 |
true |
true |
0.24 |
LCP2
|
abnormal t cell activation
|
0.62 |
true |
true |
0.24 |
IL6
|
decreased incidence of induced tumors
|
0.62 |
true |
true |
0.24 |
CD37
|
abnormal leukopoiesis
|
0.62 |
true |
true |
0.24 |
GADD45A
|
abnormal tumor incidence
|
0.62 |
true |
true |
0.24 |
TLR2
|
abnormal cytokine secretion
|
0.62 |
true |
true |
0.24 |
IRF1
|
abnormal b cell physiology
|
0.62 |
true |
true |
0.24 |
IL15
|
increased immunoglobulin level
|
0.62 |
false |
true |
0.24 |
CD22
|
abnormal igm level
|
0.62 |
true |
true |
0.24 |
CXCL10
|
abnormal interleukin level
|
0.62 |
false |
true |
0.24 |
SH2D1A
|
decreased cd8-positive, alpha-beta t cell number
|
0.62 |
false |
true |
0.24 |
LCK
|
abnormal lymphocyte physiology
|
0.62 |
true |
true |
0.24 |
CCR5
|
abnormal cd4-positive, alpha beta t cell morphology
|
0.62 |
true |
true |
0.24 |
IL10RA
|
decreased t cell number
|
0.62 |
false |
true |
0.24 |
IL2RB
|
abnormal t cell number
|
0.62 |
true |
true |
0.24 |
ITGAL
|
abnormal alpha-beta t cell number
|
0.62 |
true |
true |
0.24 |
CCR7
|
decreased igg level
|
0.62 |
true |
true |
0.24 |
IL2RG
|
abnormal lymphocyte physiology
|
0.62 |
true |
true |
0.24 |
ITGB7
|
abnormal igg level
|
0.61 |
false |
true |
0.24 |
IL10
|
abnormal circulating interleukin level
|
0.61 |
true |
true |
0.24 |
GADD45A
|
altered tumor susceptibility
|
0.61 |
true |
true |
0.24 |
PGR
|
abnormal circulating pituitary hormone level
|
0.61 |
true |
true |
0.24 |
IL4
|
altered susceptibility to infection induced morbidity/mortality
|
0.61 |
true |
true |
0.24 |
IL2RB
|
abnormal lymphopoiesis
|
0.61 |
true |
true |
0.24 |
HOXA6
|
abnormal presacral vertebrae morphology
|
0.61 |
true |
true |
0.24 |
IL10
|
autoimmune response
|
0.61 |
false |
true |
0.24 |
PGR
|
abnormal pituitary hormone level
|
0.61 |
true |
true |
0.24 |
IFNG
|
abnormal response to transplant
|
0.61 |
true |
true |
0.24 |
CD19
|
increased mature b cell number
|
0.61 |
false |
true |
0.24 |
IL4
|
autoimmune response
|
0.61 |
true |
true |
0.24 |
ITGAL
|
abnormal effector t cell morphology
|
0.61 |
true |
true |
0.24 |
CD37
|
decreased immunoglobulin level
|
0.61 |
true |
true |
0.24 |
IRF1
|
abnormal cd4-positive, alpha beta t cell morphology
|
0.61 |
true |
true |
0.24 |
PTPRC
|
abnormal immune serum protein physiology
|
0.61 |
true |
true |
0.24 |
IRF1
|
abnormal immunoglobulin level
|
0.61 |
true |
true |
0.24 |
CCR2
|
altered susceptibility to autoimmune disorder
|
0.61 |
true |
true |
0.24 |
CXCL10
|
abnormal immune serum protein physiology
|
0.61 |
true |
true |
0.24 |
ZAP70
|
abnormal leukopoiesis
|
0.61 |
true |
true |
0.24 |
IL2RG
|
abnormal alpha-beta t cell morphology
|
0.61 |
true |
true |
0.24 |
HOXA3
|
abnormal cervical vertebrae morphology
|
0.61 |
true |
true |
0.24 |
CCR5
|
abnormal professional antigen presenting cell physiology
|
0.61 |
true |
true |
0.24 |
CXCR4
|
decreased acute inflammation
|
0.61 |
false |
true |
0.24 |
CXCR4
|
altered susceptibility to viral infection
|
0.61 |
true |
true |
0.24 |
IL10
|
increased susceptibility to parasitic infection
|
0.61 |
true |
true |
0.24 |
CD37
|
increased immunoglobulin level
|
0.61 |
false |
true |
0.24 |
NR3C1
|
abnormal circulating pituitary hormone level
|
0.61 |
true |
true |
0.24 |
ITGAL
|
abnormal cd4-positive, alpha beta t cell morphology
|
0.61 |
true |
true |
0.24 |
CXCR4
|
decreased inflammatory response
|
0.61 |
false |
true |
0.24 |
IRF1
|
abnormal cytokine level
|
0.61 |
true |
true |
0.24 |
IL7R
|
abnormal humoral immune response
|
0.61 |
false |
true |
0.24 |
BIRC3
|
abnormal interleukin secretion
|
0.61 |
true |
true |
0.24 |
IL10
|
abnormal self tolerance
|
0.61 |
false |
true |
0.24 |
IL2RG
|
abnormal alpha-beta t cell number
|
0.61 |
true |
true |
0.24 |
IL15
|
abnormal dendritic cell number
|
0.61 |
true |
true |
0.24 |
NFKB1
|
abnormal t cell differentiation
|
0.61 |
true |
true |
0.24 |
CXCR4
|
increased igg level
|
0.61 |
true |
true |
0.24 |
IFNG
|
abnormal lymphocyte cell number
|
0.61 |
true |
true |
0.24 |
IFNG
|
abnormal intercellular signaling peptide or protein level
|
0.61 |
true |
true |
0.24 |
IL4
|
abnormal self tolerance
|
0.61 |
true |
true |
0.24 |
IRF1
|
abnormal leukopoiesis
|
0.61 |
true |
true |
0.24 |
PTPRC
|
increased immunoglobulin level
|
0.61 |
true |
true |
0.24 |
TRAF1
|
abnormal immunoglobulin level
|
0.61 |
false |
true |
0.24 |
HOXB4
|
abnormal pectoral girdle bone morphology
|
0.61 |
true |
true |
0.24 |
CD8A
|
abnormal t cell activation
|
0.61 |
false |
true |
0.24 |
CXCR4
|
altered susceptibility to infection
|
0.61 |
true |
true |
0.24 |
CXCR4
|
increased susceptibility to infection
|
0.61 |
true |
true |
0.24 |
CD3G
|
increased t cell number
|
0.61 |
false |
true |
0.24 |
CCR7
|
abnormal cd4-positive, alpha beta t cell morphology
|
0.61 |
true |
true |
0.24 |
CD3E
|
increased t cell number
|
0.61 |
true |
true |
0.24 |
IFNG
|
abnormal alpha-beta t cell morphology
|
0.61 |
true |
true |
0.24 |
IL10RA
|
decreased alpha-beta t cell number
|
0.61 |
false |
true |
0.24 |
GADD45A
|
abnormal incidence of induced tumors
|
0.61 |
true |
true |
0.24 |
IL15
|
decreased immunoglobulin level
|
0.61 |
true |
true |
0.24 |
HOXA3
|
abnormal vertebrae morphology
|
0.61 |
true |
true |
0.24 |
POU2AF1
|
abnormal igm level
|
0.61 |
true |
true |
0.24 |
PTPN7
|
abnormal lymphocyte physiology
|
0.61 |
false |
true |
0.24 |
IL4
|
abnormal acute inflammation
|
0.61 |
false |
true |
0.24 |
CCR7
|
abnormal igm level
|
0.61 |
false |
true |
0.24 |
CCL5
|
abnormal professional antigen presenting cell physiology
|
0.61 |
false |
true |
0.24 |
IL10
|
abnormal circulating cytokine level
|
0.61 |
true |
true |
0.24 |
IL15
|
abnormal professional antigen presenting cell morphology
|
0.61 |
true |
true |
0.24 |
IL1R2
|
abnormal interleukin secretion
|
0.61 |
false |
false |
0.24 |
CCR2
|
decreased inflammatory response
|
0.61 |
true |
true |
0.24 |
CCR7
|
abnormal b cell activation
|
0.61 |
true |
true |
0.24 |
CD3D
|
abnormal leukopoiesis
|
0.61 |
true |
true |
0.24 |
TNFSF13B
|
abnormal cytokine secretion
|
0.61 |
false |
true |
0.24 |
NFKB2
|
abnormal immunoglobulin level
|
0.61 |
true |
true |
0.24 |
IL15
|
abnormal leukopoiesis
|
0.61 |
true |
true |
0.24 |
BTK
|
abnormal b cell number
|
0.61 |
true |
true |
0.24 |
IL6
|
abnormal phagocyte morphology
|
0.61 |
true |
true |
0.24 |
BLK
|
decreased b cell proliferation
|
0.61 |
false |
true |
0.24 |
ITGB2
|
abnormal lymphocyte physiology
|
0.61 |
true |
true |
0.24 |
CCR1
|
abnormal immunoglobulin level
|
0.61 |
true |
true |
0.24 |
CXCL10
|
abnormal circulating cytokine level
|
0.61 |
false |
true |
0.24 |
DNAH9
|
heterotaxia
|
0.61 |
false |
false |
0.24 |
CD19
|
abnormal igg3 level
|
0.61 |
true |
true |
0.24 |
BLK
|
increased immunoglobulin level
|
0.61 |
false |
true |
0.24 |
IL2RB
|
abnormal lymphocyte physiology
|
0.61 |
true |
true |
0.24 |
ITGAL
|
abnormal t cell differentiation
|
0.61 |
true |
true |
0.24 |
CXCL10
|
increased susceptibility to infection
|
0.61 |
true |
true |
0.24 |
HOXA7
|
vertebral transformation
|
0.61 |
false |
true |
0.24 |
SH2D1A
|
abnormal t cell morphology
|
0.61 |
true |
true |
0.24 |
CCR7
|
decreased lymphocyte cell number
|
0.61 |
true |
true |
0.24 |
BIRC3
|
abnormal humoral immune response
|
0.61 |
true |
true |
0.24 |
CD6
|
decreased cd4-positive, alpha beta t cell number
|
0.61 |
false |
false |
0.24 |
BLK
|
decreased b-1 b cell number
|
0.61 |
false |
true |
0.24 |
SLAMF1
|
abnormal alpha-beta t cell number
|
0.61 |
false |
true |
0.24 |
TRAT1
|
decreased t cell number
|
0.61 |
false |
true |
0.24 |
NFKB2
|
decreased b cell proliferation
|
0.61 |
true |
true |
0.24 |
SLAMF1
|
abnormal cd4-positive, alpha beta t cell number
|
0.61 |
false |
true |
0.24 |
TNFSF10
|
abnormal interferon secretion
|
0.61 |
true |
true |
0.24 |
IL10
|
abnormal immune tolerance
|
0.61 |
false |
true |
0.24 |
CXCR5
|
increased immunoglobulin level
|
0.61 |
false |
true |
0.25 |
IFNG
|
abnormal immunoglobulin level
|
0.61 |
true |
true |
0.25 |
FOS
|
altered tumor pathology
|
0.61 |
true |
true |
0.24 |
CCR1
|
altered susceptibility to viral infection
|
0.61 |
true |
true |
0.24 |
NFKB2
|
abnormal lymphocyte physiology
|
0.61 |
true |
true |
0.24 |
VAV1
|
abnormal b cell number
|
0.61 |
true |
true |
0.24 |
IL4
|
abnormal immune tolerance
|
0.61 |
true |
true |
0.24 |
ZAP70
|
decreased cd8-positive, alpha-beta t cell number
|
0.61 |
true |
true |
0.24 |
CXCL10
|
abnormal innate immunity
|
0.61 |
false |
true |
0.24 |
CD3D
|
decreased lymphocyte cell number
|
0.61 |
true |
true |
0.24 |
BLK
|
abnormal professional antigen presenting cell physiology
|
0.61 |
false |
true |
0.24 |
CD3G
|
abnormal lymphopoiesis
|
0.6 |
true |
true |
0.24 |
IL10RA
|
abnormal cd8-positive, alpha beta t cell morphology
|
0.6 |
false |
true |
0.25 |
IL2RB
|
decreased alpha-beta t cell number
|
0.6 |
true |
true |
0.25 |
IL2RG
|
abnormal t cell morphology
|
0.6 |
true |
true |
0.24 |
SLAMF1
|
abnormal alpha-beta t cell morphology
|
0.6 |
false |
true |
0.25 |
LCK
|
decreased leukocyte cell number
|
0.6 |
true |
true |
0.25 |
HOXB6
|
cervical vertebral transformation
|
0.6 |
true |
true |
0.25 |
RELB
|
abnormal lymphopoiesis
|
0.6 |
true |
true |
0.24 |
TRAT1
|
abnormal t cell number
|
0.6 |
false |
true |
0.25 |
TRAF1
|
abnormal b cell physiology
|
0.6 |
false |
true |
0.25 |
RELB
|
abnormal t cell physiology
|
0.6 |
true |
true |
0.25 |
IL4
|
abnormal immunoglobulin level
|
0.6 |
true |
true |
0.25 |
NFKB1
|
abnormal igg3 level
|
0.6 |
true |
true |
0.25 |
CCR2
|
autoimmune response
|
0.6 |
true |
true |
0.25 |
CD22
|
abnormal mature b cell morphology
|
0.6 |
true |
true |
0.25 |
IRF1
|
abnormal humoral immune response
|
0.6 |
true |
true |
0.25 |
RORA
|
abnormal pituitary hormone level
|
0.6 |
false |
true |
0.25 |
IL10
|
abnormal igg2a level
|
0.6 |
true |
true |
0.25 |
CCR5
|
abnormal igg level
|
0.6 |
true |
true |
0.25 |
ITGB7
|
abnormal immunoglobulin level
|
0.6 |
false |
true |
0.25 |
CD79A
|
abnormal igg2a level
|
0.6 |
false |
true |
0.25 |
NFKB1
|
abnormal igm level
|
0.6 |
true |
true |
0.25 |
IRF1
|
abnormal intercellular signaling peptide or protein level
|
0.6 |
true |
true |
0.25 |
HOXB3
|
abnormal vertebrae morphology
|
0.6 |
true |
true |
0.25 |
CCR5
|
abnormal cytokine secretion
|
0.6 |
true |
true |
0.25 |
FLT1
|
abnormal vascular development
|
0.6 |
true |
true |
0.25 |
BIRC3
|
abnormal t cell differentiation
|
0.6 |
true |
true |
0.25 |
IL4
|
abnormal intercellular signaling peptide or protein level
|
0.6 |
false |
true |
0.25 |
ITGB2
|
abnormal b cell physiology
|
0.6 |
true |
true |
0.25 |
IL10
|
increased susceptibility to infection induced morbidity/mortality
|
0.6 |
false |
true |
0.25 |
CD247
|
abnormal cd8-positive, alpha-beta t cell number
|
0.6 |
true |
true |
0.25 |
STAT1
|
altered susceptibility to viral infection
|
0.6 |
true |
true |
0.25 |
IL7R
|
abnormal b cell physiology
|
0.6 |
false |
true |
0.25 |
CXCR4
|
abnormal response to infection
|
0.6 |
true |
true |
0.25 |
MS4A1
|
abnormal professional antigen presenting cell physiology
|
0.6 |
true |
true |
0.25 |
CCR7
|
abnormal t cell morphology
|
0.6 |
true |
true |
0.25 |
IRF1
|
abnormal professional antigen presenting cell physiology
|
0.6 |
true |
true |
0.25 |
TRAF1
|
abnormal humoral immune response
|
0.6 |
false |
true |
0.25 |
CCL5
|
abnormal response to infection
|
0.6 |
false |
true |
0.25 |
IRF1
|
increased susceptibility to viral infection
|
0.6 |
true |
true |
0.25 |
SELL
|
abnormal b cell morphology
|
0.6 |
false |
true |
0.25 |
SELL
|
abnormal b cell number
|
0.6 |
false |
true |
0.25 |
HOXA4
|
abnormal pectoral girdle bone morphology
|
0.6 |
true |
true |
0.25 |
CCR2
|
abnormal acute inflammation
|
0.6 |
true |
true |
0.25 |
STAT1
|
abnormal circulating cytokine level
|
0.6 |
true |
true |
0.25 |
IL6
|
abnormal mononuclear phagocyte morphology
|
0.6 |
true |
true |
0.25 |
CD8A
|
abnormal t cell proliferation
|
0.6 |
false |
true |
0.25 |
CCR2
|
abnormal self tolerance
|
0.6 |
true |
true |
0.25 |
POU2AF1
|
abnormal b cell morphology
|
0.6 |
true |
true |
0.25 |
IL4
|
decreased immunoglobulin level
|
0.6 |
true |
true |
0.25 |
MS4A1
|
increased mature b cell number
|
0.6 |
false |
true |
0.25 |
CD37
|
abnormal lymphocyte physiology
|
0.6 |
true |
true |
0.25 |
CD19
|
abnormal lymphopoiesis
|
0.6 |
true |
true |
0.25 |
TLR2
|
abnormal tumor necrosis factor secretion
|
0.6 |
true |
true |
0.25 |
CCR5
|
abnormal alpha-beta t cell morphology
|
0.6 |
false |
true |
0.25 |
ITGB2
|
abnormal professional antigen presenting cell morphology
|
0.6 |
true |
true |
0.25 |
POU2AF1
|
abnormal b cell physiology
|
0.6 |
true |
true |
0.25 |
CXCL10
|
altered susceptibility to autoimmune disorder
|
0.6 |
true |
true |
0.25 |
RHOH
|
abnormal lymphopoiesis
|
0.6 |
true |
true |
0.25 |
IL7R
|
abnormal igg level
|
0.6 |
false |
true |
0.25 |
PTPRC
|
decreased t cell proliferation
|
0.6 |
true |
true |
0.25 |
NFKB1
|
abnormal gut-associated lymphoid tissue morphology
|
0.6 |
true |
true |
0.25 |
IL15
|
abnormal t cell morphology
|
0.6 |
true |
true |
0.25 |
HOXC4
|
abnormal thoracic cage morphology
|
0.6 |
true |
true |
0.25 |
CXCR5
|
abnormal b cell proliferation
|
0.6 |
false |
true |
0.25 |
ICAM1
|
altered susceptibility to infection
|
0.6 |
true |
true |
0.25 |
ZAP70
|
increased lymphocyte cell number
|
0.6 |
true |
true |
0.25 |
CCR5
|
abnormal acute inflammation
|
0.6 |
true |
true |
0.25 |
CD3E
|
abnormal lymphopoiesis
|
0.6 |
true |
true |
0.25 |
IL1B
|
abnormal type iv hypersensitivity reaction
|
0.6 |
true |
true |
0.25 |
CD5
|
abnormal alpha-beta t cell number
|
0.6 |
true |
true |
0.25 |
IL2
|
abnormal response to infection
|
0.6 |
true |
true |
0.25 |
ZAP70
|
abnormal double-positive t cell morphology
|
0.6 |
true |
true |
0.25 |
CCL5
|
abnormal cytokine level
|
0.6 |
false |
true |
0.25 |
IL13
|
increased susceptibility to infection induced morbidity/mortality
|
0.6 |
true |
true |
0.25 |
IL10
|
intestinal inflammation
|
0.6 |
true |
true |
0.25 |
CCR2
|
abnormal immune tolerance
|
0.6 |
true |
true |
0.25 |
CD79B
|
abnormal spleen marginal zone morphology
|
0.6 |
true |
true |
0.25 |
CCR5
|
increased immunoglobulin level
|
0.6 |
true |
true |
0.25 |
IL2RG
|
abnormal leukopoiesis
|
0.6 |
true |
true |
0.25 |
POU2AF1
|
decreased mature b cell number
|
0.6 |
true |
true |
0.25 |
CD3E
|
abnormal t cell activation
|
0.6 |
false |
true |
0.25 |
ITGAL
|
abnormal t cell activation
|
0.6 |
true |
true |
0.25 |
CD79B
|
decreased igg1 level
|
0.6 |
true |
true |
0.25 |
PTPN7
|
abnormal immunoglobulin level
|
0.6 |
false |
true |
0.25 |
IL4
|
decreased susceptibility to autoimmune disorder
|
0.6 |
true |
true |
0.25 |
PTPRC
|
increased t cell number
|
0.6 |
true |
true |
0.25 |
FLT1
|
abnormal cardiovascular development
|
0.6 |
true |
true |
0.25 |
CD247
|
abnormal cd8-positive, alpha beta t cell morphology
|
0.6 |
true |
true |
0.25 |
CD37
|
decreased mature b cell number
|
0.6 |
false |
true |
0.25 |
CD22
|
abnormal immunoglobulin level
|
0.6 |
true |
true |
0.25 |
CD19
|
decreased igm level
|
0.6 |
true |
true |
0.25 |
CCR2
|
abnormal cytokine secretion
|
0.6 |
true |
true |
0.25 |
ITGB7
|
abnormal b cell physiology
|
0.6 |
false |
true |
0.25 |
IL10
|
abnormal myeloid leukocyte morphology
|
0.6 |
true |
true |
0.25 |
PTPN7
|
decreased leukocyte cell number
|
0.6 |
false |
true |
0.25 |
PTPN7
|
abnormal igg level
|
0.6 |
false |
true |
0.25 |
IFNG
|
abnormal t cell differentiation
|
0.6 |
false |
true |
0.25 |
CD2
|
decreased leukocyte cell number
|
0.6 |
false |
true |
0.25 |
CD79B
|
increased b cell number
|
0.6 |
true |
true |
0.25 |
TRAT1
|
abnormal t cell morphology
|
0.6 |
false |
true |
0.25 |
NFKB2
|
abnormal igg level
|
0.6 |
true |
true |
0.25 |
IL15
|
altered susceptibility to bacterial infection
|
0.6 |
true |
true |
0.25 |
IL1B
|
decreased acute inflammation
|
0.6 |
true |
true |
0.25 |
IL6
|
increased susceptibility to bacterial infection
|
0.6 |
true |
true |
0.25 |
CCR5
|
abnormal immune serum protein physiology
|
0.6 |
true |
true |
0.25 |
STAT1
|
abnormal interleukin level
|
0.6 |
true |
true |
0.25 |
ZAP70
|
abnormal lymphocyte physiology
|
0.6 |
true |
true |
0.25 |
HOXB6
|
thoracic vertebral transformation
|
0.6 |
true |
true |
0.25 |
ZAP70
|
decreased t cell proliferation
|
0.6 |
true |
true |
0.25 |
CD2
|
abnormal lymphocyte physiology
|
0.6 |
false |
true |
0.25 |
CXCR4
|
abnormal interleukin secretion
|
0.6 |
false |
true |
0.25 |
HOXA3
|
abnormal thoracic cage morphology
|
0.6 |
false |
true |
0.25 |
CD3E
|
abnormal double-positive t cell morphology
|
0.6 |
true |
true |
0.25 |
CD3D
|
decreased t cell proliferation
|
0.6 |
false |
true |
0.25 |
CCR7
|
abnormal igg3 level
|
0.6 |
true |
true |
0.25 |
BLK
|
increased igm level
|
0.6 |
false |
true |
0.25 |
CD2
|
abnormal t cell activation
|
0.6 |
false |
true |
0.25 |
CD79B
|
decreased b cell proliferation
|
0.6 |
true |
true |
0.25 |
ITGAL
|
abnormal cd4-positive, alpha beta t cell number
|
0.6 |
true |
true |
0.25 |
STAT1
|
abnormal t cell number
|
0.6 |
true |
true |
0.25 |
HOXA4
|
abnormal sternum morphology
|
0.6 |
true |
true |
0.25 |
NFKB1
|
abnormal t cell activation
|
0.6 |
true |
true |
0.25 |
TLR2
|
abnormal innate immunity
|
0.6 |
true |
true |
0.25 |
IL7R
|
abnormal immune serum protein physiology
|
0.6 |
false |
true |
0.25 |
RELB
|
abnormal lymphocyte physiology
|
0.6 |
true |
true |
0.25 |
DUSP2
|
abnormal igg level
|
0.6 |
false |
true |
0.25 |
CD3E
|
abnormal t cell proliferation
|
0.6 |
false |
true |
0.25 |
CTGF
|
abnormal vascular development
|
0.6 |
true |
true |
0.25 |
ITGB7
|
abnormal humoral immune response
|
0.6 |
false |
true |
0.25 |
CCL5
|
altered susceptibility to infection
|
0.6 |
false |
true |
0.25 |
NFKB1
|
abnormal peyer's patch morphology
|
0.6 |
true |
true |
0.25 |
CCL5
|
abnormal intercellular signaling peptide or protein level
|
0.6 |
false |
true |
0.25 |
CD5
|
abnormal alpha-beta t cell morphology
|
0.6 |
true |
true |
0.25 |
NR3C1
|
abnormal pituitary hormone level
|
0.6 |
true |
true |
0.25 |
CD37
|
abnormal b cell activation
|
0.6 |
false |
true |
0.25 |
RORA
|
abnormal circulating pituitary hormone level
|
0.6 |
false |
true |
0.25 |
POU2AF1
|
abnormal b cell number
|
0.6 |
true |
true |
0.25 |
IL15
|
increased susceptibility to parasitic infection
|
0.6 |
true |
true |
0.25 |
NFKB1
|
increased immunoglobulin level
|
0.6 |
true |
true |
0.25 |
CCL5
|
abnormal b cell physiology
|
0.6 |
false |
true |
0.25 |
PTPRC
|
abnormal b cell number
|
0.6 |
true |
true |
0.25 |
SLAMF1
|
abnormal cd4-positive, alpha beta t cell morphology
|
0.6 |
false |
true |
0.25 |
BTK
|
abnormal b cell morphology
|
0.6 |
true |
true |
0.25 |
ITGAL
|
abnormal t cell proliferation
|
0.6 |
true |
true |
0.25 |
MS4A1
|
abnormal spleen b cell follicle morphology
|
0.6 |
false |
true |
0.25 |
ITGB7
|
abnormal effector t cell morphology
|
0.6 |
true |
true |
0.25 |
SELL
|
abnormal lymphocyte physiology
|
0.6 |
true |
true |
0.25 |
CD22
|
abnormal igg level
|
0.6 |
true |
true |
0.25 |
SELL
|
abnormal b cell physiology
|
0.6 |
false |
true |
0.25 |
CXCR5
|
abnormal b cell morphology
|
0.59 |
true |
true |
0.25 |
LCP2
|
abnormal t cell proliferation
|
0.59 |
true |
true |
0.25 |
IL15
|
abnormal t cell differentiation
|
0.59 |
true |
true |
0.25 |
IFNG
|
abnormal cd8-positive, alpha-beta t cell physiology
|
0.59 |
true |
true |
0.25 |
CCR7
|
abnormal immune serum protein physiology
|
0.59 |
true |
true |
0.25 |
POU2AF1
|
abnormal b cell activation
|
0.59 |
true |
true |
0.25 |
HOXA5
|
abnormal rib morphology
|
0.59 |
true |
true |
0.25 |
PTPRC
|
abnormal iga level
|
0.59 |
true |
true |
0.25 |
ESR1
|
abnormal response/metabolism to endogenous compounds
|
0.59 |
true |
true |
0.25 |
ITGAL
|
abnormal t cell morphology
|
0.59 |
true |
true |
0.25 |
PTPRC
|
decreased immunoglobulin level
|
0.59 |
false |
true |
0.25 |
IL2RB
|
abnormal cd8-positive, alpha-beta t cell number
|
0.59 |
true |
true |
0.25 |
IFNG
|
abnormal professional antigen presenting cell physiology
|
0.59 |
true |
true |
0.25 |
IFNG
|
abnormal professional antigen presenting cell morphology
|
0.59 |
false |
true |
0.25 |
IFNG
|
abnormal interferon-gamma secretion
|
0.59 |
true |
true |
0.25 |
HCK
|
abnormal immune serum protein physiology
|
0.59 |
true |
true |
0.25 |
IL6
|
large intestinal inflammation
|
0.59 |
true |
true |
0.25 |
PTPRC
|
abnormal igg2a level
|
0.59 |
true |
true |
0.25 |
IL13
|
increased susceptibility to parasitic infection
|
0.59 |
true |
true |
0.25 |
RARG
|
abnormal cervical vertebrae morphology
|
0.59 |
true |
true |
0.25 |
NFKB1
|
decreased igg3 level
|
0.59 |
true |
true |
0.25 |
IL13
|
abnormal cytokine secretion
|
0.59 |
true |
true |
0.25 |
CCR5
|
abnormal response to infection
|
0.59 |
true |
true |
0.25 |
IFNG
|
abnormal alpha-beta t cell number
|
0.59 |
true |
true |
0.25 |
HOXB4
|
abnormal vertebrae morphology
|
0.59 |
true |
true |
0.25 |
CCR1
|
altered susceptibility to bacterial infection
|
0.59 |
true |
true |
0.25 |
NR1I3
|
abnormal free fatty acids level
|
0.59 |
false |
true |
0.25 |
PTPRC
|
abnormal cd8-positive, alpha-beta t cell physiology
|
0.59 |
true |
true |
0.25 |
IFNG
|
abnormal humoral immune response
|
0.59 |
true |
true |
0.25 |
IL7R
|
abnormal lymphocyte physiology
|
0.59 |
true |
true |
0.25 |
HOXA7
|
abnormal rib morphology
|
0.59 |
false |
true |
0.25 |
TRAF1
|
abnormal lymphopoiesis
|
0.59 |
true |
true |
0.25 |
ITGB7
|
abnormal lymphocyte physiology
|
0.59 |
true |
true |
0.25 |
HOXB5
|
cervical vertebral transformation
|
0.59 |
true |
true |
0.25 |
CCR5
|
abnormal interleukin secretion
|
0.59 |
true |
true |
0.25 |
IL15
|
abnormal circulating interleukin level
|
0.59 |
false |
true |
0.25 |
CCR7
|
abnormal effector t cell morphology
|
0.59 |
true |
true |
0.25 |
IFNG
|
abnormal cd4-positive, alpha beta t cell morphology
|
0.59 |
false |
true |
0.25 |
HCK
|
autoimmune response
|
0.59 |
false |
true |
0.25 |
POU2AF1
|
abnormal igg level
|
0.59 |
true |
true |
0.25 |
MS4A1
|
abnormal lymphopoiesis
|
0.59 |
true |
true |
0.25 |
MS4A1
|
decreased b-1 b cell number
|
0.59 |
true |
true |
0.25 |
CD3D
|
increased lymphocyte cell number
|
0.59 |
false |
true |
0.25 |
LCP2
|
abnormal t cell differentiation
|
0.59 |
true |
true |
0.25 |
CD19
|
decreased b cell proliferation
|
0.59 |
true |
true |
0.25 |
MS4A1
|
abnormal igg2a level
|
0.59 |
false |
true |
0.25 |
CCR1
|
abnormal granulocyte physiology
|
0.59 |
true |
true |
0.25 |
MDM2
|
abnormal response to radiation
|
0.59 |
true |
true |
0.25 |
MDM2
|
abnormal mortality induced by ionizing radiation
|
0.59 |
true |
true |
0.25 |
CCR7
|
abnormal leukocyte migration
|
0.59 |
true |
true |
0.25 |
HCK
|
abnormal self tolerance
|
0.59 |
false |
true |
0.25 |
STAT1
|
abnormal interferon-gamma secretion
|
0.59 |
true |
true |
0.25 |
CD79A
|
decreased igg3 level
|
0.59 |
true |
true |
0.25 |
HOXB7
|
abnormal cervical vertebrae morphology
|
0.59 |
false |
true |
0.25 |
PTPN7
|
abnormal humoral immune response
|
0.59 |
false |
true |
0.25 |
CD19
|
increased immunoglobulin level
|
0.59 |
false |
true |
0.25 |
CCR7
|
decreased leukocyte cell number
|
0.59 |
true |
true |
0.25 |
BIRC3
|
abnormal t cell physiology
|
0.59 |
true |
true |
0.25 |
PRKCB
|
decreased b cell number
|
0.59 |
true |
true |
0.25 |
RELB
|
abnormal t cell activation
|
0.59 |
true |
true |
0.25 |
BTK
|
abnormal b cell physiology
|
0.59 |
true |
true |
0.25 |
NR1I3
|
abnormal circulating free fatty acids level
|
0.59 |
false |
true |
0.25 |
HOXA4
|
abnormal rib morphology
|
0.59 |
true |
true |
0.25 |
HCK
|
abnormal immune tolerance
|
0.59 |
false |
true |
0.25 |
NCF4
|
abnormal b cell physiology
|
0.59 |
false |
true |
0.25 |
CSF2
|
abnormal cytokine level
|
0.59 |
false |
true |
0.25 |
PTPN7
|
abnormal b cell physiology
|
0.59 |
false |
true |
0.26 |
ITGB2
|
abnormal interleukin secretion
|
0.59 |
false |
true |
0.26 |
CCL5
|
abnormal innate immunity
|
0.59 |
false |
true |
0.26 |
ITGB2
|
increased immunoglobulin level
|
0.59 |
true |
true |
0.26 |
CCR7
|
abnormal spleen white pulp morphology
|
0.59 |
true |
true |
0.26 |
SELL
|
abnormal immunoglobulin level
|
0.59 |
false |
true |
0.26 |
ITGB7
|
abnormal cd4-positive, alpha beta t cell morphology
|
0.59 |
true |
true |
0.26 |
CXCL10
|
altered susceptibility to bacterial infection
|
0.59 |
false |
true |
0.26 |
CD3D
|
decreased double-positive t cell number
|
0.59 |
false |
true |
0.26 |
IL6
|
abnormal induced morbidity/mortality
|
0.59 |
true |
true |
0.26 |
CCR1
|
abnormal humoral immune response
|
0.59 |
true |
true |
0.26 |
MAP4K1
|
abnormal lymphopoiesis
|
0.59 |
true |
true |
0.26 |
CD22
|
abnormal b cell physiology
|
0.59 |
true |
true |
0.26 |
CD3D
|
abnormal double-negative t cell morphology
|
0.59 |
false |
true |
0.26 |
ITGB2
|
abnormal self tolerance
|
0.59 |
false |
true |
0.26 |
CCR5
|
abnormal t cell morphology
|
0.59 |
true |
true |
0.26 |
RHOH
|
abnormal effector t cell morphology
|
0.59 |
true |
true |
0.26 |
CD5
|
decreased alpha-beta t cell number
|
0.59 |
true |
true |
0.26 |
CD2
|
abnormal t cell proliferation
|
0.59 |
false |
true |
0.26 |
HOXB4
|
abnormal rib morphology
|
0.59 |
false |
true |
0.26 |
ZAP70
|
abnormal lymphocyte cell number
|
0.59 |
true |
true |
0.26 |
CD6
|
abnormal lymphopoiesis
|
0.59 |
false |
false |
0.26 |
ITGB2
|
abnormal immune tolerance
|
0.59 |
false |
true |
0.26 |
CCR7
|
decreased mature b cell number
|
0.59 |
false |
true |
0.26 |
IL6
|
altered susceptibility to autoimmune disorder
|
0.59 |
true |
true |
0.26 |
IL2RB
|
decreased t cell number
|
0.59 |
true |
true |
0.26 |
POU2AF1
|
abnormal lymphopoiesis
|
0.59 |
true |
true |
0.26 |
NCF4
|
abnormal immunoglobulin level
|
0.59 |
false |
true |
0.26 |
CCL5
|
decreased t cell proliferation
|
0.59 |
true |
true |
0.26 |
HOXA7
|
abnormal rib attachment
|
0.59 |
false |
true |
0.26 |
SELL
|
abnormal humoral immune response
|
0.59 |
false |
true |
0.26 |
CD5
|
abnormal effector t cell morphology
|
0.59 |
true |
true |
0.26 |
IL2RG
|
abnormal cd4-positive, alpha beta t cell number
|
0.59 |
false |
true |
0.26 |
DUSP2
|
abnormal immunoglobulin level
|
0.59 |
false |
true |
0.26 |
NCF4
|
abnormal humoral immune response
|
0.59 |
false |
true |
0.26 |
CCL5
|
abnormal t cell number
|
0.59 |
true |
true |
0.26 |
CD19
|
decreased b-1 b cell number
|
0.59 |
true |
true |
0.26 |
SLAMF1
|
abnormal t cell number
|
0.59 |
false |
true |
0.26 |
ITGAL
|
abnormal t cell physiology
|
0.59 |
true |
true |
0.26 |
TLR2
|
abnormal interleukin secretion
|
0.59 |
true |
true |
0.26 |
CCR5
|
abnormal alpha-beta t cell number
|
0.59 |
false |
true |
0.26 |
BIRC3
|
abnormal interferon-gamma secretion
|
0.59 |
true |
true |
0.26 |
CD37
|
increased b cell number
|
0.59 |
false |
true |
0.26 |
ITGAX
|
autoimmune response
|
0.59 |
true |
true |
0.26 |
CSF2
|
abnormal circulating cytokine level
|
0.59 |
false |
true |
0.26 |
CD37
|
decreased b cell number
|
0.59 |
false |
true |
0.27 |
TNFSF10
|
abnormal interferon-gamma secretion
|
0.59 |
true |
true |
0.26 |
PTPRC
|
increased b cell number
|
0.59 |
true |
true |
0.26 |
CCR2
|
abnormal professional antigen presenting cell physiology
|
0.59 |
true |
true |
0.26 |
CD19
|
abnormal transitional stage b cell morphology
|
0.59 |
false |
true |
0.26 |
ITGB2
|
autoimmune response
|
0.59 |
false |
true |
0.27 |
CCR5
|
altered susceptibility to infection
|
0.59 |
true |
true |
0.27 |
CSF2
|
abnormal intercellular signaling peptide or protein level
|
0.59 |
false |
true |
0.27 |
CD8A
|
abnormal t cell morphology
|
0.59 |
true |
true |
0.27 |
BTK
|
abnormal immunoglobulin level
|
0.59 |
true |
true |
0.27 |
PTPN7
|
decreased cd4-positive, alpha beta t cell number
|
0.59 |
false |
true |
0.27 |
IL10RA
|
abnormal cd8-positive, alpha-beta t cell number
|
0.59 |
false |
true |
0.27 |
HCK
|
abnormal cytokine secretion
|
0.59 |
true |
true |
0.27 |
CD86
|
abnormal interleukin secretion
|
0.59 |
false |
true |
0.27 |
RELB
|
abnormal b cell activation
|
0.59 |
true |
true |
0.27 |
ITGAX
|
abnormal self tolerance
|
0.59 |
true |
true |
0.27 |
IL10
|
decreased immunoglobulin level
|
0.59 |
false |
true |
0.27 |
CSF2
|
abnormal interleukin level
|
0.59 |
false |
true |
0.27 |
IRF1
|
abnormal innate immunity
|
0.59 |
true |
true |
0.27 |
CCR5
|
abnormal t cell number
|
0.59 |
true |
true |
0.27 |
ITGB7
|
abnormal alpha-beta t cell morphology
|
0.59 |
true |
true |
0.27 |
HOXA4
|
vertebral transformation
|
0.59 |
true |
true |
0.27 |
IL1B
|
autoimmune response
|
0.58 |
true |
true |
0.27 |
CD48
|
abnormal immunoglobulin level
|
0.58 |
false |
true |
0.27 |
IL6
|
abnormal interferon level
|
0.58 |
true |
true |
0.27 |
HOXA7
|
abnormal cervical vertebrae morphology
|
0.58 |
false |
true |
0.27 |
HOXA6
|
abnormal thoracic cage morphology
|
0.58 |
true |
true |
0.27 |
IL10
|
abnormal lymphocyte physiology
|
0.58 |
true |
true |
0.27 |
IL4
|
abnormal humoral immune response
|
0.58 |
true |
true |
0.27 |
CD69
|
abnormal immunoglobulin level
|
0.58 |
true |
true |
0.27 |
CD79A
|
abnormal igg2b level
|
0.58 |
true |
true |
0.27 |
PTPRC
|
abnormal b cell morphology
|
0.58 |
true |
true |
0.27 |
CD79A
|
abnormal leukopoiesis
|
0.58 |
true |
true |
0.27 |
BIRC3
|
abnormal t cell activation
|
0.58 |
true |
true |
0.27 |
IL1B
|
abnormal self tolerance
|
0.58 |
true |
true |
0.27 |
CXCR4
|
abnormal cytokine secretion
|
0.58 |
false |
true |
0.27 |
SELL
|
abnormal lymphopoiesis
|
0.58 |
true |
true |
0.27 |
IRF1
|
abnormal interleukin secretion
|
0.58 |
false |
true |
0.27 |
IL13
|
abnormal interferon-gamma secretion
|
0.58 |
true |
true |
0.27 |
CD22
|
abnormal b cell differentiation
|
0.58 |
true |
true |
0.27 |
CCL5
|
abnormal alpha-beta t cell number
|
0.58 |
true |
true |
0.27 |
CCR1
|
abnormal type iv hypersensitivity reaction
|
0.58 |
true |
true |
0.27 |
CCR5
|
abnormal t cell proliferation
|
0.58 |
true |
true |
0.27 |
IL13
|
abnormal interleukin level
|
0.58 |
true |
true |
0.27 |
CCL5
|
abnormal alpha-beta t cell morphology
|
0.58 |
true |
true |
0.27 |
ITGAX
|
abnormal immune tolerance
|
0.58 |
true |
true |
0.27 |
CCL5
|
abnormal immunoglobulin level
|
0.58 |
false |
true |
0.27 |
SH2D1A
|
abnormal t cell physiology
|
0.58 |
true |
true |
0.27 |
BTK
|
decreased mature b cell number
|
0.58 |
true |
true |
0.27 |
NFKB2
|
abnormal cytokine secretion
|
0.58 |
true |
true |
0.27 |
BLK
|
abnormal lymphopoiesis
|
0.58 |
false |
true |
0.27 |
CD5
|
abnormal t cell differentiation
|
0.58 |
true |
true |
0.27 |
PRKCB
|
decreased mature b cell number
|
0.58 |
true |
true |
0.27 |
CD19
|
decreased immature b cell number
|
0.58 |
false |
true |
0.27 |
CSF2
|
increased susceptibility to parasitic infection
|
0.58 |
true |
true |
0.27 |
ICAM1
|
abnormal response to infection
|
0.58 |
true |
true |
0.27 |
ESR1
|
abnormal circulating insulin-like growth factor i level
|
0.58 |
true |
true |
0.27 |
TRAT1
|
abnormal t cell physiology
|
0.58 |
false |
true |
0.27 |
CCR2
|
abnormal t cell physiology
|
0.58 |
true |
true |
0.27 |
IFNG
|
abnormal immune serum protein physiology
|
0.58 |
true |
true |
0.27 |
IFNG
|
abnormal t cell activation
|
0.58 |
false |
true |
0.27 |
IL15
|
abnormal innate immunity
|
0.58 |
true |
true |
0.27 |
SLAMF1
|
abnormal effector t cell morphology
|
0.58 |
false |
true |
0.27 |
IL1B
|
altered susceptibility to autoimmune disorder
|
0.58 |
true |
true |
0.27 |
CD6
|
increased t cell number
|
0.58 |
false |
false |
0.27 |
IL1B
|
abnormal immune tolerance
|
0.58 |
true |
true |
0.27 |
CD79B
|
abnormal immature b cell morphology
|
0.58 |
true |
true |
0.27 |
PTPRC
|
abnormal professional antigen presenting cell morphology
|
0.58 |
true |
true |
0.27 |
IL15
|
abnormal t cell number
|
0.58 |
true |
true |
0.27 |
HOXB7
|
abnormal rib morphology
|
0.58 |
true |
true |
0.27 |
NR1I3
|
abnormal fatty acid level
|
0.58 |
false |
true |
0.27 |
TNFSF13B
|
abnormal interleukin secretion
|
0.58 |
false |
true |
0.27 |
SELL
|
increased lymphocyte cell number
|
0.58 |
false |
true |
0.27 |
IL4
|
abnormal interleukin level
|
0.58 |
false |
true |
0.27 |
HOXA4
|
abnormal vertebrae morphology
|
0.58 |
true |
true |
0.27 |
IL6
|
abnormal macrophage physiology
|
0.58 |
true |
true |
0.27 |
IL7R
|
abnormal professional antigen presenting cell physiology
|
0.58 |
false |
true |
0.27 |
POU2AF1
|
abnormal immunoglobulin level
|
0.58 |
true |
true |
0.27 |
CCR5
|
abnormal t cell activation
|
0.58 |
true |
true |
0.27 |
CXCR4
|
abnormal induced morbidity/mortality
|
0.58 |
true |
true |
0.27 |
IRF1
|
abnormal t cell number
|
0.58 |
true |
true |
0.27 |
CD79B
|
decreased igm level
|
0.58 |
false |
true |
0.27 |
SH2D1A
|
abnormal t cell proliferation
|
0.58 |
true |
true |
0.27 |
HOXB4
|
vertebral transformation
|
0.58 |
true |
true |
0.27 |
CD79A
|
abnormal iga level
|
0.58 |
false |
true |
0.27 |
IFNG
|
impaired natural killer cell mediated cytotoxicity
|
0.58 |
true |
true |
0.27 |
BTK
|
abnormal humoral immune response
|
0.58 |
true |
true |
0.27 |
CCR2
|
abnormal immunoglobulin level
|
0.58 |
true |
true |
0.27 |
SLAMF1
|
decreased t cell number
|
0.58 |
false |
true |
0.27 |
ITGB7
|
abnormal lymphopoiesis
|
0.58 |
false |
true |
0.27 |
BLK
|
decreased marginal zone b cell number
|
0.58 |
false |
true |
0.27 |
NFKB1
|
abnormal t cell proliferation
|
0.58 |
true |
true |
0.27 |
LCP2
|
abnormal t cell physiology
|
0.58 |
true |
true |
0.27 |
TLR1
|
abnormal professional antigen presenting cell physiology
|
0.58 |
true |
true |
0.27 |
HOXB3
|
abnormal cervical vertebrae morphology
|
0.58 |
true |
true |
0.27 |
NFKB2
|
abnormal igm level
|
0.58 |
true |
true |
0.27 |
STAT1
|
abnormal nk cell physiology
|
0.58 |
true |
true |
0.27 |
CD3D
|
abnormal lymphocyte physiology
|
0.58 |
false |
true |
0.27 |
CXCL10
|
abnormal circulating interleukin level
|
0.58 |
false |
true |
0.27 |
RHOH
|
abnormal leukopoiesis
|
0.58 |
true |
true |
0.27 |
CXCR5
|
decreased mature b cell number
|
0.58 |
false |
true |
0.27 |
BTK
|
abnormal lymphopoiesis
|
0.58 |
true |
true |
0.27 |
IFNG
|
abnormal phagocyte morphology
|
0.58 |
true |
true |
0.27 |
RELB
|
abnormal t cell proliferation
|
0.58 |
true |
true |
0.27 |
ITK
|
abnormal thymus morphology
|
0.58 |
true |
true |
0.27 |
SYK
|
abnormal b cell physiology
|
0.58 |
true |
true |
0.27 |
CD22
|
abnormal humoral immune response
|
0.58 |
true |
true |
0.27 |
CD8A
|
abnormal effector t cell morphology
|
0.58 |
true |
true |
0.27 |
HOXB7
|
abnormal sternum morphology
|
0.58 |
true |
true |
0.27 |
PTPRC
|
abnormal macrophage physiology
|
0.58 |
true |
true |
0.27 |
CCR5
|
abnormal hypersensitivity reaction
|
0.58 |
true |
true |
0.27 |
CXCR4
|
decreased immature b cell number
|
0.58 |
true |
true |
0.27 |
CD247
|
decreased alpha-beta t cell number
|
0.58 |
true |
true |
0.27 |
IL4
|
abnormal igg level
|
0.58 |
true |
true |
0.27 |
IL10
|
decreased inflammatory response
|
0.58 |
false |
true |
0.27 |
CFLAR
|
abnormal immunoglobulin level
|
0.58 |
false |
true |
0.27 |
CXCR5
|
abnormal b cell number
|
0.58 |
true |
true |
0.27 |
IL2RG
|
abnormal cytokine secretion
|
0.58 |
true |
true |
0.27 |
ITGB7
|
abnormal alpha-beta t cell number
|
0.58 |
true |
true |
0.27 |
IL10RA
|
abnormal b cell physiology
|
0.58 |
true |
true |
0.27 |
STAT1
|
abnormal circulating interleukin level
|
0.58 |
true |
true |
0.27 |
CD5
|
abnormal cd4-positive, alpha beta t cell number
|
0.58 |
true |
true |
0.27 |
ITGAL
|
abnormal lymphopoiesis
|
0.58 |
true |
true |
0.27 |
IL1B
|
decreased susceptibility to autoimmune disorder
|
0.58 |
true |
true |
0.27 |
BLK
|
abnormal igg2b level
|
0.58 |
false |
true |
0.27 |
POU2AF1
|
abnormal humoral immune response
|
0.58 |
true |
true |
0.27 |
EGFR
|
abnormal innervation
|
0.58 |
true |
true |
0.27 |
NFKB2
|
abnormal humoral immune response
|
0.58 |
true |
true |
0.27 |
NR3C1
|
abnormal circulating gonadotropin level
|
0.58 |
false |
true |
0.27 |
ICAM1
|
abnormal acute inflammation
|
0.58 |
true |
true |
0.27 |
BIRC3
|
abnormal t cell morphology
|
0.58 |
true |
true |
0.27 |
ZAP70
|
decreased leukocyte cell number
|
0.58 |
true |
true |
0.27 |
CCR2
|
abnormal lymphocyte physiology
|
0.58 |
true |
true |
0.27 |
ITGAL
|
abnormal lymphocyte physiology
|
0.58 |
true |
true |
0.27 |
CCR2
|
decreased susceptibility to autoimmune disorder
|
0.58 |
true |
true |
0.26 |
IL6
|
abnormal response to injury
|
0.58 |
true |
true |
0.26 |
LCK
|
decreased double-positive t cell number
|
0.58 |
true |
true |
0.26 |
ITK
|
abnormal double-positive t cell morphology
|
0.58 |
false |
true |
0.27 |
IFNG
|
abnormal circulating cytokine level
|
0.58 |
true |
true |
0.26 |
IL6
|
intestinal inflammation
|
0.58 |
true |
true |
0.26 |
NFKB1
|
abnormal professional antigen presenting cell physiology
|
0.58 |
true |
true |
0.26 |
TLR2
|
abnormal interleukin-6 secretion
|
0.58 |
true |
true |
0.26 |
TNFSF10
|
abnormal response to infection
|
0.58 |
true |
true |
0.26 |
CXCL10
|
abnormal t cell physiology
|
0.58 |
true |
true |
0.26 |
CCR5
|
abnormal interferon secretion
|
0.58 |
true |
true |
0.26 |
PTPRC
|
abnormal lymph node size
|
0.58 |
true |
true |
0.26 |
CCR5
|
abnormal lymphocyte physiology
|
0.58 |
true |
true |
0.26 |
IL7R
|
abnormal cytokine secretion
|
0.58 |
false |
true |
0.26 |
NFKB1
|
decreased lymphocyte cell number
|
0.58 |
true |
true |
0.26 |
IFNG
|
abnormal interleukin level
|
0.58 |
true |
true |
0.26 |
CD86
|
abnormal interferon-gamma secretion
|
0.58 |
true |
true |
0.26 |
CD37
|
abnormal professional antigen presenting cell physiology
|
0.58 |
true |
true |
0.26 |
CXCR4
|
abnormal acute inflammation
|
0.58 |
false |
true |
0.26 |
RELB
|
abnormal b cell physiology
|
0.58 |
true |
true |
0.26 |
LCP2
|
abnormal lymphocyte physiology
|
0.58 |
true |
true |
0.26 |
CXCR4
|
abnormal t cell physiology
|
0.58 |
false |
true |
0.26 |
IFNG
|
abnormal natural killer cell mediated cytotoxicity
|
0.58 |
true |
true |
0.26 |
CD3D
|
abnormal lymphocyte cell number
|
0.58 |
true |
true |
0.26 |
CCR2
|
abnormal hypersensitivity reaction
|
0.58 |
true |
true |
0.26 |
DUSP2
|
abnormal humoral immune response
|
0.58 |
false |
true |
0.26 |
CCR5
|
abnormal t cell differentiation
|
0.58 |
true |
true |
0.26 |
CCR2
|
abnormal interferon-gamma secretion
|
0.58 |
true |
true |
0.26 |
IL4
|
abnormal b cell physiology
|
0.58 |
true |
true |
0.26 |
ESR1
|
abnormal osteoblast cell number
|
0.58 |
true |
true |
0.26 |
STAT1
|
abnormal interferon level
|
0.58 |
true |
true |
0.26 |
MS4A1
|
decreased igg3 level
|
0.58 |
false |
true |
0.26 |
CSF2RB
|
abnormal immunoglobulin level
|
0.58 |
false |
true |
0.26 |
CXCR3
|
abnormal t cell morphology
|
0.58 |
false |
true |
0.26 |
CSF2RB
|
abnormal humoral immune response
|
0.58 |
false |
true |
0.26 |
HCK
|
abnormal professional antigen presenting cell physiology
|
0.58 |
true |
true |
0.26 |
ESR1
|
abnormal insulin-like growth factor i level
|
0.58 |
true |
true |
0.26 |
CD69
|
abnormal b cell physiology
|
0.58 |
true |
true |
0.26 |
CD48
|
abnormal humoral immune response
|
0.58 |
false |
true |
0.26 |
NFKB2
|
abnormal t cell activation
|
0.58 |
true |
true |
0.26 |
CCR1
|
abnormal b cell physiology
|
0.58 |
true |
true |
0.26 |
IL10RA
|
autoimmune response
|
0.58 |
true |
true |
0.26 |
VAV1
|
decreased b cell number
|
0.58 |
true |
true |
0.26 |
HOXA3
|
abnormal pectoral girdle bone morphology
|
0.58 |
true |
true |
0.26 |
CD37
|
abnormal spleen white pulp morphology
|
0.58 |
true |
true |
0.26 |
ITGB2
|
abnormal cd4-positive, alpha beta t cell morphology
|
0.58 |
true |
true |
0.26 |
NFKB1
|
abnormal immune serum protein physiology
|
0.58 |
true |
true |
0.26 |
IFNG
|
abnormal cd4-positive, alpha-beta t cell physiology
|
0.58 |
false |
true |
0.26 |
IL4
|
intestinal inflammation
|
0.58 |
true |
true |
0.26 |
TNFSF10
|
altered susceptibility to infection
|
0.58 |
true |
true |
0.26 |
STAT1
|
abnormal cytokine secretion
|
0.58 |
true |
true |
0.26 |
CXCR5
|
decreased immunoglobulin level
|
0.57 |
false |
true |
0.26 |
CSF2RB
|
abnormal lymphopoiesis
|
0.57 |
false |
true |
0.26 |
RHOH
|
abnormal alpha-beta t cell number
|
0.57 |
true |
true |
0.26 |
HOXA5
|
abnormal rib attachment
|
0.57 |
true |
true |
0.26 |
CSF2RB
|
abnormal b cell physiology
|
0.57 |
false |
true |
0.26 |
CSF2
|
increased susceptibility to infection
|
0.57 |
true |
true |
0.26 |
PTPRC
|
decreased cd8-positive, alpha-beta t cell number
|
0.57 |
true |
true |
0.26 |
CD79B
|
abnormal igg3 level
|
0.57 |
false |
true |
0.26 |
IL15
|
abnormal circulating cytokine level
|
0.57 |
false |
true |
0.27 |
CCR5
|
increased igg level
|
0.57 |
true |
true |
0.26 |
IL2RA
|
abnormal t cell physiology
|
0.57 |
true |
true |
0.26 |
CCR2
|
abnormal immune serum protein physiology
|
0.57 |
true |
true |
0.26 |
IL6
|
altered susceptibility to parasitic infection
|
0.57 |
true |
true |
0.26 |
CCR2
|
abnormal b cell physiology
|
0.57 |
true |
true |
0.26 |
IL10RA
|
abnormal self tolerance
|
0.57 |
true |
true |
0.26 |
HCK
|
abnormal immunoglobulin level
|
0.57 |
false |
true |
0.26 |
ITGB7
|
abnormal t cell morphology
|
0.57 |
true |
true |
0.26 |
RELB
|
abnormal immune serum protein physiology
|
0.57 |
true |
true |
0.26 |
RHOH
|
abnormal alpha-beta t cell morphology
|
0.57 |
true |
true |
0.26 |
CD79B
|
abnormal lymphopoiesis
|
0.57 |
true |
true |
0.26 |
IL10RA
|
abnormal humoral immune response
|
0.57 |
true |
true |
0.26 |
CSF2RB
|
abnormal t cell differentiation
|
0.57 |
false |
true |
0.26 |
CD3E
|
decreased lymphocyte cell number
|
0.57 |
true |
true |
0.26 |
STAT1
|
abnormal circulating interferon level
|
0.57 |
true |
true |
0.26 |
NR3C1
|
increased circulating pituitary hormone level
|
0.57 |
true |
true |
0.26 |
PTPRC
|
autoimmune response
|
0.57 |
true |
true |
0.26 |
SH2D1A
|
abnormal t cell activation
|
0.57 |
true |
true |
0.26 |
HOXB7
|
vertebral transformation
|
0.57 |
false |
true |
0.26 |
CD27
|
abnormal lymphopoiesis
|
0.57 |
false |
true |
0.26 |
CCR5
|
abnormal t cell physiology
|
0.57 |
true |
true |
0.26 |
NFKB2
|
abnormal t cell proliferation
|
0.57 |
true |
true |
0.26 |
SLAMF1
|
abnormal t cell morphology
|
0.57 |
false |
true |
0.26 |
CD79A
|
decreased b-1 b cell number
|
0.57 |
true |
true |
0.26 |
IL2RG
|
abnormal interleukin secretion
|
0.57 |
true |
true |
0.26 |
IL4
|
abnormal professional antigen presenting cell physiology
|
0.57 |
true |
true |
0.26 |
CD14
|
altered susceptibility to infection
|
0.57 |
true |
true |
0.26 |
CCR7
|
abnormal ige level
|
0.57 |
true |
true |
0.26 |
IL4
|
abnormal immune serum protein physiology
|
0.57 |
true |
true |
0.26 |
CCR7
|
increased leukocyte cell number
|
0.57 |
true |
true |
0.26 |
IL2RG
|
abnormal cd8-positive, alpha beta t cell morphology
|
0.57 |
true |
true |
0.26 |
IRF1
|
abnormal igg level
|
0.57 |
true |
true |
0.26 |
NR3C1
|
increased pituitary hormone level
|
0.57 |
true |
true |
0.26 |
MS4A1
|
abnormal igg2b level
|
0.57 |
false |
true |
0.26 |
IL2RG
|
abnormal interferon-gamma secretion
|
0.57 |
true |
true |
0.26 |
CD86
|
abnormal interferon secretion
|
0.57 |
true |
true |
0.26 |
CXCL10
|
autoimmune response
|
0.57 |
true |
true |
0.26 |
PTPRC
|
abnormal self tolerance
|
0.57 |
true |
true |
0.26 |
BTK
|
decreased b cell number
|
0.57 |
true |
true |
0.26 |
IL15
|
abnormal dendritic cell physiology
|
0.57 |
true |
true |
0.26 |
PPARG
|
abnormal free fatty acids level
|
0.57 |
true |
true |
0.26 |
CCR7
|
abnormal t cell number
|
0.57 |
true |
true |
0.26 |
LCK
|
abnormal thymus morphology
|
0.57 |
true |
true |
0.26 |
PPARG
|
abnormal circulating free fatty acids level
|
0.57 |
true |
true |
0.26 |
CCL5
|
abnormal humoral immune response
|
0.57 |
false |
true |
0.26 |
RELB
|
abnormal t cell differentiation
|
0.57 |
true |
true |
0.26 |
IL1B
|
abnormal cytokine level
|
0.57 |
true |
true |
0.26 |
IL10RA
|
abnormal immune tolerance
|
0.57 |
true |
true |
0.26 |
STAT1
|
abnormal circulating interferon-gamma level
|
0.57 |
true |
true |
0.26 |
FLT1
|
abnormal artery morphology
|
0.57 |
true |
true |
0.26 |
HOXB3
|
abnormal thoracic cage morphology
|
0.57 |
false |
true |
0.26 |
IFNG
|
decreased lymphocyte cell number
|
0.57 |
false |
true |
0.26 |
CXCR3
|
abnormal t cell number
|
0.57 |
false |
true |
0.26 |
STAT1
|
increased susceptibility to viral infection
|
0.57 |
true |
true |
0.26 |
HOXB7
|
abnormal thoracic vertebrae morphology
|
0.57 |
false |
true |
0.26 |
LCP2
|
abnormal cytokine secretion
|
0.57 |
true |
true |
0.26 |
ITK
|
abnormal lymphocyte cell number
|
0.57 |
true |
true |
0.26 |
POU2AF1
|
abnormal b cell proliferation
|
0.57 |
true |
true |
0.26 |
CCR7
|
abnormal granulocyte physiology
|
0.57 |
false |
true |
0.26 |
CCL5
|
abnormal interleukin-4 secretion
|
0.57 |
false |
true |
0.26 |
ITGB2
|
abnormal acute inflammation
|
0.57 |
true |
true |
0.26 |
IL2RB
|
abnormal leukopoiesis
|
0.57 |
true |
true |
0.26 |
ITGAL
|
abnormal t cell number
|
0.57 |
true |
true |
0.26 |
IRF1
|
abnormal alpha-beta t cell morphology
|
0.57 |
true |
true |
0.26 |
TGFB1
|
abnormal immunoglobulin level
|
0.57 |
false |
true |
0.26 |
CCR2
|
abnormal humoral immune response
|
0.57 |
true |
true |
0.26 |
CD6
|
decreased lymphocyte cell number
|
0.57 |
false |
false |
0.26 |
HOXA3
|
vertebral transformation
|
0.57 |
false |
true |
0.26 |
CXCL10
|
abnormal interleukin secretion
|
0.57 |
false |
true |
0.26 |
PTPRC
|
abnormal immune tolerance
|
0.57 |
true |
true |
0.26 |
TRAT1
|
abnormal t cell proliferation
|
0.57 |
false |
true |
0.26 |
CD5
|
abnormal cd4-positive, alpha beta t cell morphology
|
0.57 |
true |
true |
0.26 |
SLAMF1
|
decreased alpha-beta t cell number
|
0.57 |
false |
true |
0.26 |
SLAMF1
|
abnormal t cell physiology
|
0.57 |
true |
true |
0.26 |
IRF1
|
abnormal interleukin level
|
0.57 |
true |
true |
0.26 |
CCR5
|
abnormal interferon-gamma secretion
|
0.57 |
true |
true |
0.26 |
CCR5
|
increased susceptibility to infection
|
0.57 |
true |
true |
0.26 |
RELB
|
abnormal b cell proliferation
|
0.57 |
true |
true |
0.26 |
IL1B
|
abnormal intercellular signaling peptide or protein level
|
0.57 |
true |
true |
0.26 |
IFNG
|
decreased t cell number
|
0.57 |
false |
true |
0.26 |
HCK
|
abnormal innate immunity
|
0.57 |
true |
true |
0.26 |
IFNG
|
abnormal acute inflammation
|
0.57 |
true |
true |
0.26 |
IRF1
|
abnormal circulating cytokine level
|
0.57 |
true |
true |
0.26 |
CCR7
|
abnormal t cell physiology
|
0.57 |
true |
true |
0.26 |
PTGS2
|
autoimmune response
|
0.57 |
true |
true |
0.26 |
IL13
|
abnormal interferon secretion
|
0.57 |
true |
true |
0.26 |
CD48
|
abnormal cd4-positive, alpha beta t cell morphology
|
0.57 |
true |
true |
0.26 |
CCR1
|
abnormal cytokine level
|
0.57 |
true |
true |
0.26 |
CXCL10
|
abnormal self tolerance
|
0.57 |
true |
true |
0.26 |
HOXA4
|
abnormal cervical vertebrae morphology
|
0.57 |
true |
true |
0.26 |
IFNG
|
abnormal b cell physiology
|
0.57 |
true |
true |
0.26 |
CD5
|
abnormal cd8-positive, alpha beta t cell morphology
|
0.57 |
false |
true |
0.26 |
IL1B
|
abnormal acute inflammation
|
0.57 |
true |
true |
0.26 |
IFNG
|
abnormal cytokine secretion
|
0.57 |
true |
true |
0.26 |
HCK
|
abnormal humoral immune response
|
0.57 |
false |
true |
0.26 |
CCL5
|
abnormal cd4-positive, alpha beta t cell number
|
0.57 |
true |
true |
0.26 |
CCR7
|
decreased inflammatory response
|
0.57 |
true |
true |
0.26 |
CD8A
|
abnormal cd8-positive, alpha beta t cell morphology
|
0.57 |
true |
true |
0.26 |
CXCR3
|
abnormal effector t cell morphology
|
0.57 |
false |
true |
0.26 |
TLR1
|
abnormal cytokine secretion
|
0.57 |
true |
true |
0.26 |
IL15
|
abnormal igm level
|
0.57 |
true |
true |
0.26 |
IL6
|
increased susceptibility to parasitic infection
|
0.57 |
true |
true |
0.26 |
CD79B
|
increased immunoglobulin level
|
0.57 |
true |
true |
0.26 |
VAV1
|
abnormal b cell morphology
|
0.57 |
true |
true |
0.26 |
CXCR4
|
abnormal cell migration
|
0.57 |
true |
true |
0.26 |
IL2RG
|
abnormal interleukin-2 secretion
|
0.57 |
true |
true |
0.26 |
NR1H2
|
abnormal testosterone level
|
0.57 |
false |
true |
0.26 |
MS4A1
|
abnormal transitional stage b cell morphology
|
0.57 |
true |
true |
0.26 |
ICAM1
|
abnormal intercellular signaling peptide or protein level
|
0.57 |
true |
true |
0.26 |
CD48
|
abnormal b cell physiology
|
0.57 |
false |
true |
0.26 |
CCR2
|
decreased acute inflammation
|
0.57 |
true |
true |
0.26 |
NFKB2
|
decreased immunoglobulin level
|
0.57 |
true |
true |
0.26 |
CCR7
|
decreased b cell number
|
0.57 |
false |
true |
0.26 |
TRAF1
|
abnormal leukopoiesis
|
0.57 |
true |
true |
0.26 |
CD14
|
abnormal response to infection
|
0.57 |
true |
true |
0.26 |
ITGB7
|
abnormal leukopoiesis
|
0.57 |
false |
true |
0.26 |
IRF1
|
abnormal interferon-gamma secretion
|
0.57 |
true |
true |
0.26 |
IL6
|
abnormal innate immunity
|
0.57 |
true |
true |
0.26 |
HOXC4
|
abnormal pectoral girdle bone morphology
|
0.57 |
true |
true |
0.26 |
PTGS2
|
altered susceptibility to autoimmune disorder
|
0.57 |
true |
true |
0.26 |
DNAH2
|
heterotaxia
|
0.57 |
false |
false |
0.26 |
CXCL10
|
abnormal immune tolerance
|
0.57 |
true |
true |
0.26 |
CCR7
|
decreased susceptibility to autoimmune disorder
|
0.57 |
false |
true |
0.26 |
GZMA
|
abnormal t cell physiology
|
0.57 |
true |
true |
0.26 |
SP140
|
abnormal igg level
|
0.57 |
false |
false |
0.26 |
TGFB1
|
abnormal humoral immune response
|
0.57 |
false |
true |
0.26 |
IL10RA
|
abnormal immunoglobulin level
|
0.57 |
true |
true |
0.26 |
ITGB7
|
abnormal t cell differentiation
|
0.57 |
false |
true |
0.26 |
NFKB2
|
abnormal immune serum protein physiology
|
0.57 |
true |
true |
0.26 |
PTPN7
|
abnormal b cell morphology
|
0.57 |
false |
true |
0.26 |
RUNX3
|
abnormal immunoglobulin level
|
0.57 |
true |
true |
0.26 |
SELL
|
abnormal mature b cell morphology
|
0.57 |
false |
true |
0.26 |
TRAT1
|
abnormal t cell activation
|
0.57 |
false |
true |
0.26 |
IL13
|
abnormal immunoglobulin level
|
0.57 |
true |
true |
0.26 |
CD27
|
abnormal b cell physiology
|
0.57 |
false |
true |
0.26 |
IL4
|
abnormal cytokine secretion
|
0.57 |
true |
true |
0.26 |
RELB
|
abnormal leukopoiesis
|
0.57 |
true |
true |
0.26 |
NR1H2
|
abnormal circulating androgen level
|
0.57 |
false |
true |
0.26 |
NR1H2
|
abnormal circulating testosterone level
|
0.57 |
false |
true |
0.26 |
SYK
|
abnormal humoral immune response
|
0.57 |
true |
true |
0.26 |
CD69
|
abnormal humoral immune response
|
0.57 |
true |
true |
0.26 |
STAT1
|
abnormal cytokine level
|
0.57 |
true |
true |
0.26 |
CD3G
|
decreased lymphocyte cell number
|
0.57 |
true |
true |
0.26 |
NFKB1
|
abnormal t cell morphology
|
0.57 |
true |
true |
0.26 |
IFNG
|
abnormal igg level
|
0.57 |
true |
true |
0.26 |
IL6
|
decreased incidence of tumors by chemical induction
|
0.57 |
true |
true |
0.26 |
FOS
|
tumorigenesis
|
0.57 |
true |
true |
0.26 |
ITGB2
|
abnormal igg level
|
0.57 |
true |
true |
0.26 |
IL4
|
abnormal circulating cytokine level
|
0.57 |
false |
true |
0.26 |
STAT1
|
abnormal t cell differentiation
|
0.57 |
true |
true |
0.26 |
PTPRC
|
abnormal cytokine secretion
|
0.57 |
true |
true |
0.26 |
CFLAR
|
abnormal humoral immune response
|
0.57 |
false |
true |
0.26 |
BIRC3
|
abnormal t cell proliferation
|
0.57 |
true |
true |
0.26 |
PRKCB
|
abnormal mature b cell morphology
|
0.57 |
true |
true |
0.26 |
LCP2
|
abnormal immune serum protein physiology
|
0.57 |
true |
true |
0.26 |
ITGB2
|
abnormal effector t cell morphology
|
0.57 |
true |
true |
0.26 |
NFKB2
|
decreased igg level
|
0.57 |
true |
true |
0.26 |
NFKB2
|
abnormal professional antigen presenting cell physiology
|
0.57 |
true |
true |
0.26 |
CD2
|
decreased t cell proliferation
|
0.57 |
false |
true |
0.26 |
ITGB2
|
abnormal t cell morphology
|
0.57 |
true |
true |
0.26 |
SP140
|
abnormal immunoglobulin level
|
0.57 |
false |
false |
0.26 |
CCR7
|
abnormal alpha-beta t cell morphology
|
0.57 |
true |
true |
0.26 |
CCL5
|
decreased susceptibility to type iv hypersensitivity reaction
|
0.57 |
true |
true |
0.26 |
IL10
|
altered susceptibility to bacterial infection
|
0.57 |
true |
true |
0.26 |
SYK
|
abnormal immunoglobulin level
|
0.57 |
true |
true |
0.26 |
IFNG
|
increased susceptibility to viral infection
|
0.57 |
true |
true |
0.26 |
IL4
|
abnormal interferon-gamma secretion
|
0.57 |
true |
true |
0.26 |
TLR1
|
abnormal innate immunity
|
0.57 |
true |
true |
0.26 |
BTK
|
abnormal leukopoiesis
|
0.57 |
true |
true |
0.26 |
CCR2
|
abnormal innate immunity
|
0.57 |
true |
true |
0.26 |
BIRC3
|
decreased leukocyte cell number
|
0.57 |
true |
true |
0.26 |
ICAM1
|
abnormal cytokine level
|
0.57 |
true |
true |
0.26 |
HOXB5
|
thoracic vertebral transformation
|
0.57 |
true |
true |
0.26 |
PTPN7
|
increased leukocyte cell number
|
0.57 |
false |
true |
0.26 |
IRF1
|
abnormal alpha-beta t cell number
|
0.57 |
true |
true |
0.26 |
CXCR5
|
abnormal igg1 level
|
0.57 |
false |
true |
0.26 |
CD247
|
abnormal alpha-beta t cell number
|
0.57 |
true |
true |
0.26 |
PTGS2
|
abnormal self tolerance
|
0.57 |
true |
true |
0.26 |
ITK
|
increased lymphocyte cell number
|
0.57 |
true |
true |
0.26 |
CXCR3
|
decreased t cell number
|
0.57 |
false |
true |
0.26 |
IL15
|
abnormal cytokine level
|
0.57 |
false |
true |
0.26 |
NFKB1
|
abnormal lymph node morphology
|
0.57 |
true |
true |
0.26 |
SLAMF1
|
abnormal lymphopoiesis
|
0.57 |
false |
true |
0.26 |
HOXB7
|
abnormal pectoral girdle bone morphology
|
0.57 |
true |
true |
0.26 |
IL1RN
|
abnormal cytokine level
|
0.57 |
true |
true |
0.26 |
TRAF1
|
abnormal lymphocyte physiology
|
0.57 |
true |
true |
0.26 |
MDM2
|
increased gland tumor incidence
|
0.57 |
true |
true |
0.26 |
PTPRC
|
abnormal lymph node morphology
|
0.57 |
true |
true |
0.26 |
CD6
|
decreased cd8-positive, alpha-beta t cell number
|
0.57 |
false |
false |
0.26 |
CD86
|
autoimmune response
|
0.56 |
true |
true |
0.26 |
PTGS2
|
abnormal immune tolerance
|
0.56 |
true |
true |
0.26 |
IFNG
|
abnormal ige level
|
0.56 |
true |
true |
0.26 |
CSF2
|
abnormal circulating interleukin level
|
0.56 |
false |
true |
0.26 |
PTPN7
|
abnormal b cell number
|
0.56 |
false |
true |
0.26 |
IFNG
|
abnormal myeloid leukocyte morphology
|
0.56 |
true |
true |
0.26 |
CD53
|
abnormal immunoglobulin level
|
0.56 |
false |
false |
0.26 |
IL1B
|
abnormal hypersensitivity reaction
|
0.56 |
true |
true |
0.26 |
BTK
|
abnormal igg level
|
0.56 |
true |
true |
0.26 |
IFNG
|
decreased leukocyte cell number
|
0.56 |
false |
true |
0.26 |
PTPRC
|
abnormal double-positive t cell morphology
|
0.56 |
true |
true |
0.26 |
CD247
|
decreased t cell number
|
0.56 |
true |
true |
0.26 |
CD86
|
abnormal self tolerance
|
0.56 |
true |
true |
0.26 |
MDM2
|
increased mortality induced by ionizing radiation
|
0.56 |
true |
true |
0.26 |
CD3G
|
abnormal leukopoiesis
|
0.56 |
true |
true |
0.26 |
CCR7
|
abnormal alpha-beta t cell number
|
0.56 |
true |
true |
0.26 |
RELB
|
abnormal igg level
|
0.56 |
false |
true |
0.26 |
CCR2
|
abnormal interleukin secretion
|
0.56 |
true |
true |
0.26 |
CD2
|
abnormal double-positive t cell morphology
|
0.56 |
false |
true |
0.26 |
DUSP1
|
abnormal intercellular signaling peptide or protein level
|
0.56 |
true |
true |
0.26 |
IL7R
|
abnormal interleukin secretion
|
0.56 |
false |
true |
0.26 |
ITGAL
|
decreased lymphocyte cell number
|
0.56 |
true |
true |
0.26 |
CD19
|
abnormal leukopoiesis
|
0.56 |
true |
true |
0.26 |
CCR1
|
abnormal intercellular signaling peptide or protein level
|
0.56 |
true |
true |
0.26 |
SLAMF1
|
abnormal igg level
|
0.56 |
false |
true |
0.26 |
CD247
|
abnormal alpha-beta t cell morphology
|
0.56 |
true |
true |
0.26 |
CD2
|
abnormal lymphopoiesis
|
0.56 |
false |
true |
0.26 |
PLK1
|
abnormal mitosis
|
0.56 |
true |
true |
0.26 |
CD86
|
abnormal immune tolerance
|
0.56 |
true |
true |
0.26 |
DUSP1
|
abnormal cytokine level
|
0.56 |
true |
true |
0.26 |
CCL5
|
abnormal interleukin level
|
0.56 |
false |
true |
0.26 |
STAT1
|
abnormal intercellular signaling peptide or protein level
|
0.56 |
true |
true |
0.26 |
CD2
|
increased alpha-beta t cell number
|
0.56 |
false |
true |
0.26 |
SLAMF1
|
abnormal lymphocyte physiology
|
0.56 |
true |
true |
0.26 |
STAT1
|
abnormal effector t cell morphology
|
0.56 |
false |
true |
0.26 |
CSF3
|
increased susceptibility to infection
|
0.56 |
true |
true |
0.26 |
ESR2
|
abnormal internal female genitalia morphology
|
0.56 |
true |
true |
0.26 |
RELB
|
abnormal immunoglobulin level
|
0.56 |
true |
true |
0.26 |
PLCG2
|
abnormal b cell activation
|
0.56 |
true |
true |
0.26 |
FYB
|
abnormal t cell proliferation
|
0.56 |
true |
true |
0.26 |
IL13
|
abnormal cytokine level
|
0.56 |
true |
true |
0.26 |
CCR7
|
abnormal acute inflammation
|
0.56 |
true |
true |
0.26 |
IFNG
|
increased leukocyte cell number
|
0.56 |
true |
true |
0.26 |
FYB
|
abnormal t cell activation
|
0.56 |
true |
true |
0.26 |
RHOH
|
decreased lymphocyte cell number
|
0.56 |
true |
true |
0.26 |
SLAMF1
|
abnormal t cell differentiation
|
0.56 |
false |
true |
0.26 |
HOXA5
|
abnormal thoracic vertebrae morphology
|
0.56 |
false |
true |
0.26 |
TRAF1
|
abnormal immune serum protein physiology
|
0.56 |
false |
true |
0.26 |
CCL5
|
abnormal igg level
|
0.56 |
false |
true |
0.26 |
TNFRSF17
|
abnormal b cell physiology
|
0.56 |
false |
true |
0.26 |
PTPRC
|
increased leukocyte cell number
|
0.56 |
true |
true |
0.26 |
CDKN1A
|
abnormal macrophage physiology
|
0.56 |
true |
true |
0.26 |
ITGB7
|
abnormal cd4-positive, alpha beta t cell number
|
0.56 |
true |
true |
0.26 |
CXCR5
|
increased b cell number
|
0.56 |
true |
true |
0.26 |
LCP2
|
abnormal t cell morphology
|
0.56 |
true |
true |
0.26 |
CD6
|
decreased t cell proliferation
|
0.56 |
false |
false |
0.26 |
NFKB1
|
abnormal spleen morphology
|
0.56 |
true |
true |
0.26 |
TNFSF10
|
abnormal intercellular signaling peptide or protein level
|
0.56 |
false |
true |
0.26 |
CORO1A
|
abnormal t cell differentiation
|
0.56 |
true |
true |
0.26 |
HOXC4
|
abnormal presacral vertebrae morphology
|
0.56 |
true |
true |
0.26 |
CD86
|
abnormal immune serum protein physiology
|
0.56 |
true |
true |
0.26 |
HOXB2
|
abnormal presacral vertebrae morphology
|
0.56 |
true |
true |
0.26 |
HOXC4
|
abnormal sternum morphology
|
0.56 |
true |
true |
0.26 |
ITGB7
|
abnormal t cell activation
|
0.56 |
false |
true |
0.26 |
DUSP2
|
abnormal b cell physiology
|
0.56 |
false |
true |
0.26 |
RHOH
|
abnormal cd4-positive, alpha beta t cell morphology
|
0.56 |
true |
true |
0.26 |
FYB
|
abnormal t cell physiology
|
0.56 |
true |
true |
0.26 |
ICAM1
|
abnormal t cell physiology
|
0.56 |
true |
true |
0.26 |
CD6
|
abnormal leukopoiesis
|
0.56 |
false |
false |
0.26 |
CD79A
|
increased mature b cell number
|
0.56 |
false |
true |
0.26 |
ESR2
|
abnormal estrous cycle
|
0.56 |
true |
true |
0.26 |
ESR2
|
abnormal ovulation cycle
|
0.56 |
true |
true |
0.26 |
SELL
|
abnormal igg level
|
0.56 |
false |
true |
0.26 |
CCR7
|
abnormal cell chemotaxis
|
0.56 |
false |
true |
0.26 |
TRAT1
|
decreased cd4-positive, alpha beta t cell number
|
0.56 |
false |
true |
0.26 |
SELL
|
abnormal lymphocyte cell number
|
0.56 |
true |
true |
0.26 |
RUNX3
|
abnormal effector t cell morphology
|
0.56 |
true |
true |
0.26 |
NFKB2
|
abnormal response to infection
|
0.56 |
true |
true |
0.26 |
SELL
|
abnormal b cell differentiation
|
0.56 |
false |
true |
0.26 |
IL10
|
abnormal induced morbidity/mortality
|
0.56 |
true |
true |
0.26 |
IL13
|
abnormal circulating interleukin level
|
0.56 |
true |
true |
0.26 |
CD86
|
altered susceptibility to autoimmune disorder
|
0.56 |
true |
true |
0.26 |
ITGB2
|
abnormal professional antigen presenting cell physiology
|
0.56 |
true |
true |
0.26 |
TLR2
|
abnormal cytokine level
|
0.56 |
true |
true |
0.26 |
NFKB2
|
increased susceptibility to infection
|
0.56 |
true |
true |
0.26 |
NFKB1
|
abnormal t cell physiology
|
0.56 |
true |
true |
0.26 |
TNFSF10
|
altered susceptibility to autoimmune disorder
|
0.56 |
true |
true |
0.26 |
LCP2
|
abnormal leukopoiesis
|
0.56 |
true |
true |
0.26 |
CCR1
|
increased immunoglobulin level
|
0.56 |
true |
true |
0.26 |
SELL
|
abnormal spleen white pulp morphology
|
0.56 |
true |
true |
0.26 |
BTK
|
abnormal b cell differentiation
|
0.56 |
true |
true |
0.26 |
CXCR4
|
decreased alpha-beta t cell number
|
0.56 |
false |
true |
0.26 |
CCL5
|
increased susceptibility to infection
|
0.56 |
false |
true |
0.26 |
NFKB2
|
abnormal interleukin secretion
|
0.56 |
true |
true |
0.26 |
HOXA6
|
abnormal cervical vertebrae morphology
|
0.56 |
true |
true |
0.26 |
ITGAL
|
abnormal cd8-positive, alpha beta t cell morphology
|
0.56 |
true |
true |
0.26 |
NR1I3
|
decreased fatty acid level
|
0.56 |
false |
true |
0.26 |
ITGB7
|
abnormal t cell physiology
|
0.56 |
false |
true |
0.26 |
ATR
|
increased tumor incidence
|
0.56 |
true |
true |
0.26 |
IL2RG
|
decreased alpha-beta t cell number
|
0.56 |
true |
true |
0.26 |
IL10RA
|
decreased cd4-positive, alpha beta t cell number
|
0.56 |
false |
true |
0.26 |
TGFB1
|
abnormal b cell physiology
|
0.56 |
false |
true |
0.26 |
CD3E
|
abnormal leukopoiesis
|
0.56 |
true |
true |
0.26 |
SLAMF1
|
increased t cell number
|
0.56 |
false |
true |
0.26 |
IRF4
|
abnormal b cell physiology
|
0.56 |
true |
true |
0.26 |
BLK
|
decreased igg3 level
|
0.56 |
false |
true |
0.26 |
CCR2
|
abnormal igg level
|
0.56 |
true |
true |
0.26 |
STAT1
|
abnormal interleukin secretion
|
0.56 |
true |
true |
0.26 |
PDGFRA
|
lethality throughout fetal growth and development
|
0.56 |
true |
true |
0.26 |
CD5
|
abnormal cd8-positive, alpha-beta t cell number
|
0.56 |
false |
true |
0.26 |
VAV1
|
abnormal mature b cell morphology
|
0.56 |
true |
true |
0.26 |
TLR2
|
abnormal immune serum protein physiology
|
0.56 |
true |
true |
0.26 |
CD79B
|
decreased b-1 b cell number
|
0.56 |
true |
true |
0.26 |
MS4A1
|
abnormal spleen secondary b follicle morphology
|
0.56 |
false |
true |
0.26 |
PLCG2
|
abnormal b cell proliferation
|
0.56 |
true |
true |
0.26 |
NR1I3
|
decreased circulating free fatty acid level
|
0.56 |
false |
true |
0.26 |
RUNX3
|
abnormal b cell physiology
|
0.56 |
true |
true |
0.26 |
NFKB1
|
abnormal professional antigen presenting cell morphology
|
0.56 |
true |
true |
0.26 |
PDGFRA
|
abnormal vascular development
|
0.56 |
true |
true |
0.26 |
CD48
|
abnormal t cell physiology
|
0.56 |
true |
true |
0.26 |
CD96
|
abnormal alpha-beta t cell morphology
|
0.56 |
false |
false |
0.26 |
CXCR4
|
abnormal hypersensitivity reaction
|
0.56 |
false |
true |
0.26 |
TNFAIP3
|
abnormal cytokine secretion
|
0.56 |
true |
true |
0.26 |
ESR2
|
abnormal female genitalia morphology
|
0.56 |
true |
true |
0.26 |
ITGAL
|
decreased alpha-beta t cell number
|
0.56 |
true |
true |
0.26 |
CD247
|
abnormal effector t cell morphology
|
0.56 |
true |
true |
0.26 |
MAP4K1
|
abnormal leukopoiesis
|
0.56 |
true |
true |
0.26 |
IL15
|
decreased igg level
|
0.56 |
true |
true |
0.26 |
IL6
|
decreased susceptibility to autoimmune disorder
|
0.56 |
true |
true |
0.26 |
IFNG
|
abnormal cd8-positive, alpha beta t cell morphology
|
0.56 |
true |
true |
0.26 |
PPARG
|
abnormal fatty acid level
|
0.56 |
true |
true |
0.26 |
CD53
|
abnormal humoral immune response
|
0.56 |
false |
false |
0.26 |
CD37
|
abnormal igg1 level
|
0.56 |
true |
true |
0.26 |
IL12A
|
altered susceptibility to parasitic infection
|
0.56 |
true |
true |
0.26 |
IL1R2
|
altered susceptibility to autoimmune disorder
|
0.56 |
false |
false |
0.26 |
CCR2
|
abnormal interferon secretion
|
0.56 |
true |
true |
0.26 |
ITK
|
abnormal thyroid gland morphology
|
0.56 |
true |
true |
0.26 |
CSF2RB
|
abnormal lymphocyte physiology
|
0.56 |
false |
true |
0.26 |
TRAT1
|
decreased cd8-positive, alpha-beta t cell number
|
0.56 |
false |
true |
0.26 |
CXCR3
|
abnormal t cell differentiation
|
0.56 |
false |
true |
0.26 |
IL13
|
abnormal immune serum protein physiology
|
0.56 |
true |
true |
0.26 |
RELB
|
abnormal cytokine secretion
|
0.56 |
false |
true |
0.26 |
CD27
|
abnormal immunoglobulin level
|
0.56 |
false |
true |
0.26 |
BLK
|
abnormal transitional stage b cell morphology
|
0.56 |
false |
true |
0.26 |
CD48
|
abnormal cd4-positive, alpha beta t cell number
|
0.56 |
true |
true |
0.26 |
IL2RG
|
abnormal b cell physiology
|
0.56 |
true |
true |
0.26 |
CD86
|
abnormal innate immunity
|
0.56 |
false |
true |
0.26 |
IL6
|
abnormal circulating cytokine level
|
0.56 |
true |
true |
0.26 |
ESR2
|
abnormal female reproductive system morphology
|
0.56 |
true |
true |
0.26 |
IL10RA
|
increased t cell number
|
0.56 |
false |
true |
0.26 |
ITGB2
|
abnormal hypersensitivity reaction
|
0.56 |
true |
true |
0.26 |
CXCL9
|
abnormal cytokine secretion
|
0.56 |
true |
true |
0.26 |
GADD45A
|
increased tumor incidence
|
0.56 |
true |
true |
0.26 |
TLR2
|
abnormal interleukin level
|
0.56 |
true |
true |
0.26 |
CCR5
|
abnormal cd8-positive, alpha beta t cell morphology
|
0.56 |
true |
true |
0.26 |
IL13
|
altered susceptibility to bacterial infection
|
0.56 |
true |
true |
0.26 |
LY9
|
abnormal immunoglobulin level
|
0.56 |
false |
true |
0.26 |
SLAMF1
|
abnormal immunoglobulin level
|
0.56 |
false |
true |
0.26 |
IL10RA
|
decreased lymphocyte cell number
|
0.56 |
false |
true |
0.27 |
NFKB2
|
altered susceptibility to infection
|
0.56 |
true |
true |
0.27 |
CCR5
|
abnormal cd4-positive, alpha beta t cell number
|
0.56 |
false |
true |
0.27 |
HOXA3
|
abnormal sternum morphology
|
0.56 |
false |
true |
0.27 |
RHOH
|
abnormal t cell number
|
0.56 |
true |
true |
0.27 |
CD37
|
abnormal immune serum protein physiology
|
0.56 |
true |
true |
0.27 |
SP140
|
abnormal b cell physiology
|
0.56 |
false |
false |
0.27 |
SELL
|
decreased lymphocyte cell number
|
0.56 |
true |
true |
0.27 |
NFKB1
|
abnormal lymphocyte cell number
|
0.56 |
true |
true |
0.27 |
GFI1
|
abnormal t cell differentiation
|
0.56 |
true |
true |
0.27 |
IL1RN
|
abnormal intercellular signaling peptide or protein level
|
0.56 |
true |
true |
0.27 |
CD79A
|
abnormal professional antigen presenting cell morphology
|
0.56 |
true |
true |
0.26 |
CD96
|
abnormal alpha-beta t cell number
|
0.56 |
false |
false |
0.26 |
IL10
|
large intestinal inflammation
|
0.56 |
true |
true |
0.26 |
RHOH
|
abnormal b cell differentiation
|
0.56 |
false |
true |
0.27 |
SELL
|
abnormal leukopoiesis
|
0.56 |
true |
true |
0.27 |
ITGAL
|
abnormal leukopoiesis
|
0.56 |
true |
true |
0.26 |
TNFSF13B
|
abnormal immune serum protein physiology
|
0.56 |
true |
true |
0.26 |
CD53
|
abnormal b cell physiology
|
0.56 |
false |
false |
0.26 |
SELL
|
decreased b cell number
|
0.56 |
false |
true |
0.27 |
HOXA7
|
abnormal rib-sternum attachment
|
0.56 |
false |
true |
0.27 |
CD5
|
decreased t cell number
|
0.55 |
true |
true |
0.27 |
IFNG
|
increased igg level
|
0.55 |
true |
true |
0.27 |
CD27
|
abnormal humoral immune response
|
0.55 |
false |
true |
0.27 |
BIRC3
|
decreased lymphocyte cell number
|
0.55 |
true |
true |
0.27 |
TNFAIP3
|
abnormal interleukin secretion
|
0.55 |
true |
true |
0.27 |
IFNG
|
abnormal cytotoxic t cell physiology
|
0.55 |
true |
true |
0.27 |
IL2
|
decreased lymphocyte cell number
|
0.55 |
true |
true |
0.27 |
CD3G
|
abnormal double-positive t cell morphology
|
0.55 |
false |
true |
0.27 |
ESR1
|
abnormal pain threshold
|
0.55 |
true |
true |
0.27 |
MAP4K1
|
abnormal t cell differentiation
|
0.55 |
true |
true |
0.27 |
IL15
|
abnormal intercellular signaling peptide or protein level
|
0.55 |
false |
true |
0.27 |
TRAF1
|
abnormal t cell differentiation
|
0.55 |
true |
true |
0.27 |
IL13
|
abnormal professional antigen presenting cell physiology
|
0.55 |
true |
true |
0.27 |
LCP2
|
abnormal lymphopoiesis
|
0.55 |
true |
true |
0.27 |
CCR7
|
abnormal cd4-positive, alpha beta t cell number
|
0.55 |
true |
true |
0.27 |
COL3A1
|
abnormal bone structure
|
0.55 |
false |
true |
0.27 |
CCR7
|
abnormal t cell differentiation
|
0.55 |
false |
true |
0.27 |
ITGB7
|
abnormal professional antigen presenting cell physiology
|
0.55 |
false |
true |
0.27 |
BIRC3
|
decreased immunoglobulin level
|
0.55 |
true |
true |
0.27 |
IL6
|
autoimmune response
|
0.55 |
true |
true |
0.27 |
TLR2
|
abnormal intercellular signaling peptide or protein level
|
0.55 |
true |
true |
0.27 |
CD37
|
abnormal b cell proliferation
|
0.55 |
false |
true |
0.27 |
IL13
|
abnormal induced morbidity/mortality
|
0.55 |
true |
true |
0.27 |
NCF4
|
abnormal igg level
|
0.55 |
false |
true |
0.27 |
RHOH
|
decreased t cell number
|
0.55 |
true |
true |
0.27 |
TNFSF10
|
abnormal cytokine level
|
0.55 |
false |
true |
0.27 |
CD247
|
decreased cd8-positive, alpha-beta t cell number
|
0.55 |
true |
true |
0.27 |
PRKCB
|
abnormal b cell morphology
|
0.55 |
true |
true |
0.27 |
DYNC2H1
|
heterotaxia
|
0.55 |
false |
true |
0.27 |
NFKB1
|
abnormal iga level
|
0.55 |
true |
true |
0.27 |
RHOH
|
abnormal b cell morphology
|
0.55 |
false |
true |
0.27 |
ZAP70
|
increased alpha-beta t cell number
|
0.55 |
false |
true |
0.27 |
IL10
|
abnormal mononuclear phagocyte morphology
|
0.55 |
true |
true |
0.27 |
LCP2
|
abnormal cd4-positive, alpha beta t cell morphology
|
0.55 |
true |
true |
0.27 |
SLAMF1
|
abnormal humoral immune response
|
0.55 |
false |
true |
0.27 |
NR1H4
|
abnormal thyroid-stimulating hormone level
|
0.55 |
false |
true |
0.27 |
HCK
|
abnormal igg level
|
0.55 |
false |
true |
0.27 |
IFNG
|
increased susceptibility to autoimmune disorder
|
0.55 |
true |
true |
0.27 |
NCF4
|
abnormal professional antigen presenting cell physiology
|
0.55 |
false |
true |
0.27 |
BIRC3
|
abnormal lymphocyte cell number
|
0.55 |
true |
true |
0.27 |
IRF1
|
abnormal circulating interleukin level
|
0.55 |
true |
true |
0.27 |
CSF2RB
|
abnormal leukopoiesis
|
0.55 |
false |
true |
0.27 |
SP140
|
abnormal humoral immune response
|
0.55 |
false |
false |
0.27 |
RHOH
|
abnormal igg level
|
0.55 |
false |
true |
0.27 |
BCL2A1
|
abnormal response to infection
|
0.55 |
true |
true |
0.27 |
TNFSF10
|
abnormal self tolerance
|
0.55 |
true |
true |
0.27 |
IL2RB
|
increased t cell number
|
0.55 |
true |
true |
0.27 |
TNFSF10
|
abnormal immune tolerance
|
0.55 |
true |
true |
0.27 |
IL13
|
abnormal intercellular signaling peptide or protein level
|
0.55 |
true |
true |
0.27 |
IL15
|
increased igg level
|
0.55 |
false |
true |
0.27 |
CD3G
|
decreased t cell proliferation
|
0.55 |
false |
true |
0.27 |
HOXA7
|
abnormal vertebrae morphology
|
0.55 |
false |
true |
0.27 |
IL13
|
abnormal interleukin secretion
|
0.55 |
true |
true |
0.27 |
IL13
|
abnormal b cell physiology
|
0.55 |
true |
true |
0.27 |
IL2RG
|
abnormal t cell number
|
0.55 |
true |
true |
0.27 |
PRKCB
|
decreased lymphocyte cell number
|
0.55 |
true |
true |
0.27 |
TNFSF10
|
autoimmune response
|
0.55 |
true |
true |
0.27 |
PTPRC
|
decreased igg level
|
0.55 |
false |
true |
0.27 |
CD79A
|
increased igg level
|
0.55 |
true |
true |
0.27 |
FASLG
|
abnormal t cell morphology
|
0.55 |
true |
true |
0.27 |
CCR5
|
abnormal cell chemotaxis
|
0.55 |
true |
true |
0.27 |
HCK
|
abnormal b cell physiology
|
0.55 |
false |
true |
0.27 |
IL4
|
decreased ige level
|
0.55 |
true |
true |
0.27 |
BLK
|
increased mature b cell number
|
0.55 |
false |
true |
0.27 |
TNFRSF17
|
abnormal immunoglobulin level
|
0.55 |
false |
true |
0.27 |
TNFSF10
|
increased susceptibility to infection
|
0.55 |
false |
true |
0.27 |
IL6
|
abnormal self tolerance
|
0.55 |
true |
true |
0.27 |
NFKB2
|
abnormal spleen white pulp morphology
|
0.55 |
true |
true |
0.27 |
CCR7
|
abnormal lymph node morphology
|
0.55 |
true |
true |
0.27 |
IL2RA
|
abnormal cytokine secretion
|
0.55 |
false |
true |
0.27 |
DUSP1
|
abnormal circulating cytokine level
|
0.55 |
true |
true |
0.27 |
IFNG
|
abnormal lymphopoiesis
|
0.55 |
false |
true |
0.27 |
IL4
|
increased susceptibility to infection induced morbidity/mortality
|
0.55 |
true |
true |
0.27 |
TRAT1
|
increased t cell number
|
0.55 |
false |
true |
0.27 |
HOXA6
|
abnormal sternum morphology
|
0.55 |
false |
true |
0.27 |
CD22
|
decreased igg level
|
0.55 |
true |
true |
0.27 |
ITGB2
|
abnormal t cell physiology
|
0.55 |
true |
true |
0.27 |
IL13
|
abnormal humoral immune response
|
0.55 |
true |
true |
0.27 |
RHOH
|
abnormal cd4-positive, alpha beta t cell number
|
0.55 |
true |
true |
0.27 |
HOXC6
|
abnormal thoracic cage morphology
|
0.55 |
true |
true |
0.27 |
TNFSF10
|
abnormal acute inflammation
|
0.55 |
false |
true |
0.27 |
CXCR4
|
decreased cd4-positive, alpha beta t cell number
|
0.55 |
false |
true |
0.27 |
EGFR
|
abnormal neuron differentiation
|
0.55 |
false |
true |
0.27 |
CD69
|
abnormal igg level
|
0.55 |
true |
true |
0.27 |
CCR5
|
abnormal leukopoiesis
|
0.55 |
true |
true |
0.27 |
CCR1
|
altered susceptibility to infection induced morbidity/mortality
|
0.55 |
true |
true |
0.27 |
DRD5
|
impaired behavioral response to xenobiotic
|
0.55 |
false |
true |
0.27 |
HCK
|
abnormal interleukin secretion
|
0.55 |
true |
true |
0.27 |
BCL2A1
|
abnormal innate immunity
|
0.55 |
true |
true |
0.27 |
PRKCB
|
abnormal b cell number
|
0.55 |
true |
true |
0.27 |
CD48
|
abnormal lymphocyte physiology
|
0.55 |
true |
true |
0.27 |
SELL
|
abnormal alpha-beta t cell morphology
|
0.55 |
false |
true |
0.27 |
CD52
|
abnormal immunoglobulin level
|
0.55 |
false |
true |
0.27 |
LCK
|
decreased thymocyte number
|
0.55 |
true |
true |
0.27 |
MS4A1
|
abnormal professional antigen presenting cell morphology
|
0.55 |
true |
true |
0.27 |
LCK
|
increased alpha-beta t cell number
|
0.55 |
false |
true |
0.27 |
CD5
|
abnormal t cell proliferation
|
0.55 |
true |
true |
0.27 |
IL6
|
abnormal wound healing
|
0.55 |
true |
true |
0.27 |
ITGB7
|
abnormal t cell number
|
0.55 |
true |
true |
0.27 |
CSF2
|
abnormal myeloid leukocyte morphology
|
0.55 |
true |
true |
0.27 |
PTPRC
|
decreased mature b cell number
|
0.55 |
true |
true |
0.27 |
IL10RA
|
decreased t cell proliferation
|
0.55 |
false |
true |
0.27 |
PTPRC
|
abnormal b cell differentiation
|
0.55 |
true |
true |
0.27 |
FLT1
|
abnormal angiogenesis
|
0.55 |
true |
true |
0.27 |
IL10
|
abnormal effector t cell morphology
|
0.55 |
true |
true |
0.27 |
IRF4
|
abnormal lymphopoiesis
|
0.55 |
true |
true |
0.27 |
IL2RA
|
abnormal lymphocyte physiology
|
0.55 |
true |
true |
0.27 |
CXCL10
|
decreased interferon-gamma secretion
|
0.55 |
true |
true |
0.27 |
IL6
|
abnormal macrophage morphology
|
0.55 |
true |
true |
0.27 |
CD5
|
decreased cd4-positive, alpha beta t cell number
|
0.55 |
true |
true |
0.27 |
CD8A
|
abnormal cd4-positive, alpha beta t cell morphology
|
0.55 |
true |
true |
0.27 |
ITGB7
|
abnormal immune serum protein physiology
|
0.55 |
false |
true |
0.27 |
SLAMF1
|
decreased lymphocyte cell number
|
0.55 |
false |
true |
0.27 |
RUNX3
|
abnormal humoral immune response
|
0.55 |
true |
true |
0.27 |
MAP4K1
|
abnormal igg level
|
0.55 |
false |
true |
0.27 |
TNFRSF17
|
abnormal humoral immune response
|
0.55 |
false |
true |
0.27 |
IL13
|
decreased immunoglobulin level
|
0.55 |
true |
true |
0.27 |
LCP1
|
abnormal t cell differentiation
|
0.55 |
false |
true |
0.27 |
CD48
|
abnormal igg level
|
0.55 |
false |
true |
0.27 |
IFNG
|
abnormal t cell proliferation
|
0.55 |
false |
true |
0.27 |
CD22
|
decreased immunoglobulin level
|
0.55 |
true |
true |
0.27 |
IL6
|
increased inflammatory response
|
0.55 |
true |
true |
0.27 |
POU2AF1
|
abnormal spleen white pulp morphology
|
0.55 |
true |
true |
0.27 |
CCR5
|
increased lymphocyte cell number
|
0.55 |
true |
true |
0.27 |
MS4A1
|
abnormal lymphocyte physiology
|
0.55 |
true |
true |
0.27 |
RELB
|
abnormal humoral immune response
|
0.55 |
true |
true |
0.27 |
LY9
|
abnormal igg level
|
0.55 |
false |
true |
0.27 |
TGFB1
|
abnormal igg level
|
0.55 |
false |
true |
0.27 |
CD8A
|
abnormal alpha-beta t cell morphology
|
0.55 |
true |
true |
0.27 |
IL2RG
|
abnormal cd8-positive, alpha-beta t cell number
|
0.55 |
true |
true |
0.27 |
IL10RA
|
abnormal immune serum protein physiology
|
0.55 |
true |
true |
0.27 |
HOXB6
|
abnormal axial skeleton morphology
|
0.55 |
true |
true |
0.27 |
ITGB2
|
abnormal response to infection
|
0.55 |
true |
true |
0.27 |
IL13
|
abnormal innate immunity
|
0.55 |
true |
true |
0.27 |
ITK
|
abnormal thymus size
|
0.55 |
false |
true |
0.27 |
IL2
|
abnormal immunoglobulin level
|
0.55 |
true |
true |
0.27 |
CXCR5
|
abnormal spleen marginal zone morphology
|
0.55 |
false |
true |
0.27 |
RHOH
|
abnormal t cell differentiation
|
0.55 |
true |
true |
0.27 |
COL3A1
|
abnormal trabecular bone morphology
|
0.55 |
false |
true |
0.27 |
ITGAL
|
decreased t cell number
|
0.55 |
true |
true |
0.27 |
PTPRC
|
altered susceptibility to viral infection
|
0.55 |
false |
true |
0.27 |
BCL2A1
|
altered susceptibility to infection
|
0.55 |
true |
true |
0.27 |
REL
|
abnormal spleen white pulp morphology
|
0.55 |
true |
true |
0.27 |
IFNG
|
altered susceptibility to viral infection
|
0.55 |
true |
true |
0.27 |
CCR1
|
abnormal tumor necrosis factor secretion
|
0.55 |
true |
true |
0.27 |
CCR1
|
abnormal lymphocyte physiology
|
0.55 |
true |
true |
0.27 |
ITGAL
|
abnormal cd8-positive, alpha-beta t cell number
|
0.55 |
true |
true |
0.27 |
BMP4
|
abnormal thoracic cage morphology
|
0.55 |
true |
true |
0.27 |
CD3G
|
abnormal lymphocyte cell number
|
0.55 |
true |
true |
0.27 |
IL1B
|
abnormal interleukin level
|
0.55 |
true |
true |
0.27 |
PTPRC
|
decreased leukocyte cell number
|
0.55 |
true |
true |
0.27 |
CXCL10
|
abnormal lymphocyte physiology
|
0.55 |
true |
true |
0.27 |
SLAMF1
|
increased lymphocyte cell number
|
0.55 |
false |
true |
0.27 |
BIRC3
|
abnormal macrophage physiology
|
0.55 |
true |
true |
0.27 |
NFKB2
|
increased immunoglobulin level
|
0.55 |
true |
true |
0.27 |
PTPRC
|
altered susceptibility to bacterial infection
|
0.55 |
false |
true |
0.27 |
IL6
|
abnormal myeloid leukocyte morphology
|
0.55 |
true |
true |
0.27 |
CXCL9
|
abnormal interleukin secretion
|
0.55 |
false |
true |
0.27 |
CD48
|
abnormal t cell proliferation
|
0.55 |
true |
true |
0.27 |
IRF4
|
abnormal immunoglobulin level
|
0.55 |
true |
true |
0.27 |
CCR5
|
abnormal granulocyte physiology
|
0.55 |
false |
true |
0.27 |
CSF2
|
abnormal granulocyte number
|
0.55 |
false |
true |
0.27 |
VAV1
|
abnormal lymphopoiesis
|
0.55 |
true |
true |
0.27 |
TNFSF10
|
increased inflammatory response
|
0.55 |
true |
true |
0.27 |
ITGB7
|
abnormal t cell proliferation
|
0.55 |
false |
true |
0.27 |
BCL2A1
|
abnormal cytokine secretion
|
0.55 |
false |
true |
0.27 |
LCP2
|
abnormal immunoglobulin level
|
0.55 |
true |
true |
0.27 |
IL6
|
colitis
|
0.55 |
true |
true |
0.27 |
CD69
|
abnormal lymphocyte physiology
|
0.55 |
true |
true |
0.27 |
IL2RG
|
abnormal humoral immune response
|
0.55 |
true |
true |
0.27 |
IL4
|
abnormal innate immunity
|
0.55 |
false |
true |
0.27 |
IL10RA
|
abnormal igg level
|
0.55 |
true |
true |
0.27 |
ATR
|
abnormal classified tumor incidence
|
0.55 |
false |
true |
0.27 |
ATR
|
increased classified tumor incidence
|
0.55 |
false |
true |
0.27 |
IL6
|
abnormal circulating interleukin level
|
0.55 |
true |
true |
0.27 |
CD96
|
abnormal effector t cell morphology
|
0.55 |
false |
false |
0.27 |
CORO1A
|
abnormal lymphopoiesis
|
0.55 |
true |
true |
0.27 |
MS4A1
|
increased igm level
|
0.55 |
false |
true |
0.27 |
CD48
|
abnormal alpha-beta t cell morphology
|
0.55 |
true |
true |
0.27 |
CCR5
|
abnormal lymphocyte cell number
|
0.55 |
true |
true |
0.27 |
IL6
|
abnormal immune tolerance
|
0.55 |
true |
true |
0.27 |
ITGB2
|
altered susceptibility to infection
|
0.55 |
true |
true |
0.27 |
IRF1
|
increased t cell number
|
0.55 |
true |
true |
0.27 |
HOXA3
|
abnormal rib morphology
|
0.55 |
false |
true |
0.27 |
ITGAX
|
abnormal cytokine secretion
|
0.55 |
true |
true |
0.27 |
BTK
|
abnormal igm level
|
0.55 |
true |
true |
0.27 |
CSF2
|
abnormal granulocyte morphology
|
0.55 |
false |
true |
0.27 |
ITGAL
|
abnormal lymphocyte cell number
|
0.55 |
true |
true |
0.27 |
IL4
|
abnormal effector t cell morphology
|
0.55 |
true |
true |
0.27 |
SH2D1A
|
increased t cell number
|
0.55 |
true |
true |
0.27 |
MS4A1
|
abnormal spleen germinal center morphology
|
0.55 |
false |
true |
0.27 |
CD48
|
abnormal alpha-beta t cell number
|
0.55 |
true |
true |
0.27 |
IFNG
|
abnormal leukopoiesis
|
0.55 |
false |
true |
0.27 |
CD8A
|
abnormal t cell number
|
0.55 |
true |
true |
0.27 |
ICAM1
|
increased susceptibility to infection
|
0.55 |
false |
true |
0.27 |
RHOH
|
abnormal t cell morphology
|
0.55 |
true |
true |
0.27 |
IRF7
|
altered susceptibility to infection
|
0.55 |
true |
true |
0.27 |
CD79A
|
abnormal immune serum protein physiology
|
0.55 |
true |
true |
0.27 |
PLCG2
|
abnormal b cell differentiation
|
0.55 |
true |
true |
0.27 |
CXCL10
|
abnormal hypersensitivity reaction
|
0.55 |
true |
true |
0.27 |
BLK
|
abnormal iga level
|
0.55 |
false |
true |
0.27 |
FYB
|
abnormal t cell differentiation
|
0.55 |
true |
true |
0.27 |
STAT1
|
increased susceptibility to infection
|
0.55 |
true |
true |
0.27 |
IL2
|
abnormal igg level
|
0.55 |
true |
true |
0.27 |
IRF1
|
abnormal cd4-positive, alpha beta t cell number
|
0.55 |
true |
true |
0.27 |
BLK
|
abnormal igg2a level
|
0.55 |
false |
true |
0.27 |
IL1B
|
abnormal circulating cytokine level
|
0.55 |
true |
true |
0.27 |
IL2RG
|
abnormal immunoglobulin level
|
0.55 |
true |
true |
0.27 |
PTPN7
|
abnormal immune serum protein physiology
|
0.55 |
false |
true |
0.27 |
ITGB2
|
abnormal lymphopoiesis
|
0.55 |
true |
true |
0.27 |
CD19
|
increased lymphocyte cell number
|
0.55 |
true |
true |
0.27 |
CFLAR
|
abnormal b cell physiology
|
0.55 |
false |
true |
0.27 |
CD69
|
abnormal lymphopoiesis
|
0.55 |
true |
true |
0.27 |
SELL
|
abnormal cd8-positive, alpha-beta t cell number
|
0.55 |
false |
true |
0.27 |
CD27
|
abnormal igg level
|
0.55 |
false |
true |
0.27 |
CD74
|
abnormal t cell physiology
|
0.55 |
true |
true |
0.27 |
STAT1
|
abnormal lymphopoiesis
|
0.55 |
true |
true |
0.27 |
IL2RG
|
abnormal interferon secretion
|
0.55 |
true |
true |
0.27 |
TLR2
|
abnormal macrophage physiology
|
0.55 |
true |
true |
0.27 |
CD86
|
abnormal response to infection
|
0.55 |
false |
true |
0.27 |
IL10
|
abnormal cd4-positive, alpha beta t cell morphology
|
0.55 |
true |
true |
0.27 |
IL4
|
abnormal cd4-positive, alpha beta t cell morphology
|
0.55 |
true |
true |
0.27 |
IL6
|
abnormal blood vessel physiology
|
0.55 |
false |
true |
0.27 |
IL23A
|
increased susceptibility to infection
|
0.55 |
true |
true |
0.27 |
CCL5
|
decreased t cell number
|
0.55 |
true |
true |
0.27 |
ITGB2
|
abnormal t cell differentiation
|
0.55 |
true |
true |
0.27 |
EGR1
|
abnormal mononuclear phagocyte morphology
|
0.55 |
true |
true |
0.27 |
CORO1A
|
abnormal t cell activation
|
0.55 |
true |
true |
0.27 |
IRF1
|
abnormal interferon level
|
0.55 |
true |
true |
0.27 |
RELB
|
abnormal spleen white pulp morphology
|
0.55 |
true |
true |
0.27 |
CD86
|
abnormal professional antigen presenting cell physiology
|
0.55 |
true |
true |
0.27 |
TGFB1
|
abnormal professional antigen presenting cell physiology
|
0.55 |
false |
true |
0.27 |
IRF4
|
abnormal lymphocyte physiology
|
0.55 |
true |
true |
0.27 |
NR3C1
|
increased circulating gonadotropin level
|
0.55 |
false |
true |
0.27 |
JAK3
|
abnormal t cell physiology
|
0.54 |
true |
true |
0.27 |
CFLAR
|
abnormal igg level
|
0.54 |
false |
true |
0.27 |
NFKB2
|
abnormal lymphopoiesis
|
0.54 |
true |
true |
0.27 |
IRF4
|
abnormal leukopoiesis
|
0.54 |
true |
true |
0.27 |
UBASH3A
|
abnormal alpha-beta t cell number
|
0.54 |
false |
true |
0.27 |
NR1H2
|
abnormal circulating pituitary hormone level
|
0.54 |
false |
true |
0.27 |
SELL
|
abnormal alpha-beta t cell number
|
0.54 |
false |
true |
0.27 |
PTPRC
|
decreased b cell number
|
0.54 |
true |
true |
0.27 |
CCR5
|
increased leukocyte cell number
|
0.54 |
true |
true |
0.27 |
CCR1
|
abnormal igg level
|
0.54 |
true |
true |
0.27 |
ZAP70
|
abnormal double-negative t cell morphology
|
0.54 |
false |
true |
0.27 |
CCR5
|
increased t cell number
|
0.54 |
true |
true |
0.27 |
IFNG
|
abnormal type iv hypersensitivity reaction
|
0.54 |
true |
true |
0.27 |
IL2
|
abnormal nk cell morphology
|
0.54 |
false |
true |
0.27 |
ICAM1
|
abnormal cytokine secretion
|
0.54 |
false |
true |
0.28 |
CD79A
|
increased igm level
|
0.54 |
false |
true |
0.28 |
CCR7
|
increased hematopoietic cell number
|
0.54 |
true |
true |
0.28 |
UBASH3A
|
abnormal alpha-beta t cell morphology
|
0.54 |
false |
true |
0.28 |
CD14
|
increased susceptibility to infection
|
0.54 |
true |
true |
0.28 |
CFLAR
|
abnormal immune serum protein physiology
|
0.54 |
false |
true |
0.28 |
RHOH
|
decreased alpha-beta t cell number
|
0.54 |
true |
true |
0.28 |
CCR7
|
abnormal innate immunity
|
0.54 |
false |
true |
0.28 |
HOXA5
|
abnormal rib-sternum attachment
|
0.54 |
true |
true |
0.28 |
CD37
|
abnormal igg3 level
|
0.54 |
false |
true |
0.28 |
CD27
|
abnormal leukopoiesis
|
0.54 |
true |
true |
0.28 |
IL1R2
|
abnormal interleukin level
|
0.54 |
false |
false |
0.28 |
VAV1
|
decreased lymphocyte cell number
|
0.54 |
true |
true |
0.28 |
ITGB7
|
abnormal cytokine secretion
|
0.54 |
false |
true |
0.28 |
IL2RB
|
decreased lymphocyte cell number
|
0.54 |
true |
true |
0.28 |
CXCR4
|
decreased mature b cell number
|
0.54 |
false |
true |
0.28 |
CD79B
|
decreased igg3 level
|
0.54 |
false |
true |
0.28 |
IFNG
|
increased lymphocyte cell number
|
0.54 |
true |
true |
0.28 |
FASLG
|
abnormal effector t cell morphology
|
0.54 |
false |
true |
0.28 |
RHOH
|
abnormal b cell physiology
|
0.54 |
false |
true |
0.28 |
IL4
|
abnormal circulating interleukin level
|
0.54 |
false |
true |
0.28 |
CXCL9
|
abnormal response to infection
|
0.54 |
false |
true |
0.28 |
IL4
|
abnormal cd4-positive, alpha-beta t cell physiology
|
0.54 |
true |
true |
0.28 |
IL4
|
abnormal mononuclear phagocyte morphology
|
0.54 |
true |
true |
0.28 |
SLAMF1
|
decreased cd4-positive, alpha beta t cell number
|
0.54 |
false |
true |
0.28 |
ITGAX
|
altered susceptibility to autoimmune disorder
|
0.54 |
true |
true |
0.28 |
CD52
|
abnormal b cell physiology
|
0.54 |
false |
true |
0.28 |
VAV1
|
abnormal leukopoiesis
|
0.54 |
true |
true |
0.28 |
CXCR4
|
abnormal innate immunity
|
0.54 |
true |
true |
0.28 |
FYB
|
abnormal t cell morphology
|
0.54 |
true |
true |
0.28 |
NFKB1
|
decreased leukocyte cell number
|
0.54 |
true |
true |
0.28 |
IL15
|
abnormal macrophage physiology
|
0.54 |
false |
true |
0.28 |
CXCR3
|
decreased lymphocyte cell number
|
0.54 |
false |
true |
0.28 |
CCR5
|
abnormal lymphopoiesis
|
0.54 |
true |
true |
0.28 |
CDKN1A
|
increased immunoglobulin level
|
0.54 |
true |
true |
0.28 |
CCR2
|
abnormal t cell morphology
|
0.54 |
true |
true |
0.28 |
NFKB2
|
abnormal leukopoiesis
|
0.54 |
true |
true |
0.28 |
CD27
|
abnormal lymphocyte physiology
|
0.54 |
true |
true |
0.28 |
IRF1
|
increased leukocyte cell number
|
0.54 |
true |
true |
0.28 |
PTPRC
|
abnormal double-negative t cell morphology
|
0.54 |
true |
true |
0.28 |
CD8A
|
abnormal alpha-beta t cell number
|
0.54 |
true |
true |
0.28 |
IFNG
|
abnormal interferon secretion
|
0.54 |
true |
true |
0.28 |
TNFAIP3
|
abnormal t cell activation
|
0.54 |
false |
true |
0.28 |
IFNG
|
increased t cell number
|
0.54 |
true |
true |
0.28 |
IL10
|
abnormal t cell physiology
|
0.54 |
true |
true |
0.28 |
CCL22
|
abnormal immunoglobulin level
|
0.54 |
false |
true |
0.28 |
FYB
|
abnormal alpha-beta t cell number
|
0.54 |
false |
true |
0.28 |
POU2AF1
|
decreased b cell number
|
0.54 |
true |
true |
0.28 |
CCR1
|
altered susceptibility to parasitic infection
|
0.54 |
true |
true |
0.28 |
SLAMF1
|
abnormal b cell physiology
|
0.54 |
false |
true |
0.28 |
IL12A
|
increased susceptibility to infection
|
0.54 |
true |
true |
0.28 |
IRF7
|
abnormal response to infection
|
0.54 |
true |
true |
0.28 |
CD14
|
abnormal cytokine secretion
|
0.54 |
true |
true |
0.28 |
CD48
|
abnormal effector t cell morphology
|
0.54 |
true |
true |
0.28 |
FOS
|
altered metastatic potential
|
0.54 |
true |
true |
0.28 |
FYB
|
abnormal alpha-beta t cell morphology
|
0.54 |
false |
true |
0.28 |
CD27
|
abnormal mature b cell morphology
|
0.54 |
false |
true |
0.28 |
IL6
|
altered susceptibility to bacterial infection
|
0.54 |
true |
true |
0.28 |
IRF4
|
abnormal igg level
|
0.54 |
true |
true |
0.28 |
MS4A1
|
abnormal leukopoiesis
|
0.54 |
true |
true |
0.28 |
IL15
|
decreased interferon-gamma secretion
|
0.54 |
true |
true |
0.28 |
RHOH
|
abnormal b cell number
|
0.54 |
false |
true |
0.28 |
GFI1
|
abnormal lymphopoiesis
|
0.54 |
true |
true |
0.28 |
CD52
|
abnormal humoral immune response
|
0.54 |
false |
true |
0.28 |
CD53
|
abnormal igg level
|
0.54 |
false |
false |
0.28 |
ITGB2
|
abnormal leukopoiesis
|
0.54 |
true |
true |
0.28 |
IL4
|
abnormal dendritic cell physiology
|
0.54 |
true |
true |
0.28 |
SELL
|
abnormal effector t cell morphology
|
0.54 |
false |
true |
0.28 |
IFNG
|
abnormal hypersensitivity reaction
|
0.54 |
true |
true |
0.28 |
BLK
|
abnormal lymphocyte physiology
|
0.54 |
false |
true |
0.28 |
BLK
|
abnormal leukopoiesis
|
0.54 |
false |
true |
0.28 |
IL4
|
abnormal interferon secretion
|
0.54 |
true |
true |
0.28 |
IFNG
|
decreased susceptibility to autoimmune disorder
|
0.54 |
true |
true |
0.28 |
CCR2
|
abnormal effector t cell morphology
|
0.54 |
true |
true |
0.28 |
CSF2
|
abnormal phagocyte morphology
|
0.54 |
true |
true |
0.28 |
TRAF1
|
abnormal t cell activation
|
0.54 |
true |
true |
0.28 |
LY9
|
abnormal humoral immune response
|
0.54 |
false |
true |
0.28 |
NR3C1
|
abnormal follicle stimulating hormone level
|
0.54 |
false |
true |
0.28 |
LY9
|
abnormal b cell physiology
|
0.54 |
false |
true |
0.28 |
CXCR5
|
abnormal marginal zone b cell morphology
|
0.54 |
false |
true |
0.28 |
BMP4
|
abnormal pectoral girdle bone morphology
|
0.54 |
true |
true |
0.28 |
CD8A
|
abnormal cd8-positive, alpha-beta t cell number
|
0.54 |
true |
true |
0.28 |
CCL5
|
abnormal lymphocyte cell number
|
0.54 |
true |
true |
0.28 |
CXCR5
|
decreased igg level
|
0.54 |
false |
true |
0.28 |
RHOH
|
abnormal mature b cell morphology
|
0.54 |
false |
true |
0.28 |
TNFRSF1B
|
altered susceptibility to infection
|
0.54 |
true |
true |
0.28 |
FASLG
|
abnormal alpha-beta t cell morphology
|
0.54 |
false |
true |
0.28 |
LCP1
|
abnormal t cell physiology
|
0.54 |
false |
true |
0.28 |
IL4
|
abnormal intestine physiology
|
0.54 |
true |
true |
0.28 |
TLR2
|
decreased tumor necrosis factor secretion
|
0.54 |
true |
true |
0.28 |
IFIH1
|
altered susceptibility to viral infection
|
0.54 |
true |
true |
0.28 |
FYB
|
abnormal cd4-positive, alpha beta t cell number
|
0.54 |
false |
true |
0.28 |
STAT1
|
abnormal innate immunity
|
0.54 |
true |
true |
0.28 |
SP140
|
abnormal lymphopoiesis
|
0.54 |
false |
false |
0.28 |
CSF2RB
|
abnormal t cell morphology
|
0.54 |
false |
true |
0.28 |
EGR1
|
abnormal macrophage physiology
|
0.54 |
true |
true |
0.28 |
IL4
|
abnormal macrophage morphology
|
0.54 |
true |
true |
0.28 |
IFNG
|
abnormal nk cell morphology
|
0.54 |
true |
true |
0.28 |
NFKB2
|
abnormal peyer's patch morphology
|
0.54 |
true |
true |
0.28 |
ATR
|
increased organ/body region tumor incidence
|
0.54 |
false |
true |
0.28 |
DRD5
|
impaired behavioral response to addictive substance
|
0.54 |
false |
true |
0.28 |
CXCL9
|
altered susceptibility to infection
|
0.54 |
false |
true |
0.28 |
NCF4
|
decreased lymphocyte cell number
|
0.54 |
false |
true |
0.28 |
ITGB7
|
abnormal lymphocyte cell number
|
0.54 |
true |
true |
0.28 |
NFKB2
|
abnormal t cell differentiation
|
0.54 |
true |
true |
0.28 |
IL10
|
abnormal macrophage physiology
|
0.54 |
false |
true |
0.28 |
IL2RB
|
abnormal lymphocyte cell number
|
0.54 |
true |
true |
0.28 |
IL6
|
abnormal susceptibility to induced colitis
|
0.54 |
true |
true |
0.28 |
ATR
|
abnormal organ/body region tumor incidence
|
0.54 |
false |
true |
0.28 |
SYK
|
abnormal igg level
|
0.54 |
true |
true |
0.28 |
IL13
|
decreased inflammatory response
|
0.54 |
true |
true |
0.28 |
NCF4
|
abnormal lymphopoiesis
|
0.54 |
false |
true |
0.28 |
PRKCB
|
abnormal b cell differentiation
|
0.54 |
true |
true |
0.28 |
RELB
|
decreased igg level
|
0.54 |
false |
true |
0.28 |
LCK
|
abnormal thyroid gland morphology
|
0.54 |
true |
true |
0.28 |
CCR2
|
abnormal cd4-positive, alpha beta t cell morphology
|
0.54 |
true |
true |
0.28 |
LCP2
|
abnormal effector t cell morphology
|
0.54 |
true |
true |
0.28 |
FLT1
|
abnormal heart ventricle morphology
|
0.54 |
false |
true |
0.28 |
POU2AF1
|
abnormal leukopoiesis
|
0.54 |
true |
true |
0.28 |
IL12A
|
increased susceptibility to parasitic infection
|
0.54 |
true |
true |
0.28 |
BIRC3
|
abnormal professional antigen presenting cell morphology
|
0.54 |
true |
true |
0.28 |
IFNG
|
abnormal lymph node morphology
|
0.54 |
true |
true |
0.28 |
CD52
|
abnormal igg level
|
0.54 |
false |
true |
0.28 |
UBASH3A
|
abnormal t cell differentiation
|
0.54 |
false |
true |
0.28 |
HOXA3
|
abnormal rib attachment
|
0.54 |
false |
true |
0.28 |
CXCR3
|
abnormal cd4-positive, alpha beta t cell morphology
|
0.54 |
false |
true |
0.28 |
RHOH
|
increased lymphocyte cell number
|
0.54 |
true |
true |
0.28 |
CD5
|
abnormal t cell activation
|
0.54 |
true |
true |
0.28 |
STAT1
|
decreased t cell number
|
0.54 |
false |
true |
0.28 |
TRAF1
|
decreased immunoglobulin level
|
0.54 |
false |
true |
0.28 |
CD40
|
abnormal t cell physiology
|
0.54 |
false |
true |
0.28 |
IL7R
|
abnormal cd4-positive, alpha beta t cell morphology
|
0.54 |
true |
true |
0.28 |
IFNG
|
abnormal igg2a level
|
0.54 |
true |
true |
0.28 |
FASLG
|
abnormal t cell number
|
0.54 |
true |
true |
0.28 |
CXCR4
|
abnormal igm level
|
0.54 |
true |
true |
0.28 |
IFNG
|
abnormal mononuclear phagocyte morphology
|
0.54 |
true |
true |
0.28 |
IL1R2
|
abnormal immune serum protein physiology
|
0.54 |
false |
false |
0.28 |
BIRC3
|
decreased igg level
|
0.54 |
true |
true |
0.28 |
IL4
|
abnormal ige level
|
0.54 |
true |
true |
0.28 |
IL2RG
|
abnormal igg level
|
0.54 |
true |
true |
0.28 |
NCF4
|
abnormal lymphocyte physiology
|
0.54 |
false |
true |
0.28 |
CD22
|
abnormal b cell activation
|
0.54 |
true |
true |
0.28 |
IRF1
|
increased lymphocyte cell number
|
0.54 |
true |
true |
0.28 |
CXCR5
|
abnormal professional antigen presenting cell physiology
|
0.54 |
false |
true |
0.28 |
PRKDC
|
increased classified tumor incidence
|
0.54 |
true |
true |
0.28 |
PRKDC
|
abnormal classified tumor incidence
|
0.54 |
true |
true |
0.28 |
CXCR3
|
abnormal t cell physiology
|
0.54 |
false |
true |
0.28 |
IL4
|
decreased igg level
|
0.54 |
true |
true |
0.28 |
BIRC3
|
abnormal b cell morphology
|
0.54 |
true |
true |
0.28 |
TLR1
|
abnormal interleukin secretion
|
0.54 |
true |
true |
0.28 |
HOXB5
|
abnormal vertebral column morphology
|
0.54 |
true |
true |
0.28 |
IL13
|
abnormal igg level
|
0.54 |
true |
true |
0.28 |
CXCL10
|
altered susceptibility to infection induced morbidity/mortality
|
0.54 |
false |
true |
0.28 |
LCP2
|
abnormal interleukin secretion
|
0.54 |
true |
true |
0.28 |
CCR1
|
abnormal neutrophil physiology
|
0.54 |
true |
true |
0.28 |
ITK
|
abnormal double-negative t cell morphology
|
0.54 |
true |
true |
0.28 |
ITK
|
small thymus
|
0.54 |
false |
true |
0.28 |
CD5
|
abnormal t cell number
|
0.54 |
true |
true |
0.28 |
IL1B
|
abnormal circulating interleukin level
|
0.54 |
true |
true |
0.28 |
TNFRSF17
|
abnormal igg level
|
0.54 |
false |
true |
0.28 |
BCL2A1
|
abnormal professional antigen presenting cell physiology
|
0.54 |
false |
true |
0.28 |
IL10
|
abnormal professional antigen presenting cell morphology
|
0.54 |
true |
true |
0.28 |
JAK3
|
decreased t cell number
|
0.54 |
true |
true |
0.28 |
NFKB2
|
abnormal gut-associated lymphoid tissue morphology
|
0.54 |
true |
true |
0.28 |
ITK
|
decreased leukocyte cell number
|
0.54 |
true |
true |
0.28 |
IL2RG
|
decreased immunoglobulin level
|
0.54 |
true |
true |
0.28 |
JAK3
|
abnormal t cell morphology
|
0.54 |
true |
true |
0.28 |
CD2
|
abnormal leukopoiesis
|
0.54 |
false |
true |
0.28 |
BCL2A1
|
abnormal immunoglobulin level
|
0.54 |
false |
true |
0.28 |
CCL5
|
increased immunoglobulin level
|
0.54 |
false |
true |
0.28 |
CD48
|
abnormal t cell activation
|
0.54 |
true |
true |
0.28 |
CD5
|
abnormal t cell morphology
|
0.54 |
true |
true |
0.28 |
STAT1
|
decreased interferon-gamma secretion
|
0.54 |
true |
true |
0.28 |
MAP4K1
|
abnormal b cell physiology
|
0.54 |
false |
true |
0.28 |
CXCR5
|
increased igg level
|
0.54 |
false |
true |
0.28 |
COL3A1
|
abnormal compact bone morphology
|
0.54 |
false |
true |
0.28 |
NCF4
|
abnormal b cell morphology
|
0.54 |
false |
true |
0.28 |
MS4A1
|
abnormal iga level
|
0.54 |
false |
true |
0.28 |
HCK
|
abnormal lymphocyte physiology
|
0.54 |
false |
true |
0.28 |
NR5A1
|
abnormal circulating androgen level
|
0.54 |
false |
true |
0.29 |
NR5A1
|
abnormal circulating testosterone level
|
0.54 |
false |
true |
0.29 |
PLAUR
|
abnormal innate immunity
|
0.54 |
true |
true |
0.29 |
HOXA6
|
abnormal pectoral girdle bone morphology
|
0.54 |
false |
true |
0.29 |
CORO1A
|
abnormal t cell proliferation
|
0.54 |
true |
true |
0.29 |
RHOH
|
abnormal immunoglobulin level
|
0.54 |
false |
true |
0.29 |
PTPN7
|
decreased t cell proliferation
|
0.54 |
false |
true |
0.29 |
CORO1A
|
abnormal t cell morphology
|
0.54 |
true |
true |
0.29 |
NFKB1
|
abnormal peyer's patch size
|
0.54 |
true |
true |
0.29 |
MAP4K1
|
abnormal mature b cell morphology
|
0.54 |
false |
true |
0.29 |
DNAH10
|
heterotaxia
|
0.54 |
false |
false |
0.29 |
CD22
|
abnormal igg1 level
|
0.54 |
true |
true |
0.29 |
RARB
|
abnormal cervical vertebrae morphology
|
0.54 |
true |
true |
0.29 |
CCR7
|
abnormal b cell proliferation
|
0.54 |
false |
true |
0.29 |
TNFRSF1B
|
abnormal response to infection
|
0.54 |
true |
true |
0.29 |
CD19
|
abnormal lymphocyte physiology
|
0.54 |
true |
true |
0.29 |
UBASH3A
|
abnormal t cell number
|
0.54 |
false |
true |
0.29 |
CXCR5
|
abnormal spleen b cell follicle morphology
|
0.54 |
true |
true |
0.29 |
CXCR4
|
increased t cell number
|
0.54 |
false |
true |
0.29 |
CXCL10
|
abnormal professional antigen presenting cell physiology
|
0.54 |
true |
true |
0.29 |
CCR7
|
abnormal gut-associated lymphoid tissue morphology
|
0.54 |
true |
true |
0.29 |
SLAMF1
|
abnormal lymphocyte cell number
|
0.54 |
false |
true |
0.29 |
IRF7
|
abnormal circulating cytokine level
|
0.54 |
false |
true |
0.29 |
CD3D
|
absent lymphocyte
|
0.54 |
false |
true |
0.29 |
PRKDC
|
increased organ/body region tumor incidence
|
0.54 |
true |
true |
0.29 |
TNFSF10
|
abnormal innate immunity
|
0.54 |
true |
true |
0.29 |
ITGAL
|
abnormal b cell physiology
|
0.54 |
false |
true |
0.29 |
IL15
|
decreased inflammatory response
|
0.54 |
true |
true |
0.29 |
CD3D
|
decreased interferon-gamma secretion
|
0.54 |
false |
true |
0.29 |
IL4
|
abnormal myeloid leukocyte morphology
|
0.54 |
true |
true |
0.29 |
CD19
|
decreased igg1 level
|
0.54 |
true |
true |
0.29 |
CD86
|
altered susceptibility to infection
|
0.54 |
false |
true |
0.29 |
CD3E
|
decreased t cell proliferation
|
0.54 |
false |
true |
0.29 |
FYB
|
abnormal t cell number
|
0.54 |
true |
true |
0.29 |
IRF1
|
abnormal lymphocyte cell number
|
0.54 |
true |
true |
0.29 |
NR5A1
|
abnormal testosterone level
|
0.54 |
true |
true |
0.29 |
CD6
|
abnormal lymphocyte cell number
|
0.54 |
false |
false |
0.29 |
TRAF1
|
abnormal professional antigen presenting cell physiology
|
0.54 |
false |
true |
0.29 |
NCF4
|
abnormal t cell morphology
|
0.54 |
false |
true |
0.29 |
IL10
|
abnormal intestine physiology
|
0.54 |
true |
true |
0.29 |
IL2RG
|
abnormal immune serum protein physiology
|
0.54 |
true |
true |
0.29 |
DUSP1
|
abnormal tumor necrosis factor level
|
0.54 |
true |
true |
0.29 |
CCR7
|
abnormal igg2a level
|
0.53 |
true |
true |
0.29 |
IL10RA
|
abnormal lymphocyte cell number
|
0.53 |
false |
true |
0.29 |
ESR1
|
abnormal osteoblast morphology
|
0.53 |
true |
true |
0.29 |
CCL5
|
decreased alpha-beta t cell number
|
0.53 |
true |
true |
0.29 |
CCL5
|
abnormal cd8-positive, alpha-beta t cell physiology
|
0.53 |
false |
true |
0.29 |
CTGF
|
abnormal cardiovascular development
|
0.53 |
true |
true |
0.29 |
IL15
|
abnormal lymphocyte cell number
|
0.53 |
true |
true |
0.29 |
PRKDC
|
abnormal organ/body region tumor incidence
|
0.53 |
true |
true |
0.29 |
CCL5
|
abnormal circulating cytokine level
|
0.53 |
false |
true |
0.29 |
RHOH
|
abnormal lymphocyte cell number
|
0.53 |
true |
true |
0.29 |
MYC
|
abnormal lymph node morphology
|
0.53 |
true |
true |
0.29 |
PTPN7
|
increased hematopoietic cell number
|
0.53 |
false |
true |
0.29 |
CCL22
|
abnormal humoral immune response
|
0.53 |
false |
true |
0.29 |
FASLG
|
abnormal alpha-beta t cell number
|
0.53 |
false |
true |
0.29 |
CD96
|
abnormal cd4-positive, alpha beta t cell morphology
|
0.53 |
false |
false |
0.29 |
HOXB5
|
abnormal rib attachment
|
0.53 |
false |
true |
0.29 |
RHOH
|
abnormal cd8-positive, alpha beta t cell morphology
|
0.53 |
true |
true |
0.29 |
UBASH3A
|
abnormal effector t cell morphology
|
0.53 |
false |
true |
0.29 |
ITGB7
|
increased immunoglobulin level
|
0.53 |
false |
true |
0.29 |
IRF4
|
abnormal b cell number
|
0.53 |
true |
true |
0.29 |
LCP2
|
abnormal interferon secretion
|
0.53 |
true |
true |
0.29 |
MAP4K1
|
abnormal immunoglobulin level
|
0.53 |
false |
true |
0.29 |
IL4
|
abnormal professional antigen presenting cell morphology
|
0.53 |
true |
true |
0.29 |
HOXA6
|
abnormal vertebrae morphology
|
0.53 |
true |
true |
0.29 |
IRF7
|
increased susceptibility to infection
|
0.53 |
true |
true |
0.29 |
IL7R
|
abnormal effector t cell morphology
|
0.53 |
true |
true |
0.29 |
IL2RB
|
decreased cd4-positive, alpha beta t cell number
|
0.53 |
false |
true |
0.29 |
IL1R2
|
autoimmune response
|
0.53 |
false |
false |
0.29 |
IL4
|
abnormal dendritic cell morphology
|
0.53 |
true |
true |
0.29 |
TRAF1
|
abnormal t cell morphology
|
0.53 |
true |
true |
0.29 |
NCF4
|
abnormal lymphocyte cell number
|
0.53 |
false |
true |
0.29 |
CD79B
|
abnormal leukopoiesis
|
0.53 |
true |
true |
0.29 |
JAK3
|
abnormal t cell differentiation
|
0.53 |
true |
true |
0.29 |
HOXA2
|
abnormal presacral vertebrae morphology
|
0.53 |
false |
true |
0.29 |
IL1R2
|
abnormal circulating interleukin level
|
0.53 |
false |
false |
0.29 |
IL15
|
decreased t cell number
|
0.53 |
true |
true |
0.29 |
CD48
|
abnormal lymphopoiesis
|
0.53 |
true |
true |
0.29 |
IRF1
|
increased immunoglobulin level
|
0.53 |
false |
true |
0.29 |
CD3G
|
abnormal lymphocyte physiology
|
0.53 |
true |
true |
0.29 |
ITGB2
|
abnormal cd4-positive, alpha beta t cell number
|
0.53 |
true |
true |
0.29 |
HOXB3
|
abnormal pectoral girdle bone morphology
|
0.53 |
false |
true |
0.29 |
CXCL10
|
abnormal induced morbidity/mortality
|
0.53 |
false |
true |
0.29 |
IL2RG
|
decreased interferon-gamma secretion
|
0.53 |
true |
true |
0.29 |
IFNG
|
abnormal macrophage physiology
|
0.53 |
true |
true |
0.29 |
SELL
|
abnormal cd8-positive, alpha beta t cell morphology
|
0.53 |
false |
true |
0.29 |
ESR1
|
hypoalgesia
|
0.53 |
true |
true |
0.29 |
IL13
|
abnormal circulating cytokine level
|
0.53 |
true |
true |
0.29 |
CCR7
|
abnormal t cell proliferation
|
0.53 |
false |
true |
0.29 |
MYC
|
abnormal large intestine morphology
|
0.53 |
true |
true |
0.29 |
BCL2A1
|
abnormal immune serum protein physiology
|
0.53 |
false |
true |
0.29 |
FLI1
|
abnormal b cell differentiation
|
0.53 |
true |
true |
0.29 |
TGFB1
|
abnormal lymphocyte physiology
|
0.53 |
false |
true |
0.29 |
TCL1A
|
abnormal b cell differentiation
|
0.53 |
false |
true |
0.29 |
REL
|
abnormal b cell activation
|
0.53 |
true |
true |
0.29 |
BLK
|
decreased immature b cell number
|
0.53 |
false |
true |
0.29 |
RUNX3
|
abnormal igg level
|
0.53 |
false |
true |
0.29 |
CD40
|
abnormal lymphocyte physiology
|
0.53 |
true |
true |
0.29 |
LCP2
|
abnormal igg level
|
0.53 |
true |
true |
0.29 |
MDM2
|
decreased apoptosis
|
0.53 |
true |
true |
0.29 |
MDM2
|
decreased cell death
|
0.53 |
true |
true |
0.29 |
MYC
|
tumorigenesis
|
0.53 |
true |
true |
0.29 |
LCK
|
increased double-negative t cell number
|
0.53 |
false |
true |
0.29 |
SELL
|
decreased immunoglobulin level
|
0.53 |
false |
true |
0.29 |
IKZF1
|
abnormal lymphopoiesis
|
0.53 |
true |
true |
0.29 |
IL4
|
abnormal interleukin secretion
|
0.53 |
true |
true |
0.29 |
CD3E
|
abnormal lymphocyte cell number
|
0.53 |
true |
true |
0.29 |
CD3G
|
increased lymphocyte cell number
|
0.53 |
false |
true |
0.29 |
IFNG
|
abnormal cd4-positive, alpha beta t cell number
|
0.53 |
false |
true |
0.29 |
IRF4
|
abnormal b cell morphology
|
0.53 |
true |
true |
0.29 |
CD72
|
abnormal mature b cell morphology
|
0.53 |
true |
true |
0.29 |
CD79A
|
abnormal transitional stage b cell morphology
|
0.53 |
true |
true |
0.29 |
TLR1
|
abnormal macrophage physiology
|
0.53 |
true |
true |
0.29 |
HOXB2
|
abnormal vertebrae morphology
|
0.53 |
true |
true |
0.29 |
CXCL10
|
abnormal type iv hypersensitivity reaction
|
0.53 |
true |
true |
0.29 |
CCR7
|
increased t cell number
|
0.53 |
true |
true |
0.29 |
FASLG
|
abnormal t cell differentiation
|
0.53 |
true |
true |
0.29 |
IL7R
|
increased immunoglobulin level
|
0.53 |
false |
true |
0.29 |
IRF4
|
abnormal humoral immune response
|
0.53 |
true |
true |
0.29 |
TNFAIP3
|
abnormal t cell proliferation
|
0.53 |
false |
true |
0.29 |
ITGB2
|
abnormal lymphocyte cell number
|
0.53 |
true |
true |
0.29 |
CD6
|
abnormal double-positive t cell morphology
|
0.53 |
false |
false |
0.29 |
CD14
|
abnormal innate immunity
|
0.53 |
true |
true |
0.29 |
CXCL9
|
abnormal interferon secretion
|
0.53 |
false |
true |
0.29 |
HCK
|
abnormal granulocyte physiology
|
0.53 |
true |
true |
0.29 |
IL1R2
|
abnormal self tolerance
|
0.53 |
false |
false |
0.29 |
IFNG
|
abnormal iga level
|
0.53 |
true |
true |
0.29 |
IL1B
|
decreased susceptibility to type iv hypersensitivity reaction
|
0.53 |
true |
true |
0.29 |
CD19
|
abnormal professional antigen presenting cell physiology
|
0.53 |
true |
true |
0.29 |
TLR2
|
abnormal circulating interleukin level
|
0.53 |
true |
true |
0.29 |
TLR1
|
abnormal self tolerance
|
0.53 |
false |
true |
0.29 |
NCF4
|
abnormal leukopoiesis
|
0.53 |
false |
true |
0.29 |
IL4
|
abnormal phagocyte morphology
|
0.53 |
true |
true |
0.29 |
CD48
|
decreased immunoglobulin level
|
0.53 |
false |
true |
0.29 |
HOXA6
|
abnormal rib morphology
|
0.53 |
true |
true |
0.29 |
SLAMF1
|
abnormal leukopoiesis
|
0.53 |
false |
true |
0.29 |
PTPRC
|
increased igg level
|
0.53 |
true |
true |
0.29 |
ITGB7
|
abnormal cd8-positive, alpha beta t cell morphology
|
0.53 |
false |
true |
0.29 |
IL10
|
increased susceptibility to bacterial infection
|
0.53 |
true |
true |
0.29 |
ZAP70
|
abnormal b cell physiology
|
0.53 |
true |
true |
0.29 |
ICAM1
|
altered susceptibility to parasitic infection
|
0.53 |
true |
true |
0.29 |
CD22
|
decreased mature b cell number
|
0.53 |
true |
true |
0.29 |
LCK
|
abnormal thymus size
|
0.53 |
true |
true |
0.29 |
BIRC3
|
abnormal response to infection
|
0.53 |
false |
true |
0.29 |
TRAF1
|
decreased igg level
|
0.53 |
false |
true |
0.29 |
TLR1
|
abnormal b cell physiology
|
0.53 |
true |
true |
0.29 |
IL2RB
|
abnormal b cell physiology
|
0.53 |
true |
true |
0.29 |
CD86
|
abnormal t cell physiology
|
0.53 |
true |
true |
0.29 |
CD37
|
increased igg level
|
0.53 |
false |
true |
0.29 |
IL1R2
|
abnormal acute inflammation
|
0.53 |
false |
false |
0.29 |
ITGAM
|
abnormal cytokine secretion
|
0.53 |
false |
true |
0.29 |
IL4R
|
abnormal effector t cell morphology
|
0.53 |
true |
true |
0.29 |
CSF2RB
|
abnormal effector t cell morphology
|
0.53 |
false |
true |
0.29 |
CXCR4
|
altered susceptibility to infection induced morbidity/mortality
|
0.53 |
true |
true |
0.29 |
TLR1
|
autoimmune response
|
0.53 |
false |
true |
0.29 |
CD69
|
abnormal leukopoiesis
|
0.53 |
true |
true |
0.29 |
CXCR3
|
abnormal lymphopoiesis
|
0.53 |
false |
true |
0.29 |
IL7R
|
abnormal interferon secretion
|
0.53 |
false |
true |
0.29 |
IL13
|
abnormal acute inflammation
|
0.53 |
true |
true |
0.29 |
SELL
|
abnormal t cell number
|
0.53 |
true |
true |
0.29 |
STAT1
|
abnormal lymphocyte cell number
|
0.53 |
true |
true |
0.29 |
ITGB2
|
abnormal lymph node morphology
|
0.53 |
true |
true |
0.29 |
CD247
|
abnormal t cell differentiation
|
0.53 |
true |
true |
0.29 |
CD8A
|
decreased t cell number
|
0.53 |
true |
true |
0.29 |
NFKB2
|
abnormal igg1 level
|
0.53 |
true |
true |
0.29 |
IL10RA
|
decreased leukocyte cell number
|
0.53 |
false |
true |
0.29 |
VAV1
|
abnormal lymphocyte cell number
|
0.53 |
true |
true |
0.29 |
IRF7
|
abnormal interleukin level
|
0.53 |
false |
true |
0.29 |
LCP2
|
abnormal humoral immune response
|
0.53 |
true |
true |
0.29 |
FASLG
|
abnormal t cell physiology
|
0.53 |
true |
true |
0.29 |
NR1H4
|
abnormal thyroid physiology
|
0.53 |
false |
true |
0.29 |
FCER2
|
abnormal b cell physiology
|
0.53 |
true |
true |
0.29 |
IL6
|
abnormal professional antigen presenting cell morphology
|
0.53 |
true |
true |
0.29 |
CCR7
|
abnormal peyer's patch morphology
|
0.53 |
true |
true |
0.29 |
REL
|
decreased igg level
|
0.53 |
true |
true |
0.29 |
IRF7
|
abnormal lymphocyte physiology
|
0.53 |
true |
true |
0.29 |
RHOH
|
decreased b cell number
|
0.53 |
false |
true |
0.29 |
CD96
|
decreased alpha-beta t cell number
|
0.53 |
false |
false |
0.29 |
GADD45A
|
altered tumor pathology
|
0.53 |
false |
true |
0.29 |
CD27
|
abnormal t cell differentiation
|
0.53 |
false |
true |
0.29 |
TLR1
|
abnormal immune tolerance
|
0.53 |
false |
true |
0.29 |
RHOH
|
abnormal humoral immune response
|
0.53 |
false |
true |
0.29 |
BTK
|
abnormal lymphocyte physiology
|
0.53 |
true |
true |
0.29 |
CCR5
|
abnormal granulocyte morphology
|
0.53 |
false |
true |
0.29 |
ICAM1
|
abnormal induced morbidity/mortality
|
0.53 |
true |
true |
0.29 |
SP140
|
abnormal mature b cell morphology
|
0.53 |
false |
false |
0.29 |
CD19
|
increased igm level
|
0.53 |
false |
true |
0.29 |
TNFSF13B
|
abnormal lymphocyte physiology
|
0.53 |
true |
true |
0.29 |
IFNG
|
increased hematopoietic cell number
|
0.53 |
true |
true |
0.29 |
HOXA7
|
abnormal thoracic vertebrae morphology
|
0.53 |
false |
true |
0.29 |
TNFRSF1B
|
abnormal cytokine secretion
|
0.53 |
true |
true |
0.29 |
CD48
|
abnormal t cell differentiation
|
0.53 |
true |
true |
0.29 |
PLCG2
|
abnormal mature b cell morphology
|
0.53 |
true |
true |
0.29 |
IL1A
|
abnormal cytokine level
|
0.53 |
true |
true |
0.29 |
IL2RG
|
decreased t cell number
|
0.53 |
true |
true |
0.29 |
TGFB1
|
abnormal response to infection
|
0.53 |
false |
true |
0.29 |
IL1R2
|
abnormal immune tolerance
|
0.53 |
false |
false |
0.29 |
CCR2
|
abnormal t cell proliferation
|
0.53 |
true |
true |
0.29 |
TNFRSF1B
|
increased immunoglobulin level
|
0.53 |
false |
true |
0.29 |
CFLAR
|
abnormal lymphocyte physiology
|
0.53 |
false |
true |
0.29 |
CCR2
|
abnormal leukopoiesis
|
0.53 |
true |
true |
0.29 |
PGR
|
abnormal circulating gonadotropin level
|
0.53 |
true |
true |
0.29 |
IL4
|
abnormal induced morbidity/mortality
|
0.53 |
true |
true |
0.29 |
CD53
|
abnormal lymphocyte physiology
|
0.53 |
false |
false |
0.29 |
IL1A
|
abnormal innate immunity
|
0.53 |
false |
true |
0.29 |
TNFRSF1B
|
abnormal t cell activation
|
0.53 |
true |
true |
0.29 |
FCER2
|
abnormal immunoglobulin level
|
0.53 |
true |
true |
0.29 |
IL7R
|
abnormal t cell physiology
|
0.53 |
true |
true |
0.29 |
MS4A1
|
increased igg level
|
0.53 |
false |
true |
0.29 |
SLA
|
abnormal t cell differentiation
|
0.53 |
true |
true |
0.29 |
PTPRC
|
abnormal plasma cell morphology
|
0.53 |
true |
true |
0.29 |
PTPRC
|
abnormal cytotoxic t cell physiology
|
0.53 |
true |
true |
0.29 |
TLR2
|
decreased interleukin-6 secretion
|
0.53 |
true |
true |
0.29 |
IL7R
|
abnormal self tolerance
|
0.53 |
false |
true |
0.29 |
TNFSF10
|
abnormal professional antigen presenting cell physiology
|
0.53 |
true |
true |
0.29 |
CD37
|
abnormal t cell activation
|
0.53 |
false |
true |
0.29 |
IL7R
|
autoimmune response
|
0.53 |
false |
true |
0.29 |
CCL5
|
abnormal circulating interleukin level
|
0.53 |
false |
true |
0.29 |
IFNG
|
abnormal interferon level
|
0.53 |
false |
true |
0.29 |
TNFSF10
|
abnormal circulating cytokine level
|
0.53 |
false |
true |
0.29 |
IL10
|
abnormal leukopoiesis
|
0.53 |
true |
true |
0.29 |
ESR2
|
abnormal uterus morphology
|
0.53 |
false |
true |
0.29 |
IL2
|
decreased t cell number
|
0.53 |
true |
true |
0.29 |
CCR7
|
abnormal spleen marginal zone morphology
|
0.53 |
false |
true |
0.3 |
CCR2
|
abnormal leukocyte migration
|
0.53 |
true |
true |
0.3 |
CXCL10
|
abnormal nk cell physiology
|
0.53 |
false |
true |
0.3 |
GRIA2
|
abnormal cns synaptic transmission
|
0.53 |
true |
true |
0.3 |
IL10
|
increased immunoglobulin level
|
0.53 |
true |
true |
0.3 |
RUNX3
|
abnormal mature b cell morphology
|
0.53 |
false |
true |
0.3 |
IRF1
|
abnormal macrophage physiology
|
0.53 |
true |
true |
0.3 |
PLK1
|
abnormal cell nucleus morphology
|
0.53 |
true |
true |
0.3 |
RUNX3
|
abnormal b cell morphology
|
0.53 |
false |
true |
0.3 |
CXCL10
|
decreased susceptibility to autoimmune disorder
|
0.53 |
false |
true |
0.3 |
CD3E
|
abnormal lymphocyte physiology
|
0.53 |
true |
true |
0.3 |
TLR1
|
abnormal immune serum protein physiology
|
0.53 |
true |
true |
0.3 |
CXCR3
|
abnormal alpha-beta t cell morphology
|
0.53 |
false |
true |
0.3 |
FYB
|
abnormal effector t cell morphology
|
0.53 |
false |
true |
0.3 |
FOS
|
abnormal circulating cytokine level
|
0.53 |
true |
true |
0.3 |
RARA
|
abnormal cervical vertebrae morphology
|
0.53 |
true |
true |
0.3 |
MYC
|
increased leukocyte cell number
|
0.53 |
true |
true |
0.3 |
CSF2RB
|
abnormal cd4-positive, alpha beta t cell morphology
|
0.53 |
false |
true |
0.3 |
RELB
|
abnormal igm level
|
0.53 |
true |
true |
0.3 |
STAT4
|
abnormal lymphocyte physiology
|
0.53 |
true |
true |
0.3 |
IL6
|
abnormal incidence of induced tumors
|
0.53 |
true |
true |
0.3 |
IL2RG
|
abnormal ige level
|
0.53 |
true |
true |
0.3 |
NFKB2
|
abnormal tumor necrosis factor secretion
|
0.53 |
true |
true |
0.3 |
CD8A
|
abnormal lymphocyte physiology
|
0.53 |
true |
true |
0.3 |
CD19
|
abnormal professional antigen presenting cell morphology
|
0.53 |
true |
true |
0.3 |
CCR2
|
abnormal t cell differentiation
|
0.53 |
true |
true |
0.29 |
PLEK
|
abnormal t cell physiology
|
0.53 |
false |
true |
0.3 |
CXCR5
|
abnormal igg3 level
|
0.53 |
false |
true |
0.3 |
PRKCB
|
abnormal lymphopoiesis
|
0.53 |
true |
true |
0.3 |
ITGB2
|
abnormal t cell number
|
0.53 |
true |
true |
0.3 |
ITGAL
|
abnormal humoral immune response
|
0.53 |
true |
true |
0.3 |
BIRC3
|
abnormal b cell number
|
0.53 |
true |
true |
0.3 |
RHOH
|
abnormal lymphocyte physiology
|
0.53 |
true |
true |
0.29 |
MYC
|
abnormal lymphopoiesis
|
0.53 |
true |
true |
0.29 |
ITK
|
abnormal lymphocyte physiology
|
0.53 |
true |
true |
0.29 |
NCF4
|
abnormal b cell number
|
0.53 |
false |
true |
0.3 |
IRF1
|
decreased t cell number
|
0.53 |
true |
true |
0.29 |
PGR
|
increased circulating gonadotropin level
|
0.53 |
true |
true |
0.29 |
SYK
|
abnormal lymphopoiesis
|
0.53 |
true |
true |
0.29 |
ITGAL
|
increased t cell number
|
0.53 |
true |
true |
0.29 |
FCER2
|
abnormal humoral immune response
|
0.53 |
true |
true |
0.29 |
STAT1
|
abnormal leukopoiesis
|
0.53 |
true |
true |
0.29 |
JAK3
|
abnormal t cell number
|
0.53 |
true |
true |
0.29 |
UBASH3A
|
abnormal t cell morphology
|
0.53 |
false |
true |
0.29 |
TNFAIP3
|
altered susceptibility to infection
|
0.53 |
false |
true |
0.29 |
BMP4
|
abnormal sternum morphology
|
0.53 |
true |
true |
0.29 |
REL
|
abnormal igm level
|
0.53 |
true |
true |
0.29 |
IL12B
|
abnormal immune serum protein physiology
|
0.53 |
true |
true |
0.29 |
RUNX3
|
abnormal cd4-positive, alpha beta t cell morphology
|
0.53 |
false |
true |
0.29 |
IL15
|
decreased leukocyte cell number
|
0.53 |
true |
true |
0.29 |
CSF3
|
increased susceptibility to infection induced morbidity/mortality
|
0.53 |
false |
true |
0.29 |
CXCL9
|
abnormal interferon-gamma secretion
|
0.53 |
false |
true |
0.3 |
UBASH3A
|
abnormal cd8-positive, alpha beta t cell morphology
|
0.53 |
false |
true |
0.3 |
IRF7
|
abnormal cytokine level
|
0.53 |
true |
true |
0.3 |
HOXB4
|
abnormal rib attachment
|
0.53 |
false |
true |
0.3 |
ESR2
|
abnormal circulating pituitary hormone level
|
0.53 |
true |
true |
0.3 |
IL1A
|
abnormal intercellular signaling peptide or protein level
|
0.53 |
true |
true |
0.3 |
ZAP70
|
abnormal b cell morphology
|
0.53 |
true |
true |
0.3 |
IL7R
|
abnormal lymphopoiesis
|
0.53 |
true |
true |
0.29 |
HOXB2
|
abnormal cervical vertebrae morphology
|
0.53 |
true |
true |
0.29 |
CD6
|
abnormal lymphocyte physiology
|
0.53 |
false |
false |
0.29 |
ZAP70
|
abnormal thymus morphology
|
0.53 |
true |
true |
0.29 |
POU2AF1
|
increased b cell number
|
0.53 |
false |
true |
0.3 |
IL4R
|
abnormal cd4-positive, alpha beta t cell morphology
|
0.53 |
true |
true |
0.29 |
HOXA6
|
abnormal rib attachment
|
0.53 |
true |
true |
0.29 |
CCR2
|
abnormal lymphopoiesis
|
0.53 |
true |
true |
0.29 |
AR
|
increased pituitary hormone level
|
0.53 |
true |
true |
0.29 |
IFNG
|
altered susceptibility to bacterial infection
|
0.53 |
true |
true |
0.29 |
RELB
|
decreased b cell proliferation
|
0.53 |
true |
true |
0.29 |
ESR1
|
abnormal luteinizing hormone level
|
0.53 |
true |
true |
0.29 |
FOS
|
abnormal tumor necrosis factor level
|
0.53 |
true |
true |
0.29 |
THRB
|
abnormal pituitary hormone level
|
0.53 |
true |
true |
0.29 |
IL12B
|
abnormal interferon secretion
|
0.53 |
true |
true |
0.29 |
CCR5
|
abnormal macrophage physiology
|
0.53 |
true |
true |
0.29 |
IRF1
|
decreased susceptibility to autoimmune disorder
|
0.53 |
true |
true |
0.29 |
RUNX3
|
abnormal alpha-beta t cell number
|
0.53 |
false |
true |
0.29 |
CXCL10
|
altered susceptibility to viral infection
|
0.53 |
true |
true |
0.29 |
CD74
|
abnormal t cell activation
|
0.53 |
true |
true |
0.29 |
DUSP1
|
abnormal interleukin level
|
0.53 |
true |
true |
0.29 |
TNFAIP3
|
abnormal response to infection
|
0.53 |
false |
true |
0.29 |
NFKB1
|
decreased marginal zone b cell number
|
0.53 |
true |
true |
0.29 |
IL4
|
abnormal igg2a level
|
0.53 |
true |
true |
0.29 |
CD96
|
abnormal cd4-positive, alpha beta t cell number
|
0.53 |
false |
false |
0.29 |
RHOH
|
abnormal cd8-positive, alpha-beta t cell number
|
0.53 |
true |
true |
0.29 |
IL2
|
abnormal humoral immune response
|
0.53 |
true |
true |
0.29 |
STAT1
|
abnormal cd4-positive, alpha beta t cell morphology
|
0.53 |
false |
true |
0.29 |
PTPRC
|
increased hematopoietic cell number
|
0.53 |
true |
true |
0.29 |
DRD1
|
abnormal behavioral response to addictive substance
|
0.53 |
true |
true |
0.29 |
RUNX3
|
abnormal alpha-beta t cell morphology
|
0.53 |
false |
true |
0.29 |
CD74
|
altered susceptibility to autoimmune disorder
|
0.53 |
true |
true |
0.29 |
CD5
|
abnormal t cell physiology
|
0.53 |
true |
true |
0.29 |
IL10RA
|
abnormal response to infection
|
0.53 |
true |
true |
0.29 |
CFLAR
|
decreased igg level
|
0.53 |
false |
true |
0.29 |
IRF1
|
altered susceptibility to bacterial infection
|
0.53 |
true |
true |
0.29 |
GFI1
|
abnormal igg level
|
0.53 |
false |
true |
0.29 |
ITGAM
|
altered susceptibility to infection
|
0.52 |
true |
true |
0.29 |
THRB
|
abnormal circulating pituitary hormone level
|
0.52 |
true |
true |
0.29 |
GFI1
|
abnormal leukopoiesis
|
0.52 |
true |
true |
0.29 |
CCNA2
|
embryonic lethality prior to tooth bud stage
|
0.52 |
true |
true |
0.29 |
CCNA2
|
embryonic lethality prior to organogenesis
|
0.52 |
true |
true |
0.29 |
CD247
|
abnormal cd4-positive, alpha beta t cell morphology
|
0.52 |
true |
true |
0.29 |
CFLAR
|
decreased immunoglobulin level
|
0.52 |
false |
true |
0.29 |
IL12B
|
abnormal interferon-gamma secretion
|
0.52 |
true |
true |
0.29 |
ITGAL
|
abnormal b cell number
|
0.52 |
true |
true |
0.29 |
MYC
|
abnormal leukopoiesis
|
0.52 |
true |
true |
0.29 |
RELB
|
abnormal interleukin secretion
|
0.52 |
false |
true |
0.29 |
CD3E
|
increased lymphocyte cell number
|
0.52 |
true |
true |
0.29 |
IL7R
|
abnormal immune tolerance
|
0.52 |
false |
true |
0.29 |
CCR7
|
abnormal t cell activation
|
0.52 |
false |
true |
0.29 |
CD72
|
abnormal b cell physiology
|
0.52 |
true |
true |
0.29 |
CD3D
|
abnormal interferon-gamma secretion
|
0.52 |
false |
true |
0.29 |
CD86
|
increased susceptibility to infection
|
0.52 |
false |
true |
0.29 |
NR1H2
|
abnormal pituitary hormone level
|
0.52 |
false |
true |
0.29 |
CCR1
|
increased igg level
|
0.52 |
true |
true |
0.29 |
CD3E
|
decreased double-positive t cell number
|
0.52 |
true |
true |
0.29 |
DUSP1
|
abnormal circulating interleukin level
|
0.52 |
true |
true |
0.29 |
CCL22
|
abnormal b cell physiology
|
0.52 |
false |
true |
0.29 |
IRF1
|
altered susceptibility to infection induced morbidity/mortality
|
0.52 |
true |
true |
0.29 |
UBASH3A
|
decreased t cell number
|
0.52 |
false |
true |
0.29 |
MCM3
|
abnormal classified tumor incidence
|
0.52 |
false |
true |
0.29 |
MCM3
|
increased classified tumor incidence
|
0.52 |
false |
true |
0.3 |
IL2RB
|
abnormal interferon-gamma secretion
|
0.52 |
false |
true |
0.3 |
NFKB1
|
increased leukocyte cell number
|
0.52 |
true |
true |
0.3 |
BCL2A1
|
increased susceptibility to infection
|
0.52 |
false |
true |
0.3 |
DNAH9
|
abnormal lung position or orientation
|
0.52 |
false |
false |
0.3 |
CD22
|
abnormal b cell morphology
|
0.52 |
true |
true |
0.3 |
FYB
|
abnormal cd4-positive, alpha beta t cell morphology
|
0.52 |
false |
true |
0.3 |
IL12B
|
abnormal cytokine secretion
|
0.52 |
true |
true |
0.3 |
CXCL2
|
abnormal intercellular signaling peptide or protein level
|
0.52 |
false |
false |
0.3 |
CDKN1A
|
abnormal innate immunity
|
0.52 |
true |
true |
0.3 |
TGFB1
|
abnormal leukopoiesis
|
0.52 |
false |
true |
0.3 |
CD79B
|
abnormal transitional stage b cell morphology
|
0.52 |
true |
true |
0.3 |
CORO1A
|
abnormal alpha-beta t cell morphology
|
0.52 |
true |
true |
0.3 |
GZMA
|
abnormal t cell differentiation
|
0.52 |
false |
true |
0.3 |
ESR2
|
abnormal corpus luteum morphology
|
0.52 |
true |
true |
0.3 |
MAP4K1
|
abnormal humoral immune response
|
0.52 |
true |
true |
0.3 |
IL10
|
colitis
|
0.52 |
true |
true |
0.3 |
CD247
|
abnormal cd4-positive, alpha beta t cell number
|
0.52 |
true |
true |
0.3 |
CD79A
|
decreased immature b cell number
|
0.52 |
true |
true |
0.3 |
IL4
|
altered susceptibility to bacterial infection
|
0.52 |
false |
true |
0.3 |
LCP2
|
abnormal b cell physiology
|
0.52 |
true |
true |
0.3 |
CSF2RB
|
decreased immunoglobulin level
|
0.52 |
false |
true |
0.3 |
NFKB1
|
decreased igg1 level
|
0.52 |
true |
true |
0.3 |
IL4R
|
abnormal alpha-beta t cell morphology
|
0.52 |
true |
true |
0.3 |
IL2
|
increased immunoglobulin level
|
0.52 |
true |
true |
0.3 |
LCK
|
abnormal igg level
|
0.52 |
true |
true |
0.3 |
CSF2RB
|
abnormal t cell physiology
|
0.52 |
false |
true |
0.3 |
HOXB3
|
abnormal vertebral column morphology
|
0.52 |
true |
true |
0.3 |
ITGB2
|
abnormal interferon secretion
|
0.52 |
true |
true |
0.3 |
BLK
|
abnormal follicular b cell morphology
|
0.52 |
false |
true |
0.3 |
SELL
|
abnormal professional antigen presenting cell physiology
|
0.52 |
true |
true |
0.3 |
CORO1A
|
abnormal leukopoiesis
|
0.52 |
true |
true |
0.3 |
DNAH6
|
heterotaxia
|
0.52 |
false |
false |
0.3 |
CD72
|
abnormal b cell number
|
0.52 |
true |
true |
0.3 |
CTSS
|
abnormal cytokine secretion
|
0.52 |
true |
true |
0.3 |
CD8A
|
decreased alpha-beta t cell number
|
0.52 |
true |
true |
0.29 |
CD79B
|
abnormal lymphocyte physiology
|
0.52 |
true |
true |
0.29 |
PTPN7
|
abnormal double-positive t cell morphology
|
0.52 |
false |
true |
0.3 |
ITGB7
|
abnormal interferon-gamma secretion
|
0.52 |
false |
true |
0.3 |
CCL22
|
abnormal igg level
|
0.52 |
false |
true |
0.3 |
DRD5
|
abnormal behavioral response to xenobiotic
|
0.52 |
true |
true |
0.3 |
DNAH9
|
abnormal heart position or orientation
|
0.52 |
false |
false |
0.3 |
CXCL9
|
increased susceptibility to infection
|
0.52 |
false |
true |
0.3 |
ITGAL
|
increased lymphocyte cell number
|
0.52 |
true |
true |
0.3 |
CENPA
|
abnormal cell cycle
|
0.52 |
true |
true |
0.3 |
RUNX3
|
increased lymphocyte cell number
|
0.52 |
false |
true |
0.3 |
CD72
|
abnormal immunoglobulin level
|
0.52 |
true |
true |
0.3 |
CXCR4
|
decreased immunoglobulin level
|
0.52 |
false |
true |
0.3 |
NFKB2
|
abnormal phagocyte morphology
|
0.52 |
true |
true |
0.3 |
CXCR3
|
abnormal leukopoiesis
|
0.52 |
false |
true |
0.3 |
ITGAM
|
abnormal response to infection
|
0.52 |
true |
true |
0.3 |
CCL5
|
abnormal cd4-positive, alpha-beta t cell physiology
|
0.52 |
false |
true |
0.3 |
STAT1
|
abnormal immune serum protein physiology
|
0.52 |
true |
true |
0.3 |
CORO1A
|
abnormal effector t cell morphology
|
0.52 |
true |
true |
0.3 |
LAPTM5
|
abnormal leukopoiesis
|
0.52 |
true |
true |
0.3 |
NFKB2
|
abnormal igg3 level
|
0.52 |
true |
true |
0.3 |
IL4
|
decreased susceptibility to infection
|
0.52 |
true |
true |
0.3 |
IL2
|
decreased leukocyte cell number
|
0.52 |
true |
true |
0.3 |
IL2RA
|
abnormal immune serum protein physiology
|
0.52 |
true |
true |
0.3 |
CXCR5
|
decreased b cell number
|
0.52 |
false |
true |
0.3 |
CCR7
|
abnormal cytokine secretion
|
0.52 |
false |
true |
0.3 |
ITGB2
|
increased susceptibility to infection
|
0.52 |
true |
true |
0.3 |
CD37
|
abnormal t cell proliferation
|
0.52 |
false |
true |
0.3 |
BCL2A1
|
abnormal humoral immune response
|
0.52 |
false |
true |
0.3 |
CD22
|
abnormal b cell number
|
0.52 |
true |
true |
0.3 |
SLAMF1
|
abnormal cd8-positive, alpha beta t cell morphology
|
0.52 |
false |
true |
0.3 |
NR1I3
|
increased body weight
|
0.52 |
false |
true |
0.3 |
NR1I3
|
increased total tissue mass
|
0.52 |
false |
true |
0.3 |
SLA
|
abnormal t cell activation
|
0.52 |
false |
true |
0.3 |
ITGAX
|
abnormal immune serum protein physiology
|
0.52 |
true |
true |
0.3 |
FOS
|
abnormal interleukin level
|
0.52 |
true |
true |
0.3 |
RUNX3
|
abnormal lymphocyte physiology
|
0.52 |
true |
true |
0.3 |
ITGB2
|
abnormal alpha-beta t cell morphology
|
0.52 |
true |
true |
0.3 |
CORO1A
|
abnormal t cell number
|
0.52 |
true |
true |
0.3 |
IL13
|
abnormal cd4-positive helper t cell morphology
|
0.52 |
true |
true |
0.3 |
IL2
|
abnormal igg2a level
|
0.52 |
true |
true |
0.3 |
SP140
|
abnormal lymphocyte physiology
|
0.52 |
false |
false |
0.3 |
ITGAL
|
abnormal b cell morphology
|
0.52 |
true |
true |
0.3 |
CXCR3
|
abnormal lymphocyte cell number
|
0.52 |
false |
true |
0.3 |
ITGB2
|
abnormal phagocyte morphology
|
0.52 |
true |
true |
0.3 |
CXCL9
|
decreased inflammatory response
|
0.52 |
true |
true |
0.3 |
ITGAL
|
abnormal immunoglobulin level
|
0.52 |
false |
true |
0.3 |
TNFSF13B
|
abnormal self tolerance
|
0.52 |
false |
true |
0.3 |
IL2RA
|
abnormal interleukin secretion
|
0.52 |
false |
true |
0.3 |
ITGB2
|
abnormal innate immunity
|
0.52 |
true |
true |
0.3 |
CD72
|
abnormal lymphopoiesis
|
0.52 |
true |
true |
0.3 |
TRAT1
|
abnormal lymphopoiesis
|
0.52 |
false |
true |
0.3 |
CD19
|
decreased igg3 level
|
0.52 |
true |
true |
0.3 |
IL10
|
abnormal lymphopoiesis
|
0.52 |
true |
true |
0.3 |
CD8A
|
abnormal lymphopoiesis
|
0.52 |
true |
true |
0.3 |
STAT1
|
abnormal alpha-beta t cell number
|
0.52 |
false |
true |
0.3 |
CSF2
|
abnormal response to infection
|
0.52 |
true |
true |
0.3 |
IL2
|
abnormal t cell number
|
0.52 |
true |
true |
0.3 |
ZAP70
|
decreased double-positive t cell number
|
0.52 |
false |
true |
0.3 |
TNFSF13B
|
abnormal immune tolerance
|
0.52 |
false |
true |
0.3 |
RUNX3
|
abnormal b cell number
|
0.52 |
false |
true |
0.3 |
IL1A
|
abnormal interleukin level
|
0.52 |
true |
true |
0.3 |
CXCR3
|
abnormal alpha-beta t cell number
|
0.52 |
false |
true |
0.3 |
VAV1
|
decreased leukocyte cell number
|
0.52 |
true |
true |
0.3 |
TNFSF13B
|
abnormal t cell physiology
|
0.52 |
true |
true |
0.3 |
BTK
|
decreased lymphocyte cell number
|
0.52 |
true |
true |
0.3 |
IL15
|
increased susceptibility to bacterial infection
|
0.52 |
false |
true |
0.3 |
ITGB2
|
abnormal myeloid leukocyte morphology
|
0.52 |
true |
true |
0.3 |
POU2AF1
|
abnormal lymphocyte physiology
|
0.52 |
true |
true |
0.3 |
IL12B
|
decreased immunoglobulin level
|
0.52 |
false |
true |
0.3 |
IFNG
|
increased susceptibility to bacterial infection
|
0.52 |
true |
true |
0.3 |
JUN
|
abnormal liver physiology
|
0.52 |
true |
true |
0.3 |
ZAP70
|
abnormal memory t cell number
|
0.52 |
true |
true |
0.3 |
CD74
|
abnormal t cell proliferation
|
0.52 |
true |
true |
0.3 |
PTPRC
|
decreased double-positive t cell number
|
0.52 |
true |
true |
0.3 |
SYK
|
abnormal professional antigen presenting cell physiology
|
0.52 |
true |
true |
0.3 |
CD28
|
abnormal t cell differentiation
|
0.52 |
true |
true |
0.3 |
TNFSF13B
|
autoimmune response
|
0.52 |
false |
true |
0.3 |
GFI1
|
abnormal immunoglobulin level
|
0.52 |
false |
true |
0.3 |
ITGB2
|
abnormal t cell activation
|
0.52 |
true |
true |
0.3 |
CD3D
|
decreased leukocyte cell number
|
0.52 |
true |
true |
0.3 |
CD96
|
abnormal t cell differentiation
|
0.52 |
false |
false |
0.3 |
PTPRC
|
abnormal interferon secretion
|
0.52 |
false |
true |
0.3 |
PTPN7
|
abnormal b cell differentiation
|
0.52 |
false |
true |
0.3 |
UBASH3A
|
abnormal cd4-positive, alpha beta t cell morphology
|
0.52 |
false |
true |
0.3 |
NFKB1
|
abnormal t cell number
|
0.52 |
true |
true |
0.3 |
CD27
|
abnormal b cell morphology
|
0.52 |
false |
true |
0.3 |
IL15
|
abnormal phagocyte morphology
|
0.52 |
false |
true |
0.3 |
CSF2RB
|
abnormal eosinophil morphology
|
0.52 |
true |
true |
0.3 |
CXCR5
|
increased mature b cell number
|
0.52 |
false |
true |
0.3 |
IL7R
|
abnormal igg1 level
|
0.52 |
false |
true |
0.3 |
PTPRC
|
abnormal interferon-gamma secretion
|
0.52 |
false |
true |
0.3 |
BCL2A1
|
abnormal t cell physiology
|
0.52 |
false |
true |
0.3 |
FYB
|
decreased t cell number
|
0.52 |
true |
true |
0.3 |
TNFRSF17
|
abnormal mature b cell morphology
|
0.52 |
true |
true |
0.3 |
IL4R
|
abnormal cd4-positive, alpha beta t cell number
|
0.52 |
true |
true |
0.3 |
EGR1
|
abnormal macrophage morphology
|
0.52 |
true |
true |
0.3 |
ZAP70
|
abnormal memory t cell morphology
|
0.52 |
true |
true |
0.3 |
LCP2
|
abnormal interferon-gamma secretion
|
0.52 |
true |
true |
0.3 |
IL1B
|
abnormal innate immunity
|
0.52 |
true |
true |
0.3 |
IFNG
|
abnormal antigen presentation
|
0.52 |
true |
true |
0.3 |
CD79B
|
abnormal professional antigen presenting cell physiology
|
0.52 |
true |
true |
0.3 |
CCR7
|
abnormal dendritic cell morphology
|
0.52 |
true |
true |
0.3 |
PCNA
|
abnormal blastocyst morphology
|
0.52 |
false |
true |
0.3 |
IL10RA
|
increased lymphocyte cell number
|
0.52 |
false |
true |
0.3 |
CD22
|
abnormal b cell proliferation
|
0.52 |
true |
true |
0.3 |
CDC20
|
abnormal cell nucleus morphology
|
0.52 |
true |
true |
0.3 |
BCL2A1
|
abnormal b cell physiology
|
0.52 |
false |
true |
0.3 |
CD48
|
abnormal leukopoiesis
|
0.52 |
true |
true |
0.3 |
BIRC3
|
decreased b cell number
|
0.52 |
true |
true |
0.3 |
CSF2
|
abnormal mononuclear phagocyte morphology
|
0.52 |
true |
true |
0.3 |
IFNG
|
abnormal circulating interleukin level
|
0.52 |
true |
true |
0.3 |
TLR2
|
abnormal circulating cytokine level
|
0.52 |
true |
true |
0.3 |
SLAMF1
|
abnormal cd8-positive, alpha-beta t cell number
|
0.52 |
false |
true |
0.3 |
BLK
|
abnormal spleen b cell follicle morphology
|
0.52 |
false |
true |
0.3 |
ITGAX
|
abnormal humoral immune response
|
0.52 |
false |
true |
0.3 |
PTPN7
|
abnormal lymph node morphology
|
0.52 |
false |
true |
0.3 |
STAT1
|
abnormal alpha-beta t cell morphology
|
0.52 |
false |
true |
0.3 |
JUN
|
abnormal hepatobiliary system physiology
|
0.52 |
true |
true |
0.3 |
DUSP1
|
increased circulating tumor necrosis factor level
|
0.52 |
true |
true |
0.3 |
TNFRSF1B
|
abnormal immunoglobulin level
|
0.52 |
false |
true |
0.3 |
REL
|
abnormal b cell proliferation
|
0.52 |
true |
true |
0.3 |
IL15
|
abnormal tumor necrosis factor level
|
0.52 |
false |
true |
0.3 |
CD8A
|
decreased t cell proliferation
|
0.52 |
false |
true |
0.3 |
BCL2A1
|
abnormal interleukin secretion
|
0.52 |
false |
true |
0.3 |
HOXA3
|
abnormal rib-sternum attachment
|
0.52 |
false |
true |
0.3 |
EGR1
|
abnormal innate immunity
|
0.52 |
true |
true |
0.3 |
RHOH
|
increased t cell number
|
0.52 |
true |
true |
0.3 |
CCR2
|
abnormal t cell number
|
0.52 |
true |
true |
0.3 |
LCK
|
abnormal b cell physiology
|
0.52 |
true |
true |
0.3 |
IL10RA
|
altered susceptibility to infection
|
0.52 |
true |
true |
0.3 |
NFKB1
|
small peyer's patches
|
0.52 |
true |
true |
0.3 |
ITGB2
|
altered susceptibility to autoimmune disorder
|
0.52 |
false |
true |
0.3 |
IL10RA
|
abnormal cytokine secretion
|
0.52 |
false |
true |
0.3 |
MYC
|
altered tumor susceptibility
|
0.52 |
true |
true |
0.3 |
ITGB2
|
abnormal alpha-beta t cell number
|
0.52 |
true |
true |
0.3 |
IRF4
|
abnormal t cell physiology
|
0.52 |
true |
true |
0.3 |
TGFB1
|
abnormal immune serum protein physiology
|
0.52 |
true |
true |
0.3 |
CD247
|
abnormal t cell number
|
0.52 |
true |
true |
0.3 |
CSF2
|
altered susceptibility to infection
|
0.52 |
true |
true |
0.3 |
LCP1
|
abnormal lymphopoiesis
|
0.52 |
false |
true |
0.3 |
IRF4
|
decreased immunoglobulin level
|
0.52 |
true |
true |
0.3 |
IL4R
|
abnormal alpha-beta t cell number
|
0.52 |
true |
true |
0.3 |
CSF2RB
|
abnormal igg level
|
0.52 |
false |
true |
0.3 |
IL10
|
abnormal dendritic cell physiology
|
0.52 |
true |
true |
0.3 |
TLR1
|
abnormal immunoglobulin level
|
0.52 |
true |
true |
0.3 |
CD53
|
abnormal t cell activation
|
0.52 |
false |
false |
0.3 |
CCR7
|
increased mature b cell number
|
0.52 |
false |
true |
0.3 |
ITGB7
|
abnormal interferon secretion
|
0.52 |
false |
true |
0.3 |
LCP2
|
abnormal alpha-beta t cell morphology
|
0.52 |
true |
true |
0.3 |
CXCR4
|
abnormal t cell proliferation
|
0.52 |
false |
true |
0.3 |
IL13
|
abnormal myeloid leukocyte morphology
|
0.52 |
true |
true |
0.3 |
POU2AF1
|
decreased igg level
|
0.52 |
true |
true |
0.3 |
IL2
|
abnormal self tolerance
|
0.52 |
true |
true |
0.3 |
TGFB1
|
abnormal lymphopoiesis
|
0.52 |
false |
true |
0.3 |
TNFAIP3
|
abnormal immune serum protein physiology
|
0.52 |
true |
true |
0.3 |
STAT1
|
abnormal b cell physiology
|
0.52 |
true |
true |
0.3 |
IRF1
|
decreased immunoglobulin level
|
0.52 |
true |
true |
0.3 |
FASLG
|
abnormal t cell activation
|
0.52 |
true |
true |
0.3 |
GZMA
|
abnormal effector t cell morphology
|
0.52 |
false |
true |
0.3 |
JAK3
|
abnormal lymphocyte physiology
|
0.52 |
true |
true |
0.3 |
ITGB7
|
decreased lymphocyte cell number
|
0.52 |
true |
true |
0.3 |
TLR10
|
abnormal immunoglobulin level
|
0.52 |
false |
false |
0.3 |
VCAM1
|
altered susceptibility to infection
|
0.52 |
false |
true |
0.3 |
CCR7
|
abnormal marginal zone b cell morphology
|
0.52 |
false |
true |
0.3 |
IRF7
|
abnormal intercellular signaling peptide or protein level
|
0.52 |
true |
true |
0.3 |
HOXC4
|
abnormal rib morphology
|
0.52 |
true |
true |
0.3 |
IL15
|
abnormal t cell activation
|
0.52 |
false |
true |
0.3 |
JAK3
|
decreased lymphocyte cell number
|
0.52 |
true |
true |
0.3 |
TNFRSF1B
|
abnormal interleukin secretion
|
0.52 |
true |
true |
0.3 |
CXCL2
|
abnormal cytokine level
|
0.52 |
false |
false |
0.3 |
TNFSF8
|
abnormal b cell physiology
|
0.52 |
false |
true |
0.3 |
CD53
|
abnormal lymphopoiesis
|
0.52 |
false |
false |
0.3 |
CD74
|
abnormal immune tolerance
|
0.52 |
true |
true |
0.3 |
CD7
|
abnormal t cell morphology
|
0.52 |
true |
true |
0.3 |
CD79B
|
increased mature b cell number
|
0.52 |
true |
true |
0.3 |
IRF1
|
decreased leukocyte cell number
|
0.52 |
true |
true |
0.3 |
CD28
|
abnormal t cell proliferation
|
0.52 |
true |
true |
0.3 |
IL10
|
abnormal ige level
|
0.52 |
true |
true |
0.3 |
IL2
|
autoimmune response
|
0.52 |
true |
true |
0.3 |
CD22
|
increased b cell number
|
0.52 |
true |
true |
0.3 |
CXCR4
|
abnormal t cell activation
|
0.52 |
false |
true |
0.3 |
IL15
|
abnormal b cell morphology
|
0.52 |
false |
true |
0.3 |
IFNG
|
increased alpha-beta t cell number
|
0.52 |
true |
true |
0.3 |
MAP4K1
|
abnormal b cell number
|
0.52 |
false |
true |
0.3 |
IL13
|
intestinal inflammation
|
0.52 |
true |
true |
0.3 |
STAT1
|
abnormal t cell activation
|
0.52 |
true |
true |
0.3 |
CD74
|
abnormal self tolerance
|
0.52 |
true |
true |
0.3 |
HCK
|
abnormal granulocyte number
|
0.52 |
true |
true |
0.3 |
IL1R2
|
abnormal cytokine level
|
0.52 |
false |
false |
0.3 |
SP140
|
abnormal leukopoiesis
|
0.52 |
false |
false |
0.3 |
TLR2
|
abnormal professional antigen presenting cell physiology
|
0.52 |
true |
true |
0.3 |
PDGFRA
|
abnormal heart ventricle morphology
|
0.52 |
true |
true |
0.3 |
TNFSF10
|
joint inflammation
|
0.52 |
true |
true |
0.3 |
SELL
|
decreased t cell number
|
0.52 |
true |
true |
0.3 |
IL6
|
abnormal osteoclast morphology
|
0.52 |
true |
true |
0.3 |
BTK
|
decreased igg level
|
0.52 |
true |
true |
0.3 |
SELL
|
abnormal lymph node morphology
|
0.52 |
true |
true |
0.3 |
ESR1
|
abnormal nociception after inflammation
|
0.52 |
true |
true |
0.3 |
HCK
|
abnormal granulocyte morphology
|
0.52 |
true |
true |
0.3 |
HOXA3
|
abnormal vertebral column morphology
|
0.52 |
true |
true |
0.3 |
NCF4
|
abnormal t cell differentiation
|
0.52 |
false |
true |
0.3 |
IL15
|
intestinal inflammation
|
0.52 |
false |
true |
0.3 |
ITGB7
|
increased lymphocyte cell number
|
0.52 |
false |
true |
0.3 |
NR1I3
|
increased body size
|
0.52 |
false |
true |
0.3 |
IL1RN
|
abnormal interleukin level
|
0.52 |
true |
true |
0.3 |
IL6
|
abnormal bone remodeling
|
0.52 |
true |
true |
0.3 |
CXCR4
|
increased leukocyte cell number
|
0.52 |
true |
true |
0.3 |
SH2D1A
|
decreased t cell proliferation
|
0.52 |
false |
true |
0.3 |
CD3E
|
abnormal double-negative t cell morphology
|
0.52 |
true |
true |
0.3 |
NFKB2
|
abnormal granulocyte number
|
0.52 |
true |
true |
0.3 |
IL13
|
abnormal ige level
|
0.52 |
true |
true |
0.3 |
MYC
|
abnormal tumor incidence
|
0.52 |
true |
true |
0.3 |
NCF4
|
decreased leukocyte cell number
|
0.52 |
false |
true |
0.3 |
BTK
|
increased immunoglobulin level
|
0.52 |
true |
true |
0.3 |
BCL2A1
|
abnormal lymphocyte physiology
|
0.52 |
false |
true |
0.3 |
BCL2A1
|
autoimmune response
|
0.52 |
false |
true |
0.3 |
MYC
|
abnormal intestinal epithelium morphology
|
0.52 |
true |
true |
0.3 |
IL3
|
increased susceptibility to infection
|
0.52 |
true |
true |
0.3 |
SLAMF1
|
decreased immunoglobulin level
|
0.52 |
false |
true |
0.3 |
FYB
|
decreased alpha-beta t cell number
|
0.52 |
false |
true |
0.3 |
IL13
|
altered susceptibility to autoimmune disorder
|
0.52 |
true |
true |
0.3 |
CD7
|
abnormal t cell differentiation
|
0.52 |
true |
true |
0.3 |
RHOH
|
abnormal t cell physiology
|
0.52 |
true |
true |
0.3 |
BIRC3
|
altered susceptibility to infection
|
0.52 |
false |
true |
0.3 |
PTPN7
|
abnormal cytokine secretion
|
0.52 |
false |
true |
0.3 |
HOXB3
|
abnormal sternum morphology
|
0.52 |
false |
true |
0.3 |
CD28
|
abnormal t cell activation
|
0.52 |
true |
true |
0.3 |
PTPN7
|
decreased immunoglobulin level
|
0.52 |
false |
true |
0.3 |
ICAM1
|
abnormal interferon secretion
|
0.52 |
false |
true |
0.3 |
IRF4
|
abnormal mature b cell morphology
|
0.52 |
true |
true |
0.3 |
NFKB1
|
increased igg level
|
0.52 |
true |
true |
0.3 |
CD27
|
abnormal b cell number
|
0.52 |
false |
true |
0.3 |
CCR7
|
decreased acute inflammation
|
0.52 |
true |
true |
0.3 |
CD48
|
abnormal t cell morphology
|
0.52 |
true |
true |
0.3 |
IL2
|
abnormal immune tolerance
|
0.51 |
true |
true |
0.3 |
CD96
|
abnormal cd8-positive, alpha beta t cell morphology
|
0.51 |
false |
false |
0.3 |
SELL
|
abnormal t cell physiology
|
0.51 |
true |
true |
0.3 |
TRAF1
|
abnormal t cell proliferation
|
0.51 |
true |
true |
0.3 |
NFKB2
|
abnormal myeloid leukocyte morphology
|
0.51 |
true |
true |
0.3 |
IL1B
|
abnormal interferon-gamma secretion
|
0.51 |
true |
true |
0.3 |
ITGB7
|
abnormal lymph node morphology
|
0.51 |
false |
true |
0.3 |
CD96
|
abnormal t cell number
|
0.51 |
false |
false |
0.3 |
CD40
|
abnormal t cell activation
|
0.51 |
false |
true |
0.3 |
FOS
|
abnormal intercellular signaling peptide or protein level
|
0.51 |
true |
true |
0.3 |
HOXB7
|
abnormal vertebrae morphology
|
0.51 |
false |
true |
0.3 |
ITGB7
|
decreased alpha-beta t cell number
|
0.51 |
true |
true |
0.3 |
BIRC3
|
abnormal lymph node morphology
|
0.51 |
true |
true |
0.3 |
MAP4K1
|
abnormal t cell morphology
|
0.51 |
true |
true |
0.3 |
CDKN1A
|
increased igg level
|
0.51 |
true |
true |
0.3 |
HOXA5
|
cervical vertebral transformation
|
0.51 |
true |
true |
0.3 |
CCR2
|
abnormal t cell activation
|
0.51 |
true |
true |
0.3 |
CD86
|
abnormal lymphocyte physiology
|
0.51 |
true |
true |
0.3 |
PLEK
|
abnormal lymphocyte physiology
|
0.51 |
false |
true |
0.3 |
ITGB7
|
decreased t cell number
|
0.51 |
true |
true |
0.3 |
MYC
|
increased lymphocyte cell number
|
0.51 |
true |
true |
0.3 |
ITGB2
|
abnormal t cell proliferation
|
0.51 |
true |
true |
0.3 |
CD7
|
abnormal effector t cell morphology
|
0.51 |
false |
true |
0.3 |
TNFSF8
|
abnormal lymphocyte physiology
|
0.51 |
false |
true |
0.3 |
HOXB4
|
abnormal thoracic vertebrae morphology
|
0.51 |
false |
true |
0.3 |
CCR5
|
decreased t cell number
|
0.51 |
false |
true |
0.3 |
POU2AF1
|
abnormal igg1 level
|
0.51 |
true |
true |
0.3 |
CD96
|
abnormal t cell physiology
|
0.51 |
false |
false |
0.3 |
STAT1
|
altered susceptibility to infection
|
0.51 |
true |
true |
0.3 |
SELL
|
abnormal t cell morphology
|
0.51 |
true |
true |
0.3 |
CCR5
|
decreased inflammatory response
|
0.51 |
true |
true |
0.3 |
PTPRC
|
altered susceptibility to infection induced morbidity/mortality
|
0.51 |
false |
true |
0.3 |
MDM2
|
abnormal bone marrow cell morphology/development
|
0.51 |
true |
true |
0.3 |
NFKB2
|
abnormal professional antigen presenting cell morphology
|
0.51 |
true |
true |
0.3 |
LCP2
|
abnormal alpha-beta t cell number
|
0.51 |
true |
true |
0.3 |
BIRC3
|
abnormal b cell differentiation
|
0.51 |
true |
true |
0.3 |
TNFSF8
|
abnormal immunoglobulin level
|
0.51 |
false |
true |
0.3 |
CXCR3
|
abnormal immunoglobulin level
|
0.51 |
false |
true |
0.3 |
IKZF1
|
decreased t cell number
|
0.51 |
true |
true |
0.3 |
IL10
|
increased inflammatory response
|
0.51 |
true |
true |
0.3 |
MDM2
|
abnormal thymus physiology
|
0.51 |
true |
true |
0.3 |
HOXB7
|
thoracic vertebral transformation
|
0.51 |
false |
true |
0.3 |
ITGB7
|
abnormal cd8-positive, alpha-beta t cell number
|
0.51 |
false |
true |
0.3 |
IRF7
|
abnormal cytokine secretion
|
0.51 |
true |
true |
0.3 |
CCR2
|
abnormal alpha-beta t cell morphology
|
0.51 |
true |
true |
0.3 |
IL2RG
|
altered susceptibility to autoimmune disorder
|
0.51 |
false |
true |
0.3 |
CSF3
|
altered susceptibility to infection
|
0.51 |
true |
true |
0.3 |
ICAM1
|
abnormal interferon-gamma secretion
|
0.51 |
false |
true |
0.3 |
MS4A1
|
decreased immature b cell number
|
0.51 |
false |
true |
0.3 |
PRKCB
|
abnormal igm level
|
0.51 |
true |
true |
0.3 |
CD96
|
abnormal t cell morphology
|
0.51 |
false |
false |
0.3 |
DRD2
|
abnormal behavioral response to addictive substance
|
0.51 |
true |
true |
0.3 |
ITGAL
|
decreased cd4-positive, alpha beta t cell number
|
0.51 |
true |
true |
0.3 |
ICAM1
|
abnormal immune serum protein physiology
|
0.51 |
true |
true |
0.3 |
CORO1A
|
abnormal cd8-positive, alpha beta t cell morphology
|
0.51 |
true |
true |
0.3 |
IRF1
|
decreased t cell proliferation
|
0.51 |
false |
true |
0.3 |
CXCL10
|
increased susceptibility to bacterial infection
|
0.51 |
false |
true |
0.3 |
CD96
|
decreased t cell number
|
0.51 |
false |
false |
0.3 |
SYK
|
abnormal lymphocyte physiology
|
0.51 |
true |
true |
0.3 |
IL2RB
|
abnormal interferon secretion
|
0.51 |
false |
true |
0.3 |
MDM2
|
decreased erythrocyte cell number
|
0.51 |
true |
true |
0.3 |
CD74
|
autoimmune response
|
0.51 |
true |
true |
0.3 |
NFKB2
|
decreased igg3 level
|
0.51 |
true |
true |
0.3 |
LCK
|
abnormal interferon-gamma secretion
|
0.51 |
false |
true |
0.3 |
TNFRSF1B
|
abnormal humoral immune response
|
0.51 |
false |
true |
0.3 |
TNFSF8
|
abnormal humoral immune response
|
0.51 |
false |
true |
0.3 |
MAP4K1
|
abnormal b cell differentiation
|
0.51 |
false |
true |
0.3 |
TGFB1
|
altered susceptibility to infection
|
0.51 |
false |
true |
0.3 |
IL6
|
arthritis
|
0.51 |
true |
true |
0.3 |
CXCR3
|
autoimmune response
|
0.51 |
false |
true |
0.3 |
FASLG
|
abnormal lymphopoiesis
|
0.51 |
true |
true |
0.3 |
ITGAX
|
abnormal immunoglobulin level
|
0.51 |
false |
true |
0.3 |
STAT1
|
abnormal response to infection
|
0.51 |
true |
true |
0.3 |
CSF2RB
|
abnormal eosinophil cell number
|
0.51 |
true |
true |
0.3 |
IL15
|
decreased lymphocyte cell number
|
0.51 |
true |
true |
0.3 |
NFKB1
|
increased hematopoietic cell number
|
0.51 |
true |
true |
0.3 |
CDKN1A
|
abnormal incidence of induced tumors
|
0.51 |
true |
true |
0.3 |
TGFB1
|
increased susceptibility to infection
|
0.51 |
false |
true |
0.3 |
BIRC3
|
abnormal igg1 level
|
0.51 |
true |
true |
0.3 |
CCR5
|
abnormal myeloid leukocyte morphology
|
0.51 |
true |
true |
0.3 |
GZMA
|
abnormal alpha-beta t cell number
|
0.51 |
false |
true |
0.3 |
IL2RG
|
decreased igg level
|
0.51 |
true |
true |
0.3 |
IL13
|
abnormal phagocyte morphology
|
0.51 |
true |
true |
0.3 |
CD6
|
increased lymphocyte cell number
|
0.51 |
false |
false |
0.3 |
CSF2RB
|
abnormal alpha-beta t cell morphology
|
0.51 |
false |
true |
0.3 |
GZMA
|
abnormal alpha-beta t cell morphology
|
0.51 |
false |
true |
0.3 |
FGR
|
autoimmune response
|
0.51 |
false |
true |
0.3 |
CCR5
|
decreased susceptibility to infection
|
0.51 |
true |
true |
0.3 |
CCR1
|
increased inflammatory response
|
0.51 |
true |
true |
0.3 |
FGR
|
abnormal self tolerance
|
0.51 |
false |
true |
0.3 |
ITGB2
|
increased lymphocyte cell number
|
0.51 |
true |
true |
0.3 |
CXCL9
|
abnormal t cell physiology
|
0.51 |
false |
true |
0.3 |
IL4
|
abnormal mammary gland development
|
0.51 |
true |
true |
0.3 |
BIRC3
|
increased immunoglobulin level
|
0.51 |
true |
true |
0.3 |
MAP4K1
|
abnormal igm level
|
0.51 |
false |
true |
0.3 |
RUNX3
|
abnormal cd8-positive, alpha beta t cell morphology
|
0.51 |
true |
true |
0.3 |
BCL2A1
|
abnormal self tolerance
|
0.51 |
false |
true |
0.3 |
VCAM1
|
abnormal response to infection
|
0.51 |
false |
true |
0.3 |
ESR2
|
abnormal female reproductive gland morphology
|
0.51 |
true |
true |
0.3 |
CXCL10
|
abnormal macrophage physiology
|
0.51 |
false |
true |
0.3 |
ITK
|
decreased double-positive t cell number
|
0.51 |
false |
true |
0.3 |
UBASH3A
|
abnormal cd8-positive, alpha-beta t cell number
|
0.51 |
false |
true |
0.3 |
JAK3
|
abnormal effector t cell morphology
|
0.51 |
true |
true |
0.3 |
BTK
|
increased b cell number
|
0.51 |
true |
true |
0.3 |
IRF7
|
altered susceptibility to viral infection
|
0.51 |
true |
true |
0.3 |
RHOH
|
decreased leukocyte cell number
|
0.51 |
true |
true |
0.3 |
IL12B
|
increased susceptibility to infection
|
0.51 |
true |
true |
0.3 |
STAT1
|
abnormal self tolerance
|
0.51 |
false |
true |
0.3 |
LCP2
|
abnormal cd4-positive, alpha beta t cell number
|
0.51 |
true |
true |
0.3 |
IL7R
|
abnormal interferon-gamma secretion
|
0.51 |
false |
true |
0.3 |
CXCR3
|
abnormal humoral immune response
|
0.51 |
false |
true |
0.31 |
UBASH3A
|
abnormal cd4-positive, alpha beta t cell number
|
0.51 |
false |
true |
0.31 |
REL
|
abnormal igg level
|
0.51 |
true |
true |
0.31 |
TNFRSF17
|
decreased immunoglobulin level
|
0.51 |
false |
true |
0.31 |
CXCR3
|
abnormal self tolerance
|
0.51 |
false |
true |
0.31 |
CD74
|
decreased susceptibility to autoimmune disorder
|
0.51 |
true |
true |
0.31 |
GFI1
|
abnormal b cell physiology
|
0.51 |
false |
true |
0.31 |
HCK
|
altered susceptibility to autoimmune disorder
|
0.51 |
false |
true |
0.31 |
IFNG
|
decreased interferon-gamma secretion
|
0.51 |
true |
true |
0.31 |
CORO1A
|
abnormal alpha-beta t cell number
|
0.51 |
true |
true |
0.31 |
CXCR4
|
abnormal lymph node morphology
|
0.51 |
true |
true |
0.31 |
CSF2RB
|
abnormal t cell activation
|
0.51 |
false |
true |
0.31 |
EGFR
|
abnormal dorsal root ganglion morphology
|
0.51 |
true |
true |
0.31 |
GADD45A
|
increased incidence of induced tumors
|
0.51 |
true |
true |
0.31 |
ITGB7
|
abnormal interleukin secretion
|
0.51 |
false |
true |
0.31 |
CCR2
|
abnormal myeloid leukocyte morphology
|
0.51 |
true |
true |
0.31 |
IL13
|
abnormal lymphocyte physiology
|
0.51 |
true |
true |
0.31 |
IFNG
|
abnormal interleukin secretion
|
0.51 |
true |
true |
0.31 |
HOXC6
|
abnormal presacral vertebrae morphology
|
0.51 |
true |
true |
0.31 |
FOS
|
abnormal cytokine level
|
0.51 |
true |
true |
0.31 |
JUNB
|
abnormal interleukin level
|
0.51 |
false |
false |
0.31 |
CCR1
|
abnormal induced morbidity/mortality
|
0.51 |
true |
true |
0.31 |
IFNG
|
abnormal cd8-positive, alpha-beta t cell number
|
0.51 |
true |
true |
0.31 |
GRIA2
|
abnormal synaptic transmission
|
0.51 |
true |
true |
0.31 |
CD74
|
abnormal b cell physiology
|
0.51 |
true |
true |
0.31 |
TNFRSF1B
|
abnormal t cell proliferation
|
0.51 |
true |
true |
0.3 |
ESR1
|
abnormal long bone epiphyseal plate morphology
|
0.51 |
true |
true |
0.3 |
CD3E
|
thymus hypoplasia
|
0.51 |
true |
true |
0.3 |
PTPRC
|
altered susceptibility to autoimmune disorder
|
0.51 |
true |
true |
0.3 |
ESR1
|
abnormal ovulation
|
0.51 |
true |
true |
0.3 |
TNFRSF1B
|
abnormal immune serum protein physiology
|
0.51 |
true |
true |
0.3 |
CCR2
|
abnormal lymphocyte cell number
|
0.51 |
true |
true |
0.3 |
CD3D
|
increased double-negative t cell number
|
0.51 |
false |
true |
0.3 |
TNFRSF1B
|
increased susceptibility to infection
|
0.51 |
true |
true |
0.3 |
THRA
|
abnormal thyroid hormone level
|
0.51 |
true |
true |
0.3 |
HOXA3
|
abnormal thoracic vertebrae morphology
|
0.51 |
false |
true |
0.3 |
TCL1A
|
abnormal igg level
|
0.51 |
false |
true |
0.3 |
CD14
|
abnormal acute inflammation
|
0.51 |
true |
true |
0.3 |
COL3A1
|
abnormal osteoblast morphology
|
0.51 |
false |
true |
0.3 |
BLK
|
abnormal professional antigen presenting cell morphology
|
0.51 |
false |
true |
0.31 |
IRF7
|
abnormal b cell physiology
|
0.51 |
false |
true |
0.31 |
IL13
|
decreased susceptibility to infection
|
0.51 |
true |
true |
0.31 |
CD8A
|
abnormal cd4-positive, alpha beta t cell number
|
0.51 |
true |
true |
0.31 |
PRKDC
|
increased tumor incidence
|
0.51 |
true |
true |
0.31 |
PTPRC
|
enlarged lymph nodes
|
0.51 |
true |
true |
0.3 |
ZAP70
|
abnormal immune tolerance
|
0.51 |
true |
true |
0.3 |
ITGAM
|
abnormal interleukin secretion
|
0.51 |
false |
true |
0.31 |
FLT1
|
abnormal pericardium morphology
|
0.51 |
false |
true |
0.31 |
SP140
|
abnormal b cell number
|
0.51 |
false |
false |
0.31 |
IL1R2
|
abnormal intercellular signaling peptide or protein level
|
0.51 |
false |
false |
0.31 |
VAV1
|
decreased mature b cell number
|
0.51 |
true |
true |
0.31 |
HOXC4
|
abnormal cervical vertebrae morphology
|
0.51 |
false |
true |
0.31 |
BCL2A1
|
abnormal immune tolerance
|
0.51 |
false |
true |
0.31 |
IL15
|
abnormal igg2a level
|
0.51 |
false |
true |
0.31 |
FGR
|
abnormal immune tolerance
|
0.51 |
false |
true |
0.31 |
STAT1
|
autoimmune response
|
0.51 |
false |
true |
0.31 |
CD37
|
abnormal t cell differentiation
|
0.51 |
false |
true |
0.31 |
ZAP70
|
abnormal self tolerance
|
0.51 |
true |
true |
0.31 |
RUNX3
|
abnormal b cell differentiation
|
0.51 |
false |
true |
0.31 |
IL6
|
joint inflammation
|
0.51 |
true |
true |
0.31 |
IL2RB
|
abnormal igg level
|
0.51 |
true |
true |
0.31 |
IL10
|
abnormal t cell differentiation
|
0.51 |
true |
true |
0.31 |
IKZF1
|
abnormal t cell differentiation
|
0.51 |
true |
true |
0.31 |
NFKB1
|
increased b cell proliferation
|
0.51 |
true |
true |
0.31 |
PTPRC
|
altered susceptibility to parasitic infection
|
0.51 |
false |
true |
0.31 |
PTPRC
|
increased double-negative t cell number
|
0.51 |
true |
true |
0.31 |
CSF2RB
|
abnormal immune serum protein physiology
|
0.51 |
false |
true |
0.31 |
CD72
|
abnormal b cell morphology
|
0.51 |
true |
true |
0.31 |
DNAH9
|
dextrocardia
|
0.51 |
false |
false |
0.31 |
IRF7
|
abnormal immune serum protein physiology
|
0.51 |
true |
true |
0.31 |
IL6
|
abnormal intestine physiology
|
0.51 |
true |
true |
0.31 |
DUSP2
|
decreased immunoglobulin level
|
0.51 |
false |
true |
0.31 |
FASLG
|
abnormal cd4-positive, alpha beta t cell morphology
|
0.51 |
false |
true |
0.31 |
CD19
|
abnormal igg2a level
|
0.51 |
true |
true |
0.31 |
DUSP2
|
abnormal professional antigen presenting cell physiology
|
0.51 |
true |
true |
0.31 |
CD53
|
abnormal t cell proliferation
|
0.51 |
false |
false |
0.31 |
PTPN7
|
abnormal mature b cell morphology
|
0.51 |
false |
true |
0.31 |
SP140
|
abnormal b cell morphology
|
0.51 |
false |
false |
0.31 |
CD69
|
abnormal professional antigen presenting cell physiology
|
0.51 |
true |
true |
0.31 |
CXCL10
|
abnormal interferon level
|
0.51 |
true |
true |
0.31 |
ZAP70
|
autoimmune response
|
0.51 |
true |
true |
0.31 |
CD2
|
abnormal double-negative t cell morphology
|
0.51 |
false |
true |
0.31 |
NFKB2
|
abnormal t cell morphology
|
0.51 |
true |
true |
0.31 |
IRF4
|
abnormal effector t cell morphology
|
0.51 |
true |
true |
0.31 |
CXCR3
|
abnormal immune tolerance
|
0.51 |
false |
true |
0.31 |
IL2RG
|
abnormal professional antigen presenting cell physiology
|
0.51 |
true |
true |
0.31 |
IL4
|
abnormal lymphocyte physiology
|
0.51 |
true |
true |
0.31 |
TCL1A
|
abnormal lymphopoiesis
|
0.51 |
false |
true |
0.31 |
CXCR4
|
abnormal spleen marginal zone morphology
|
0.51 |
false |
true |
0.31 |
ICAM1
|
decreased inflammatory response
|
0.51 |
true |
true |
0.31 |
CXCL9
|
abnormal acute inflammation
|
0.51 |
false |
true |
0.31 |
PLAUR
|
decreased acute inflammation
|
0.51 |
false |
true |
0.31 |
NCF4
|
abnormal t cell number
|
0.51 |
false |
true |
0.31 |
FCER2
|
abnormal igg level
|
0.51 |
true |
true |
0.31 |
ICAM1
|
abnormal innate immunity
|
0.51 |
true |
true |
0.31 |
MCM3
|
increased organ/body region tumor incidence
|
0.51 |
false |
true |
0.31 |
CD69
|
abnormal immune serum protein physiology
|
0.51 |
true |
true |
0.31 |
CD3D
|
thymus hypoplasia
|
0.51 |
false |
true |
0.31 |
IL2
|
abnormal lymphocyte cell number
|
0.51 |
true |
true |
0.31 |
TLR2
|
decreased inflammatory response
|
0.51 |
true |
true |
0.31 |
REL
|
decreased immunoglobulin level
|
0.51 |
true |
true |
0.31 |
CCL2
|
abnormal cytokine level
|
0.51 |
false |
false |
0.31 |
ITGB2
|
increased igg level
|
0.51 |
true |
true |
0.31 |
IL12B
|
abnormal interleukin secretion
|
0.51 |
true |
true |
0.31 |
TNFRSF1B
|
abnormal t cell physiology
|
0.51 |
true |
true |
0.31 |
CD96
|
abnormal cd8-positive, alpha-beta t cell number
|
0.51 |
false |
false |
0.31 |
MDM2
|
increased hemolymphoid system tumor incidence
|
0.51 |
true |
true |
0.31 |
IL2RA
|
abnormal t cell activation
|
0.51 |
true |
true |
0.31 |
CSF1
|
abnormal innate immunity
|
0.51 |
true |
true |
0.31 |
CD7
|
abnormal lymphopoiesis
|
0.51 |
true |
true |
0.31 |
CD37
|
decreased lymphocyte cell number
|
0.51 |
false |
true |
0.31 |
ICAM1
|
altered susceptibility to infection induced morbidity/mortality
|
0.51 |
true |
true |
0.31 |
PTPRC
|
abnormal immature b cell morphology
|
0.51 |
true |
true |
0.31 |
CCR7
|
altered susceptibility to viral infection
|
0.51 |
false |
true |
0.31 |
HOXC4
|
abnormal vertebrae morphology
|
0.51 |
true |
true |
0.31 |
IL10
|
abnormal lymphocyte cell number
|
0.51 |
true |
true |
0.31 |
MAP4K1
|
abnormal b cell morphology
|
0.51 |
false |
true |
0.31 |
JAK3
|
abnormal t cell activation
|
0.51 |
true |
true |
0.31 |
STAT1
|
abnormal immune tolerance
|
0.51 |
false |
true |
0.31 |
HOXB4
|
cervical vertebral transformation
|
0.51 |
true |
true |
0.31 |
CD28
|
abnormal t cell physiology
|
0.51 |
true |
true |
0.31 |
CD5
|
increased t cell number
|
0.51 |
true |
true |
0.31 |
IL2
|
abnormal b cell physiology
|
0.51 |
true |
true |
0.31 |
ESR2
|
abnormal circulating gonadotropin level
|
0.51 |
true |
true |
0.31 |
IL10RA
|
altered susceptibility to autoimmune disorder
|
0.51 |
false |
true |
0.31 |
BTK
|
abnormal t cell activation
|
0.51 |
false |
true |
0.31 |
CCL5
|
abnormal macrophage physiology
|
0.51 |
false |
true |
0.31 |
TLR10
|
abnormal b cell physiology
|
0.51 |
false |
false |
0.31 |
IL15
|
abnormal response to injury
|
0.51 |
false |
true |
0.31 |
CCL5
|
decreased lymphocyte cell number
|
0.51 |
true |
true |
0.31 |
CDKN1A
|
increased incidence of induced tumors
|
0.51 |
true |
true |
0.31 |
CXCR3
|
abnormal cd8-positive, alpha beta t cell morphology
|
0.51 |
false |
true |
0.31 |
SELL
|
decreased mature b cell number
|
0.51 |
false |
true |
0.31 |
HOXB6
|
abnormal lumbar vertebrae morphology
|
0.51 |
false |
true |
0.31 |
CCR2
|
abnormal phagocyte morphology
|
0.51 |
true |
true |
0.31 |
CD69
|
abnormal self tolerance
|
0.51 |
true |
true |
0.31 |
POU2AF1
|
abnormal immature b cell morphology
|
0.51 |
true |
true |
0.31 |
CCR2
|
abnormal response to infection
|
0.51 |
true |
true |
0.31 |
MDM2
|
abnormal thymus size
|
0.51 |
true |
true |
0.31 |
STAT4
|
abnormal t cell physiology
|
0.51 |
true |
true |
0.31 |
IL1R2
|
decreased inflammatory response
|
0.51 |
false |
false |
0.31 |
HOXA6
|
vertebral transformation
|
0.51 |
true |
true |
0.31 |
ATR
|
increased hemolymphoid system tumor incidence
|
0.51 |
false |
true |
0.31 |
CD79B
|
abnormal igg2b level
|
0.51 |
false |
true |
0.31 |
NFKB2
|
decreased lymphocyte cell number
|
0.51 |
true |
true |
0.31 |
ITGAL
|
decreased leukocyte cell number
|
0.51 |
true |
true |
0.31 |
RUNX3
|
abnormal lymphopoiesis
|
0.51 |
true |
true |
0.31 |
PTPRC
|
decreased susceptibility to infection
|
0.51 |
false |
true |
0.31 |
IL10
|
abnormal hypersensitivity reaction
|
0.51 |
true |
true |
0.31 |
CCR1
|
abnormal t cell physiology
|
0.51 |
false |
true |
0.31 |
FASLG
|
abnormal interferon-gamma secretion
|
0.51 |
false |
true |
0.31 |
CDKN1A
|
abnormal bone marrow cell morphology/development
|
0.51 |
true |
true |
0.31 |
CCR2
|
abnormal alpha-beta t cell number
|
0.51 |
true |
true |
0.31 |
ITGB2
|
altered susceptibility to viral infection
|
0.51 |
false |
true |
0.31 |
TLR1
|
altered susceptibility to autoimmune disorder
|
0.51 |
false |
true |
0.31 |
PTPN7
|
decreased cd8-positive, alpha-beta t cell number
|
0.51 |
false |
true |
0.31 |
PTPN7
|
decreased b cell number
|
0.51 |
false |
true |
0.31 |
PTPN7
|
increased immunoglobulin level
|
0.51 |
false |
true |
0.31 |
IL10RA
|
increased susceptibility to infection
|
0.51 |
true |
true |
0.31 |
MAP4K1
|
abnormal lymphocyte physiology
|
0.51 |
true |
true |
0.31 |
IL12B
|
abnormal immunoglobulin level
|
0.51 |
false |
true |
0.31 |
DUSP1
|
increased circulating interleukin-6 level
|
0.51 |
true |
true |
0.31 |
IL2RA
|
abnormal interferon secretion
|
0.51 |
false |
true |
0.31 |
SH2D1A
|
decreased lymphocyte cell number
|
0.51 |
true |
true |
0.31 |
NR1I3
|
abnormal thyroid physiology
|
0.51 |
false |
true |
0.31 |
DUSP2
|
abnormal immune serum protein physiology
|
0.51 |
true |
true |
0.31 |
RARG
|
abnormal cervical atlas morphology
|
0.51 |
true |
true |
0.31 |
CD69
|
abnormal immune tolerance
|
0.51 |
true |
true |
0.31 |
SYK
|
abnormal t cell activation
|
0.51 |
false |
true |
0.31 |
CCL5
|
increased susceptibility to autoimmune disorder
|
0.51 |
false |
true |
0.31 |
CXCR3
|
abnormal lymphocyte physiology
|
0.51 |
false |
true |
0.31 |
RELB
|
increased immunoglobulin level
|
0.51 |
true |
true |
0.31 |
CCR2
|
abnormal professional antigen presenting cell morphology
|
0.51 |
true |
true |
0.31 |
ATR
|
abnormal tumor incidence
|
0.51 |
true |
true |
0.31 |
CSF2
|
abnormal innate immunity
|
0.51 |
true |
true |
0.31 |
VAV1
|
abnormal cd4-positive, alpha beta t cell morphology
|
0.51 |
true |
true |
0.31 |
RELB
|
abnormal lymph node morphology
|
0.51 |
true |
true |
0.31 |
FOS
|
abnormal circulating interleukin-6 level
|
0.51 |
true |
true |
0.31 |
CD72
|
abnormal humoral immune response
|
0.51 |
true |
true |
0.31 |
CD86
|
abnormal immunoglobulin level
|
0.51 |
true |
true |
0.31 |
ATR
|
altered tumor susceptibility
|
0.51 |
true |
true |
0.31 |
CD69
|
autoimmune response
|
0.51 |
true |
true |
0.31 |
GRM2
|
abnormal cns synaptic transmission
|
0.51 |
true |
true |
0.31 |
HOXA4
|
abnormal vertebral column morphology
|
0.51 |
true |
true |
0.31 |
ITGAX
|
abnormal lymphocyte physiology
|
0.51 |
true |
true |
0.31 |
SELL
|
autoimmune response
|
0.51 |
true |
true |
0.31 |
CD40
|
abnormal immunoglobulin level
|
0.51 |
true |
true |
0.31 |
ITGB2
|
abnormal interferon-gamma secretion
|
0.51 |
true |
true |
0.31 |
MCM3
|
abnormal organ/body region tumor incidence
|
0.51 |
false |
true |
0.31 |
NFKB1
|
decreased igm level
|
0.51 |
true |
true |
0.31 |
FASLG
|
abnormal lymphocyte physiology
|
0.51 |
true |
true |
0.31 |
CCL5
|
abnormal professional antigen presenting cell morphology
|
0.51 |
false |
true |
0.31 |
MYC
|
abnormal intestine morphology
|
0.51 |
true |
true |
0.31 |
SELL
|
abnormal self tolerance
|
0.51 |
true |
true |
0.31 |
CD247
|
abnormal t cell morphology
|
0.51 |
true |
true |
0.31 |
CCR5
|
increased hematopoietic cell number
|
0.51 |
true |
true |
0.31 |
IL2RG
|
abnormal immune tolerance
|
0.51 |
false |
true |
0.31 |
CXCL9
|
altered susceptibility to infection induced morbidity/mortality
|
0.51 |
false |
true |
0.31 |
CD40
|
abnormal igg level
|
0.51 |
true |
true |
0.31 |
IKZF1
|
abnormal leukopoiesis
|
0.51 |
true |
true |
0.31 |
IL2RG
|
abnormal interleukin-4 secretion
|
0.51 |
true |
true |
0.31 |
ITGAL
|
decreased b cell number
|
0.51 |
true |
true |
0.31 |
IL13
|
abnormal granulocyte number
|
0.51 |
true |
true |
0.31 |
IRF8
|
abnormal mature b cell morphology
|
0.51 |
true |
true |
0.31 |
ICAM1
|
abnormal hypersensitivity reaction
|
0.51 |
true |
true |
0.31 |
PTPN7
|
abnormal self tolerance
|
0.51 |
false |
true |
0.31 |
PTPN7
|
autoimmune response
|
0.51 |
false |
true |
0.31 |
IRF8
|
abnormal immunoglobulin level
|
0.51 |
true |
true |
0.31 |
SLAMF1
|
decreased igg level
|
0.51 |
false |
true |
0.31 |
IL15
|
abnormal b cell differentiation
|
0.51 |
false |
true |
0.31 |
SELL
|
abnormal immune tolerance
|
0.51 |
true |
true |
0.31 |
BUB1
|
abnormal cell nucleus morphology
|
0.51 |
true |
true |
0.31 |
CD53
|
abnormal t cell physiology
|
0.51 |
false |
false |
0.31 |
PTPN7
|
abnormal interferon-gamma secretion
|
0.51 |
false |
true |
0.31 |
HOXC6
|
abnormal vertebrae morphology
|
0.51 |
true |
true |
0.31 |
CD14
|
abnormal granulocyte physiology
|
0.51 |
true |
true |
0.31 |
ZAP70
|
abnormal immunoglobulin level
|
0.51 |
true |
true |
0.31 |
IL1R2
|
abnormal circulating cytokine level
|
0.51 |
false |
false |
0.31 |
IL4
|
abnormal interleukin-4 secretion
|
0.51 |
true |
true |
0.31 |
GRM3
|
abnormal cns synaptic transmission
|
0.51 |
false |
true |
0.31 |
TNFSF10
|
arthritis
|
0.51 |
true |
true |
0.31 |
CCL2
|
abnormal intercellular signaling peptide or protein level
|
0.51 |
false |
false |
0.31 |
BTK
|
decreased immunoglobulin level
|
0.51 |
true |
true |
0.31 |
PLAUR
|
decreased inflammatory response
|
0.51 |
false |
true |
0.31 |
POU2AF1
|
decreased immunoglobulin level
|
0.51 |
true |
true |
0.31 |
IRF8
|
abnormal lymphocyte physiology
|
0.51 |
true |
true |
0.31 |
CCR1
|
abnormal dendritic cell physiology
|
0.51 |
false |
true |
0.31 |
PTPRC
|
increased iga level
|
0.51 |
true |
true |
0.31 |
IFNG
|
abnormal macrophage morphology
|
0.51 |
false |
true |
0.31 |
CD3E
|
abnormal thymus size
|
0.51 |
true |
true |
0.31 |
ESR1
|
abnormal epiphyseal plate morphology
|
0.51 |
true |
true |
0.31 |
BIRC3
|
increased lymphocyte cell number
|
0.51 |
true |
true |
0.31 |
GFI1
|
abnormal t cell activation
|
0.51 |
true |
true |
0.31 |
CD8A
|
abnormal leukopoiesis
|
0.51 |
true |
true |
0.31 |
HOXA5
|
abnormal appendicular skeleton morphology
|
0.51 |
true |
true |
0.31 |
IL1RN
|
abnormal acute inflammation
|
0.51 |
true |
true |
0.31 |
IL2RG
|
autoimmune response
|
0.51 |
false |
true |
0.31 |
PTPN7
|
abnormal immune tolerance
|
0.51 |
false |
true |
0.31 |
CD6
|
abnormal double-negative t cell morphology
|
0.51 |
false |
false |
0.31 |
BCL2A1
|
abnormal igg level
|
0.51 |
false |
true |
0.31 |
CCR1
|
abnormal granulocyte morphology
|
0.51 |
true |
true |
0.31 |
IL2
|
abnormal effector t cell morphology
|
0.51 |
true |
true |
0.31 |
CD86
|
abnormal humoral immune response
|
0.51 |
true |
true |
0.31 |
IL2RG
|
abnormal self tolerance
|
0.51 |
false |
true |
0.31 |
NCF4
|
abnormal effector t cell morphology
|
0.51 |
false |
true |
0.31 |
IRF4
|
abnormal cd4-positive, alpha beta t cell morphology
|
0.51 |
true |
true |
0.31 |
CD40
|
abnormal cytokine secretion
|
0.51 |
false |
true |
0.31 |
NCF4
|
decreased immunoglobulin level
|
0.51 |
false |
true |
0.31 |
GFI1
|
abnormal humoral immune response
|
0.51 |
false |
true |
0.31 |
ZAP70
|
abnormal b cell number
|
0.51 |
true |
true |
0.31 |
RELB
|
abnormal igg1 level
|
0.51 |
false |
true |
0.31 |
CD3D
|
abnormal gamma-delta t cell morphology
|
0.51 |
false |
true |
0.31 |
CCR1
|
decreased susceptibility to bacterial infection
|
0.51 |
true |
true |
0.31 |
BLK
|
abnormal spleen morphology
|
0.51 |
false |
true |
0.31 |
IRF1
|
increased hematopoietic cell number
|
0.51 |
true |
true |
0.31 |
TNFSF8
|
abnormal igg level
|
0.51 |
false |
true |
0.31 |
SLA
|
abnormal t cell physiology
|
0.51 |
false |
true |
0.31 |
IFNG
|
abnormal induced morbidity/mortality
|
0.51 |
true |
true |
0.31 |
CCR7
|
abnormal spleen morphology
|
0.51 |
true |
true |
0.31 |
CD14
|
abnormal interleukin secretion
|
0.51 |
true |
true |
0.31 |
ZAP70
|
abnormal humoral immune response
|
0.51 |
true |
true |
0.31 |
RELB
|
decreased immunoglobulin level
|
0.51 |
false |
true |
0.31 |
CCL5
|
increased igg level
|
0.51 |
false |
true |
0.31 |
IL13
|
decreased igg level
|
0.51 |
true |
true |
0.31 |
CXCR4
|
abnormal tumor necrosis factor secretion
|
0.51 |
false |
true |
0.31 |
IL10RA
|
increased immunoglobulin level
|
0.51 |
true |
true |
0.31 |
PTGS2
|
abnormal cytokine secretion
|
0.51 |
true |
true |
0.31 |
CD53
|
abnormal professional antigen presenting cell physiology
|
0.51 |
false |
false |
0.31 |
BLK
|
increased igg level
|
0.51 |
false |
true |
0.31 |
IL2
|
abnormal professional antigen presenting cell physiology
|
0.51 |
true |
true |
0.31 |
BIRC3
|
abnormal t cell number
|
0.5 |
true |
true |
0.31 |
VAV1
|
abnormal professional antigen presenting cell morphology
|
0.5 |
true |
true |
0.31 |
TRAF1
|
abnormal t cell physiology
|
0.5 |
true |
true |
0.31 |
CD2
|
increased leukocyte cell number
|
0.5 |
false |
true |
0.31 |
ATR
|
tumorigenesis
|
0.5 |
true |
true |
0.31 |
NFKB1
|
increased lymphocyte cell number
|
0.5 |
false |
true |
0.31 |
CCR2
|
altered susceptibility to infection
|
0.5 |
true |
true |
0.31 |
TNFRSF17
|
abnormal igm level
|
0.5 |
false |
true |
0.31 |
CD14
|
abnormal immune serum protein physiology
|
0.5 |
true |
true |
0.31 |
JUNB
|
abnormal innate immunity
|
0.5 |
false |
false |
0.31 |
CD69
|
abnormal b cell morphology
|
0.5 |
true |
true |
0.31 |
CD7
|
abnormal alpha-beta t cell morphology
|
0.5 |
false |
true |
0.31 |
CD37
|
increased mature b cell number
|
0.5 |
false |
true |
0.31 |
CCR2
|
abnormal cd4-positive, alpha beta t cell number
|
0.5 |
true |
true |
0.31 |
CD69
|
abnormal interferon secretion
|
0.5 |
true |
true |
0.31 |
NR3C1
|
abnormal gland physiology
|
0.5 |
true |
true |
0.31 |
IL2RG
|
decreased interleukin-2 secretion
|
0.5 |
true |
true |
0.31 |
CD48
|
abnormal mature b cell morphology
|
0.5 |
false |
true |
0.31 |
ITGAM
|
abnormal immune serum protein physiology
|
0.5 |
false |
true |
0.31 |
IL2RB
|
decreased leukocyte cell number
|
0.5 |
true |
true |
0.31 |
IL2
|
altered susceptibility to autoimmune disorder
|
0.5 |
true |
true |
0.31 |
COL3A1
|
decreased bone mineral density
|
0.5 |
false |
true |
0.31 |
ESR2
|
increased circulating pituitary hormone level
|
0.5 |
true |
true |
0.31 |
LAPTM5
|
abnormal lymphopoiesis
|
0.5 |
true |
true |
0.31 |
FYB
|
decreased t cell proliferation
|
0.5 |
true |
true |
0.31 |
CCR1
|
abnormal cell chemotaxis
|
0.5 |
false |
true |
0.31 |
CORO1A
|
abnormal lymphocyte cell number
|
0.5 |
true |
true |
0.31 |
RELB
|
abnormal response to infection
|
0.5 |
true |
true |
0.31 |
LCK
|
abnormal b cell differentiation
|
0.5 |
false |
true |
0.31 |
CSF2RB
|
abnormal t cell number
|
0.5 |
false |
true |
0.31 |
BIRC3
|
abnormal mature b cell morphology
|
0.5 |
true |
true |
0.31 |
LCK
|
small thymus
|
0.5 |
true |
true |
0.31 |
CCR7
|
abnormal dendritic cell physiology
|
0.5 |
true |
true |
0.31 |
CCR5
|
abnormal cell migration
|
0.5 |
true |
true |
0.31 |
CORO1A
|
decreased lymphocyte cell number
|
0.5 |
true |
true |
0.31 |
BCL2A1
|
decreased interferon-gamma secretion
|
0.5 |
false |
true |
0.31 |
HOXA5
|
thoracic vertebral transformation
|
0.5 |
false |
true |
0.31 |
IL15
|
abnormal intestine physiology
|
0.5 |
false |
true |
0.31 |
ESR2
|
abnormal ovulation
|
0.5 |
true |
true |
0.31 |
IL10RA
|
abnormal professional antigen presenting cell physiology
|
0.5 |
true |
true |
0.31 |
CD247
|
decreased cd4-positive, alpha beta t cell number
|
0.5 |
true |
true |
0.31 |
NR3C1
|
abnormal luteinizing hormone level
|
0.5 |
false |
true |
0.31 |
HOXB4
|
abnormal vertebral column morphology
|
0.5 |
true |
true |
0.31 |
IL7R
|
decreased immunoglobulin level
|
0.5 |
false |
true |
0.31 |
IL13
|
abnormal intestine physiology
|
0.5 |
true |
true |
0.31 |
SOCS3
|
abnormal intercellular signaling peptide or protein level
|
0.5 |
false |
true |
0.31 |
EGR1
|
abnormal cytokine level
|
0.5 |
true |
true |
0.31 |
HOXA4
|
abnormal rib attachment
|
0.5 |
true |
true |
0.31 |
SELL
|
abnormal t cell differentiation
|
0.5 |
true |
true |
0.31 |
CXCR4
|
abnormal interleukin-6 secretion
|
0.5 |
false |
true |
0.31 |
ZAP70
|
decreased thymocyte number
|
0.5 |
false |
true |
0.31 |
THRA
|
abnormal thyroxine level
|
0.5 |
true |
true |
0.31 |
NFKB1
|
increased susceptibility to infection
|
0.5 |
true |
true |
0.31 |
MDM2
|
tumorigenesis
|
0.5 |
true |
true |
0.31 |
IL2RB
|
increased lymphocyte cell number
|
0.5 |
true |
true |
0.31 |
TP53
|
abnormal t cell apoptosis
|
0.5 |
true |
true |
0.31 |
CCR2
|
decreased leukocyte cell number
|
0.5 |
true |
true |
0.31 |
CCR5
|
abnormal lymph node morphology
|
0.5 |
false |
true |
0.31 |
PPP1R16B
|
abnormal b cell physiology
|
0.5 |
false |
true |
0.31 |
CXCR3
|
abnormal interferon-gamma secretion
|
0.5 |
false |
true |
0.31 |
FASLG
|
abnormal cytokine secretion
|
0.5 |
false |
true |
0.31 |
IKZF1
|
abnormal effector t cell morphology
|
0.5 |
false |
true |
0.31 |
MYC
|
increased hematopoietic cell number
|
0.5 |
true |
true |
0.31 |
CD7
|
abnormal alpha-beta t cell number
|
0.5 |
false |
true |
0.31 |
ITGB2
|
abnormal granulocyte physiology
|
0.5 |
true |
true |
0.31 |
VAV1
|
abnormal effector t cell morphology
|
0.5 |
true |
true |
0.31 |
PRKDC
|
increased t cell derived lymphoma incidence
|
0.5 |
true |
true |
0.31 |
PRKDC
|
increased thymus tumor incidence
|
0.5 |
true |
true |
0.31 |
TLR10
|
abnormal humoral immune response
|
0.5 |
false |
false |
0.31 |
IRF7
|
abnormal circulating interleukin level
|
0.5 |
false |
true |
0.31 |
ZAP70
|
abnormal thyroid gland morphology
|
0.5 |
true |
true |
0.31 |
CCL22
|
abnormal immune serum protein physiology
|
0.5 |
false |
true |
0.31 |
IFIH1
|
increased susceptibility to viral infection
|
0.5 |
true |
true |
0.31 |
INPP5D
|
abnormal igg level
|
0.5 |
true |
true |
0.31 |
IL2RB
|
decreased cd8-positive, alpha-beta t cell number
|
0.5 |
true |
true |
0.31 |
NFKB2
|
abnormal b cell differentiation
|
0.5 |
true |
true |
0.31 |
RHOH
|
decreased cd4-positive, alpha beta t cell number
|
0.5 |
true |
true |
0.31 |
LCP2
|
abnormal t cell number
|
0.5 |
true |
true |
0.31 |
IL2RA
|
abnormal t cell proliferation
|
0.5 |
false |
true |
0.31 |
IRF7
|
abnormal interferon secretion
|
0.5 |
true |
true |
0.31 |
STAT1
|
abnormal professional antigen presenting cell physiology
|
0.5 |
true |
true |
0.31 |
BCL2A1
|
abnormal interferon-gamma secretion
|
0.5 |
false |
true |
0.31 |
CORO1A
|
decreased t cell number
|
0.5 |
true |
true |
0.31 |
TNFRSF17
|
abnormal lymphocyte physiology
|
0.5 |
false |
true |
0.31 |
CCR7
|
abnormal interferon-gamma secretion
|
0.5 |
false |
true |
0.31 |
RUNX3
|
increased immunoglobulin level
|
0.5 |
true |
true |
0.31 |
FASLG
|
abnormal interferon secretion
|
0.5 |
false |
true |
0.31 |
CXCR4
|
abnormal interferon-gamma secretion
|
0.5 |
false |
true |
0.31 |
CD83
|
decreased inflammatory response
|
0.5 |
true |
true |
0.31 |
REL
|
abnormal b cell differentiation
|
0.5 |
true |
true |
0.31 |
JUNB
|
abnormal circulating interleukin level
|
0.5 |
false |
false |
0.31 |
IL3
|
altered susceptibility to parasitic infection
|
0.5 |
true |
true |
0.31 |
DNAH9
|
left-sided isomerism
|
0.5 |
false |
false |
0.31 |
NR1I3
|
decreased body temperature
|
0.5 |
false |
true |
0.31 |
CD37
|
increased igm level
|
0.5 |
false |
true |
0.31 |
DOCK2
|
abnormal alpha-beta t cell morphology
|
0.5 |
true |
true |
0.31 |
CCR5
|
altered susceptibility to parasitic infection
|
0.5 |
false |
true |
0.31 |
IL4
|
abnormal granulocyte morphology
|
0.5 |
true |
true |
0.31 |
GZMA
|
abnormal cd4-positive, alpha beta t cell morphology
|
0.5 |
false |
true |
0.31 |
LCP2
|
increased lymphocyte cell number
|
0.5 |
true |
true |
0.31 |
CD40
|
abnormal t cell proliferation
|
0.5 |
false |
true |
0.31 |
CD37
|
abnormal professional antigen presenting cell morphology
|
0.5 |
false |
true |
0.31 |
CD3D
|
absent t cells
|
0.5 |
false |
true |
0.31 |
BTK
|
abnormal t cell proliferation
|
0.5 |
false |
true |
0.31 |
IL10
|
abnormal t cell morphology
|
0.5 |
true |
true |
0.31 |
LCP2
|
abnormal immune tolerance
|
0.5 |
true |
true |
0.31 |
IL10
|
abnormal neutrophil morphology
|
0.5 |
false |
true |
0.31 |
RELB
|
abnormal t cell morphology
|
0.5 |
true |
true |
0.31 |
JAK3
|
abnormal cd4-positive, alpha beta t cell morphology
|
0.5 |
true |
true |
0.31 |
CD19
|
abnormal igg2b level
|
0.5 |
true |
true |
0.31 |
STAT1
|
abnormal immunoglobulin level
|
0.5 |
true |
true |
0.31 |
CD5
|
decreased cd8-positive, alpha-beta t cell number
|
0.5 |
false |
true |
0.31 |
CCR5
|
decreased lymphocyte cell number
|
0.5 |
true |
true |
0.31 |
GRM3
|
abnormal synaptic transmission
|
0.5 |
false |
true |
0.31 |
PLCG2
|
abnormal igm level
|
0.5 |
true |
true |
0.31 |
ITGB7
|
abnormal b cell number
|
0.5 |
true |
true |
0.31 |
CCR1
|
abnormal interleukin-6 secretion
|
0.5 |
false |
true |
0.31 |
SLA
|
abnormal t cell proliferation
|
0.5 |
false |
true |
0.31 |
NFKB2
|
increased granulocyte number
|
0.5 |
true |
true |
0.31 |
PTPRC
|
abnormal igm level
|
0.5 |
false |
true |
0.31 |
CORO1A
|
abnormal t cell physiology
|
0.5 |
true |
true |
0.31 |
NFKB2
|
decreased t cell number
|
0.5 |
true |
true |
0.31 |
IKZF3
|
abnormal lymphopoiesis
|
0.5 |
true |
true |
0.31 |
FASLG
|
abnormal t cell proliferation
|
0.5 |
true |
true |
0.31 |
CDKN1A
|
abnormal cell migration
|
0.5 |
true |
true |
0.31 |
CCR5
|
decreased leukocyte cell number
|
0.5 |
true |
true |
0.31 |
BTK
|
abnormal b cell activation
|
0.5 |
true |
true |
0.31 |
LCK
|
abnormal interferon secretion
|
0.5 |
false |
true |
0.31 |
RUNX3
|
|